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Because of their abundance, C–H bonds are highly attractive starting materials for 
the elaboration of complex molecules. Transition metal catalysis can enable these 
typically inert bonds to undergo functionalization via a metal-catalyzed C–H activation 
step. In particular, ligand-directed PdII/PdIV-catalyzed C–H functionalization reactions 
have emerged as powerful techniques for diverse bond constructions. Nevertheless, these 
methodologies face a number of challenges that limit their applicability. These challenges 
include the common requirement for harsh reaction conditions, the shortage of examples 
of asymmetric functionalization reactions, and the poor transformability of most directing 
groups. This thesis describes the development of new methodologies that aim to address 
these challenges. 
Chapter 2 describes a new photoredox Pd/Ir-catalyzed C–H arylation reaction that 
reroutes the mechanism of Pd-catalyzed C–H arylation with diaryliodonium salts from an 
ionic pathway through a radical-mediated pathway. This radical-mediated transformation 
proceeds at room temperature in a non-acidic solvent, conditions that are considerably 
milder than those required for C–H arylation with diaryliodonium salts via a traditional 
PdII/PdIV mechanism (100 ºC in acetic acid). 
Chapter 3 details the development of a Pd-catalyzed C–H alkylation reaction that 
utilizes convenient potassium alkyltrifluoroborate salts in combination with a 1 e– oxidant 
(MnIII). Several pieces of evidence support an alkyl radical-mediated mechanism for this 
transformation. The alkylation reaction requires only mild temperatures (25–40 ºC), in 
contrast to the significantly higher temperatures (70–110 ºC) needed for previous 
examples of analogous transformations. 
Chapter 4 describes efforts toward understanding the interplay of chiral directing 
groups with Pd in the context of high oxidation state Pd catalysis. In this work, we 
xxv 
developed a chiral ligand-directed Pd-catalyzed asymmetric alkene dioxygenation 
reaction. 
Chapter 5 describes the identification of a transformable directing ligand for Pd-
catalyzed C–H functionalization reactions. In situ generated O-acetyl oxime ethers were 
shown to be effective directing groups that are stable under the reaction conditions 
required for Pd-catalyzed C–H oxygenation, but can then be readily manipulated to 










1.1  C–H Functionalization 
Most synthetic organic transformations involve conversion of one preexisting 
functional group into another. This functional group interconversion strategy is well 
illustrated by transition metal-catalyzed cross-coupling reactions that join two 
prefunctionalized hydrocarbon fragments. For instance, biaryls can be synthesized by a 
palladium-catalyzed Suzuki-Miyaura coupling of an aryl halide and an aryl boronic acid 
(Scheme 1.1). 
 
Scheme 1.1. Example of a Functional Group Interconversion Strategy 
 
 
Although transformations like these are extremely powerful, they have a number 
of drawbacks. First, as illustrated in Scheme 1.1, functional group interconversion 
reactions necessarily generate stoichiometric waste – the unwanted byproducts of 
preexisting functional groups. Second, it is not always feasible (or desirable) to carry the 
necessary functional groups through several steps of a synthesis, or to regioselectively 
install the ‘prefunctionalization’ into an advanced intermediate. As such, functional group 
interconversion strategies are often non-ideal for the derivatization of complex molecules 
at a late stage. 
An efficient strategy that avoids the requirement for at least one prefunctionalized 
starting material is the direct conversion of C–H bonds into the target C–X bonds. This 
X (HO)2B
cat. Pd0
R1 R2 R1 R2
X = Cl, Br, I, OTf
+
base
+ X– + (HO)2B base
2 
strategy is not usually feasible using traditional organic reaction methodology because 
unactivated C–H bonds are inert to both homolytic and heterolytic cleavage under most 
conditions. As illustrated by Figure 1.1A, typical C–H bonds have large bond 
dissociation energies (BDE) that range from ~90–115 kcal mol-1. Similarly, unactivated 
C–H bonds have very high pKa values relative to bonds that can be deprotonated by 
moderate bases (Figure 1.1B). 
 
 
Figure 1.1. Homolytic and Heterolytic Bond Strengths of C–H Bonds1 
 
However, a number of transition metals (e.g., Pt, Pd, Ni, Ir, Rh, Ru) have been 
demonstrated to ‘activate’ C–H bonds by converting them into reactive carbon–metal 
species 1 (Scheme 1.2).2 These intermediate organometallic complexes are typically 
unstable and readily participate in subsequent steps to afford products in which a C–H 
bond has been replaced by a new functional group (2). This unique reactivity of transition 
metals, in combination with the ubiquity of C–H bonds in organic molecules, makes 
transition-metal catalyzed C–H functionalization a powerful alternative to traditional 
functional group interconversion strategies.   
Homolytic Bond Strength (BDE, kcal/mol):







































1.2  Controlling the Site Selectivity of C–H Functionalization 
The great abundance of C–H bonds relative to any other functional group makes 
them attractive starting materials for the elaboration of complex molecules. However, this 
same characteristic also presents a major challenge to developing practical methods for 
C–H bond functionalization. To achieve useful yields of a single product, 
functionalization must occur with high site selectivity for one C–H bond over all the 
others within a substrate.   
One approach to targeting just a single C–H bond is to engineer an intramolecular 
C–H functionalization reaction. For instance, molecule 3 in Scheme 1.3 contains 8 
different C–H bonds, but complete selectivity was observed for activation of H1 in the 
presence of a palladium catalyst, affording carbazole product 5.3 This exquisite 
selectivity can be explained by the structure of PdII intermediate 4, formed by oxidative 
addition of Pd0 into the carbon–iodine bond of 3. In intermediate 4, a single C–H bond 
(H1) is geometrically accessible to the Pd center, thereby facilitating selective activation 
of C–H1 over all of the other C–H bonds. While effective, this intramolecular approach to 
controlling site selectivity is inherently limited to a small subset of target molecules and 
is only useful for forming cyclic products. 
 
Scheme 1.3. Intramolecular C–H Functionalization3 
 
 
























An alternative approach for controlling site selectivity is to employ substrates (6) 
containing coordinating ligands (L) that can reversibly bind to a metal center and direct 
C–H activation at a proximal site (Scheme 1.4). Directed C–H activation results in a 
metallacycle intermediate 7 that undergoes further functionalization with external 
nucleophiles or oxidants. The overall transformation affords products of a net 
intermolecular C–H functionalization (8), and both the metal and the directing ligand 
undergo no net change. As such, this ligand-directed strategy for C–H functionalization 
exploits the kinetic advantages of intramolecular transformations without being limited to 
the formation of cyclic products. This strategy has proven particularly powerful for C–H 
functionalization reactions catalyzed by palladium. 
 




1.3  Pd Catalysis for C–H Functionalization 
Palladium provides several advantages over other transition metals for C–H 
functionalization.4 Many of these advantages relate to (1) the +2 oxidation state of the 
metal species that undergoes C–H activation, (2) the square planar geometry of the PdII 
intermediate that is produced upon C–H activation, and (3) the accessibility of a +4 
oxidation state under oxidizing conditions.  
Palladium activates C–H bonds from its +2 oxidation state by an ‘electrophilic’ 
mechanism that results in no net change in oxidation state (Scheme 1.5). In contrast, 
several other metals activate C–H bonds by an oxidative addition pathway (Scheme 1.6), 
requiring that catalysis is initiated by a low-valent metal species (IrI, RhI, and Ru0).2 
Metals in low oxidation states such as these tend to be unstable to oxygen; therefore, care 
must be taken to exclude ambient air from reactions involving these metal species (i.e., 
glovebox or Schlenk techniques are required). However, PdII species are stable to air 
under most conditions, and most Pd-catalyzed C–H functionalization reactions are 









needed to effect functionalization, unlike most low valent metal species. Finally, although 
low valent metal species – including Pd0 – often undergo facile oxidative addition into 
bonds such as C–halogen, PdII does not usually react with these types of functional 
groups. As such, PdII-catalyzed reactions are often characterized by a broader functional 
group tolerance than transformations catalyzed by other metals. 
 




Scheme 1.6. Oxidative Addition Mechanism for C–H Activation at IrI 
 
 
The product of electrophilic C–H activation at PdII is a square planar PdII species 
(9, Scheme 1.5) that is coordinatively unsaturated, allowing for relatively facile further 
functionalization to occur. Other metal species that also undergo C–H activation through 
an electrophilic mechanism (RhIII, IrIII) often result in coordinatively saturated octahedral 
complexes that do not easily participate in subsequent reactions. Thus, the square planar 
geometry of PdII contributes to its relative versatility compared to other metals for the 
construction of diverse C–X bonds. 
In addition to Pd0 and PdII, higher oxidation states of Pd (+3 and +4) can be 
accessed under oxidizing conditions. Because carbon ligands (especially alkyl and aryl) 
are electron-donating toward metal centers, the PdII–carbon species generated upon C–H 
activation is more susceptible to oxidation than simple PdII salt precursors. As such, C–H 
activation can be followed by oxidative interception of the resultant PdII complex to 
afford a high valent PdIV–carbon intermediate 10 (Scheme 1.7). Such species are 
typically unstable, and reductive elimination from high valent Pd is relatively facile and 
















elimination at PdII (e.g., C–O, C–N, C–Cl). Furthermore, high valent Pd catalysis can be 
used to install C–Br and C–I bonds that are typically unfeasible by reductive elimination 
at PdII because the resultant Pd0 species readily reinserts into C–X. Together, all of these 
attributes make high valent Pd catalysis particularly appealing for C–H functionalization 
reactions. 
 




1.4  Challenges 
Over the past decade, an enormous number of transformations have been reported 
that combine the advantages of a ligand-directed approach (site selectivity) with those of 
high valent Pd catalysis (convenient reaction protocols, access to diverse bond 
constructions). Figure 1.2 presents a sampling of the types of products that can be formed 
by ligand-directed Pd-catalyzed oxidative C–H functionalization, demonstrated by our 
group5 and others.4f 
 
 
Figure 1.2. Examples of Bond Constructions Achieved by Ligand-Directed High-Valent 
Pd-Catalyzed C–H Functionalization 
oxidant–X













































While great strides have been made over the past decade, these transformations 
still face a number of key challenges including the following: First, they are frequently 
sluggish and require relatively high temperatures, often in conjunction with strong acids 
or bases, to proceed efficiently (Challenge 1). Second, asymmetric examples of Pd-
catalyzed oxidative C–H functionalization reactions remain relatively rare (Challenge 2). 
Third, removal or transformation of the directing ligand is often desirable to access a 
final target molecule; however, most directing groups commonly used for C–H 
functionalizations are difficult to transform (Challenge 3). The work described in this 
thesis aims to address each of these three challenges. 
Challenge 1. The majority of examples of Pd-catalyzed C–H activation/C–C bond 
forming reactions proceed through either a PdII/PdIV or a PdII/Pd0 mechanistic pathway. 
C–H arylation has been demonstrated using PdII/PdIV catalysis in conjunction with 2 e– 
oxidants such as diaryliodonium salts (Scheme 1.8A).6 Alternatively, several examples of 
C–H arylation and C–H alkylation utilize carbon–[M] reagents (e.g., alkyl–B(OH)2) and 
proceed through a PdII/Pd0 catalytic cycle involving transmetallation. These 
transformations usually require high reaction temperatures (~100 ºC) and/or strongly 
acidic or basic conditions to proceed efficiently. Consequently, these methodologies have 
limited applicability for the derivatization of complex molecules containing sensitive 
functional groups. Mechanistic studies on Pd-catalyzed C–H arylation with 
diaryliodonium oxidants have shown that the rate-limiting step of this transformation is 
oxidation of PdII to PdIV.6b As such, it is likely that a more facile oxidation step would 
enable C–H arylation and alkylation reactions to take place under milder conditions. Our 
group has been interested in developing strategies to accelerate the rate of oxidation, with 
the goal of developing novel transformations that can proceed under less forcing reaction 
conditions. Recently, we initiated investigations into the use of carbon-centered radicals 
as 1 e– oxidants for Pd.7a The high kinetic reactivity of radicals makes this oxidation step 
fast relative to a 2 e– oxidation step using traditional reagents. 
To this end, Chapter 2 describes a new photoredox Pd/Ir-catalyzed C–H arylation 
reaction that reroutes the mechanism of Pd-catalyzed C–H arylation with diaryliodonium 
salts from an ionic pathway through a radical-mediated pathway (Scheme 1.8B).8 
Importantly, this transformation uses reagents that are identical to those used in 
8 
previously reported thermal C–H arylation reactions – namely, diaryliodonium salts. 
Unlike previous examples, however, this transformation proceeds efficiently at room 
temperature. 
 
Scheme 1.8. Rerouting C–H Arylation with Ph2I+ Through a Radical-Mediated Pathway 
 
 
 Chapter 3 describes the development of a Pd-catalyzed C–H alkylation reaction 
that utilizes convenient potassium alkyltrifluoroborate salts in combination with a 1 e– 
oxidant (Scheme 1.9). This transformation is effective for the installation of methyl and 
1º alkyl groups into aryl substrates containing pyridine and amide directing ligands. 
Though relatively rare, previous examples of Pd-catalyzed C–H alkylation with boronic 
acid derivatives proceed through a PdII/Pd0 catalytic cycle involving transmetallation 
from boron to palladium. In contrast, several pieces of evidence support an alkyl radical-
mediated reaction mechanism for the alkylation reaction described in Chapter 3. Notably, 
this transformation proceeds at mild temperatures (25–40 ºC), unlike the significantly 
higher temperatures (70–110 ºC) required for all previous examples of analogous 


















     [previous work]
(B) radical/
     photocatalytic
       [Chapter 2]
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Challenge 2. A large number of examples of Pd-catalyzed transformations exist 
that employ chiral ancillary ligands to construct bonds asymmetrically using Pd0/PdII 
catalysis. However, examples of asymmetric transformations that proceed through high 
valent Pd are extremely rare. Most of the ancillary ligands that are well-studied for 
Pd0/PdII catalysis are not stable to oxidative conditions (e.g., phosphines), an attribute that 
may contribute to the dearth of examples of asymmetric transformations at high 
oxidation-state Pd. One promising approach to asymmetric oxidative C–H 
functionalization reactions is to use substrates containing chiral directing ligands. 
Chapter 4 describes efforts toward understanding the interplay of chiral directing groups 
with Pd in the context of high oxidation state Pd catalysis. For this work, we focused on a 
different type of oxidative transformation – a Pd-catalyzed alkene difunctionalization 
(Scheme 1.10). This asymmetric reaction is directed by a chiral oxime ether auxiliary, 
and the best auxiliary identified provides dioxygenated products with diastereomeric 
ratios up to 90:10.9 
 




Challenge 3. The synthetic utility of most Pd-catalyzed ligand-directed 
transformations (like those presented in Chapters 2–4) would be significantly enhanced if 



















interested in identifying general and efficient directing ligands that can be removed or 
otherwise transformed after they are no longer needed to direct functionalization (Scheme 
1.11). To this end, we have demonstrated the use of in situ generated O-acetyl oxime 
ethers as effective directing groups in Pd-catalyzed C–H oxygenation reactions.10 These 
directing groups are stable under the reaction conditions, but can then be readily 
manipulated to afford ketones, alcohols, amines, and heterocycles. 
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Room-Temperature Photoredox Pd/Ir-Catalyzed C–H 
Arylation with Ph2I+ 
 
2.1  Background and Significance 
Substituted biphenyl scaffolds are prevalent in bioactive natural and synthetic 
products (Figure 2.1), including ~4.3% of known therapeutic drugs.1a Inclusion of this 
‘privileged’ substructure in small molecules has been shown to impart binding affinity for 
a wide range of protein targets; furthermore, variation of the substituents on the scaffold 
can afford compounds with high levels of binding specificity.1 Biaryl motifs are also 
common in numerous synthetic polymers, semiconductors, and other valuable materials. 
As such, vast amounts of research over the last century have been dedicated to 
developing methods to construct aryl–aryl bonds.2  
 
 


































Without question, the most successful Ar–Ar bond-forming methodologies to date 
involve cross-coupling between an aryl organometallic reagent and an aryl halide 
(Scheme 2.1). Despite their well-deserved recognition with the 2010 Nobel Prize, such 
methodologies possess the disadvantage of requiring two prefunctionalized starting 
materials. Such precursors can be difficult or costly to access, particularly at a late stage 
of a lengthy synthesis, and they necessarily result in the formation of stoichiometric 
waste. 
 
Scheme 2.1. Pd- and Ni-Catalyzed Aryl–Aryl Cross-Coupling Reactions 
 
 
An attractive alternative to classic cross-coupling reactions would involve the 
direct arylation of a C–H bond, a transformation that would preclude the need for at least 
one prefunctionalized starting material (Scheme 2.2). A protocol for C–H arylation that is 
highly site-selective, utilizes mild reaction conditions, displays high functional group 
tolerance, and can successfully install diverse aryl groups could be extremely valuable for 
small molecule synthesis, particularly for late stage derivatization of complex molecules.  
 
Scheme 2.2. Biaryl Formation by C–H Arylation  
 
 
As an example, Scheme 2.3 presents a literature synthesis for a class of NK1 
receptor antagonists.5 Structure-activity relationship studies were conducted by preparing 
a small library of derivatives of 5 (including 3 in Figure 2.1) via a synthetic route that 
utilizes a Cu-catalyzed cross-coupling reaction. Because the aryl–Br moiety in coupling 
partner 4 may be difficult to install at a later stage or to carry through over multiple steps, 
the aryl–aryl coupling reaction is conducted first. Consequently, the assorted final 
[M] X
cat. Pd(0) or Ni(0)
R1 R2 R1 R2
+
[M] = B(OR)2Suzuki
X = Cl, Br, I, OTf
      = SnR3Stille
      = ZnXNegishi
      = MgBrKumada
      = SiR3Hiyama
H Y
[catalyst]
R1 R2 R1 R2
+
Y = B, Sn, Zn, Mg, Si, 
      Cl, Br, I, OTf, etc.
15 
products 5 do not share a common late-stage intermediate and their preparation is 
laborious. Instead, the synthesis of a library of compounds with diverse aryl–R1 groups 
could be streamlined by the route presented in Scheme 2.4.  
 




Scheme 2.4. Biaryl Formation at a Late Stage in the Synthesis of 5 via C–H Arylation 
 
 
The past quarter of a century has seen an escalation of research efforts directed 
toward transition metal-mediated C–H arylation.6 Palladium salts in particular have 
proven to be versatile catalysts for such transformations, and a large number of Pd-
catalyzed C–H arylation reactions have been reported representing an eclectic assortment 
of aryl–H substrates and aryl coupling partners.6,7 The mechanisms of these 
transformations are typically described by one of the manifolds depicted in Scheme 2.5 
involving a Pd0/II, PdII/0, or PdII/IV catalytic cycle (for clarity, additional ligands on the 













































Scheme 2.5. Common Mechanistic Manifolds for Pd-Catalyzed C–H Arylation Reactions 
 
 
A key challenge associated with developing any practical C–H functionalization 
reaction is the issue of site selectivity (see Chapter 1), and C–H arylation methodology 
has been no exception.  One approach to achieving selectivity is to couple two arenes that 
are within the same molecule. Seminal work by Ames and coworkers in the early 1980s 
demonstrated Pd-catalyzed intramolecular coupling of aryl–H with an aryl halide to 
afford dibenzofurans (Scheme 2.6), carbazoles, and fluorenones.8 Many similar examples 
have since been reported; however, this intramolecular approach to controlling site 
selectivity is inherently limited to a small subset of target molecules and is only useful for 
forming cyclic products. 
 
Scheme 2.6. Intramolecular C–H Arylation to Form Dibenzofurans8 
 
 
A more broadly applicable approach to controlling the site selectivity of C–H 
arylation is to use a directing group. Miura and coworkers demonstrated one of the first 
examples of Pd-catalyzed intermolecular direct arylation using a phenol as a directing 
PdII Ar1
Ar2–[M] PdII Ar1
Ar2 Pd0C–H activation transmetallation reductiveelimination
PdII Ar1
Ar2–[X] PdIV Ar1






























10 mol % Pd(OAc)2
1.2 equiv Na2CO3
DMA




group.9 Arylation occurs selectively at the 2ʹ′-position of 2-phenylphenols (Scheme 2.7) 
or the 8-position of 1-naphthol (Scheme 2.8).  
 




Scheme 2.8. Directed C–H Arylation of 1-Naphthol9 
 
 
In 2005, our group reported a ligand-directed C–H arylation reaction that utilizes 
diaryliodonium reagents as the aryl source (Scheme 2.9).10–12 This transformation is 
effective for a variety of directing groups (e.g., pyridines, pyrrolidinones, oxizolidinones,  
and quinolines) and substituted arenes. However, like the majority of Pd-catalyzed 
methodologies for arylation of unactivated C–H bonds, arylation with Ar2I+ oxidants has 
the drawback of requiring high reaction temperatures (>80 ºC). For example, as depicted 
in Scheme 2.9, the phenylation of 7 is extremely sluggish at room temperature. 
 





5 mol % Pd(OAc)2
1.2 equiv Cs2CO3
4 Å mol. sieves
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Similarly, most examples of Pd-catalyzed ligand-directed C–H arylation with aryl 
iodides13 (Scheme 2.10), aryl chlorides13c (Scheme 2.11), aryl boronic acids14,15 (Scheme 
2.12), and trialkoxyarylsilanes13d (Scheme 2.13) all require elevated temperatures to 
proceed in high yield.  
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Scheme 2.13. Directed C–H Arylation with Trialkoxyarylsilanes13d 
 
 
In one unusual example, room temperature C–H arylation of phenol esters with 
diaryliodonium salts was reported (Scheme 2.14).16 However, this reaction requires 
TfOH as an additive and has not been demonstrated with any other directing groups. It is 
likely that these acid-catalyzed reaction conditions would be incompatible with more 
common nitrogen-containing directing groups that feature a basic site (e.g., pyridines). 
 




Some insight into the thermal requirements for C–H arylation with Ar2I+ has been 
provided by recent mechanistic work from our group.17 Kinetic studies of the arylation of 
7 with diaryliodonium reagents revealed that the rate-limiting step of the transformation 



































10 mol % Pd(OAc)2
10 mol % TfOH
0.5 equiv Ac2O
DCE




Scheme 2.15. Thermal C–H Arylation with Ar2I+ is Limited by the Oxidation Step17 
 
 
In light of these studies, we reasoned that the rate of C–H arylation could be 
accelerated by the use of kinetically more reactive oxidants for PdII. Recently, the 
combination of transition metal catalysis with radical chemistry has emerged as a 
powerful strategy for achieving fast, high-yielding transformations under mild 
conditions.18 A striking example of this strategy’s potential in Pd catalysis was reported 
in 2009 by Knochel and coworkers.19 In this example, an alkyl radical-mediated Kumada 
coupling displayed remarkable rate acceleration and functional group tolerance at room 
temperature (Scheme 2.16). This reaction utilizes textbook Kumada coupling reagents (an 
aryl Grignard, an aryl bromide, and a Pd catalyst), but is believed to proceed through a 
mechanistic manifold that is fundamentally different from ‘traditional’ Pd0/PdII catalysis. 
Intermediate alkyl radicals, putatively generated by the reaction of an added alkyl iodide 
with Pd0, are proposed to initiate a PdI/PdIII catalytic cycle that allows for more rapid 
product formation (i.e., 92% vs 8% yield of the biaryl product after 15 min at 0 ºC). 
Consequently, this transformation could be extended to the cross-coupling of diverse 



































Scheme 2.16. Radical-Accelerated Kumada Cross-Coupling19 
 
 
Although the thermal Pd-catalyzed arylation with Ar2I+ is believed to proceed via 
an ionic mechanism involving 2e- oxidation of Pd by Ar2I+ (Scheme 2.5 C), we reasoned 
that the rate of this reaction could potentially be enhanced by rerouting it through a 
radical pathway in which Ar2I+ is converted into Ar• in situ. Because Ar• would be a 
more kinetically reactive oxidant than Ar2I+, the slow oxidation step should be 
accelerated relative to the thermal/ionic reaction. Intriguingly, sporadic reports from the 
polymer literature have shown that diaryliodonium salts can serve as precursors to Ar• in 
the presence of visible light and a photoredox catalyst (Scheme 2.17).20 Thus we 
envisioned that the combination of Pd- and photoredox catalysis could provide a means 
for achieving room temperature C–H arylation with diaryliodonium salts. 
 





THF, 0 ºC, 15 min
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Precedent for Ar•-mediated Pd-catalyzed C–H arylation was provided by 
literature reports that used aryl acylperoxides or aryldiazonium salts as Ar• precursors. In 
the former case, a high reaction temperature (100 ºC) is needed to generate Ar• from the 
aryl acylperoxide precursor (Scheme 2.18).21 The latter case, a transformation published 
by our group, demonstrated the feasibility of room-temperature Pd-catalyzed C–H 
arylation with Ar• generated from ArN2+ using photoredox catalysis (Scheme 2.19).22 
 








Encouraged by this precedent, we began our studies with the goal of rerouting the 
mechanism of Pd-catalyzed C–H arylation with Ar2I+ from an ionic pathway (Scheme 
2.20, path a) to an alternative radical-mediated pathway (path b) that would enable the 
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2.2  Reaction Optimization 
We initiated our investigations of Pd-catalyzed C–H phenylation of substrate 9 
with [Ph2I]BF4 in combination with either Ru(bpy)3Cl2 or Ir(ppy)3, the photocatalysts 
precedented20 for use with diarlyiodonium salts (Scheme 2.17). Substrate 9 was selected 
for study because (1) its arylation with Ar2I+ reagents under thermal conditions has been 
previously demonstrated,10,22 (2) unlike aryl pyridines, it has not been shown to be 
undergo competing oxidative homodimerization,23 and (3) it is a convenient 
commercially available crystalline solid. Visible light irradiation was provided by a 26 W 
household fluorescent light bulb, and the reactions were set up on the bench top with no 
precautions to exclude moisture or air. Remarkably, the use of Ru(bpy)3Cl2 resulted in a 
modest yield (18%) of the desired arylated product 10 after 15 h in MeOH at room 
temperature (Table 2.1, entry 1). Evaluation of a number of different PdII salts showed 
that Pd(NO3)2 provided better results, affording 10 in 23% yield. Although Ru(bpy)3Cl2 
and Ir(ppy)3 afforded comparable results, the cationic photocatalyst Ir(ppy)2(dtbbpy)PF6 
(dtbbpy = 4,4ʹ′-di-tert-butyl-2,2ʹ′-bipyridine)24 provided a significant improvement (57% 
yield). Replacing [Ph2I]BF4 with the corresponding triflate salt led to a further 
enhancement in yield (66%). Finally, briefly sparging the mixture with N2 prior to the 
start of the reaction resulted in 94% yield of 10. Notably, [Ph2I]BF4 performed 












     [previous work]
(b) radical/
     photocatalytic
       [this work]
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Table 2.1. Optimization of the Room-Temperature C–H Phenylation of 9 with Ph2I+ a 
 
 
Importantly, both of the metal catalysts, as well as visible light, are critical for 
efficient room temperature C–H phenylation. Without any one of these three components, 



















MeOH, 15 h, rt
10 mol % PdII
5 mol % photocatalyst
2 equiv [Ph2I]X













5 Pd(NO3)2 Ir(ppy)2(dtbbpy)PF6 66%OTf–
(9) (10)
3 Pd(NO3)2 Ir(ppy)3 17%BF4–
H
aGeneral conditions: 9 (1 equiv), Pd II (0.10 equiv), photocatalyst 
(0.05 equiv), [Ph2I]X (2 equiv), MeOH (0.2 M in 9), 26 W lightbulb, 
15 h, rt. bYields determined by GC. cReaction was degassed by 
sparging with N2 for 1 min.
7c Pd(NO3)2 Ir(ppy)2(dtbbpy)PF6 94%BF4–
25 
Table 2.2. Control Reactions for the Pd/Ir-Catalyzed C–H Phenylation of 9 with Ph2I+ a 
 
 
The yield enhancement observed upon sparging with N2 (Table 2.1, entries 5 vs 6) 
suggests that O2 is detrimental to the desired transformation. This effect could be 
attributed to (i) radical termination by a reaction between Ar• and O2 or (ii) quenching of 
photoexcited Ir3+* by O2. Although we cannot conclusively rule out the first explanation, 
the expected byproduct of a reaction between Ar• and O2, phenol, has not been observed 
by gas chromatography. Instead, rationale (ii) appears to be more likely based on 
literature precedent25 and a subsequent observation that O2 is not detrimental to a related 
C–H arylation reaction that uses Ar• generated through a non-photoredox pathway 
(Chapter 3, section 3.10). 
In contrast to the effect of oxygen, the presence of trace water does not appear to 
influence the course of the reaction. As illustrated in Figure 2.2, reactions set up with wet 
MeOH can be degassed by brief sparging with N2 to afford results that are equally 
satisfactory to those obtained by setting up the reactions in a glovebox using rigorously 





none 5 mol % 2%
10 mol % none 2%
















entry Pd Ir yieldblight source
aGeneral conditions: 9 (1 equiv), [Ph2I]OTf (2 equiv), MeOH (0.2 
M in 9),15 h, rt, degassed by sparging with N2 for 1 min. bYields 
determined by GC. cReaction vial was covered with aluminum foil.
26 
 
Figure 2.2. Comparison of Dry/Degassed, Wet/Degassed, and Wet/Non-Degassed 
MeOH for the Pd/Ir-Catalyzed C–H Arylation of 9 
 
The benchtop sparging method is arguably more convenient than the use of a 
glovebox. Furthermore, for liquid substrates such as arylpyridine 7, we found the 
sparging method to provide better results with improved reproducibility (average yield = 
61 ± 2% over 5 runs) than the glovebox method (average yield = 53 ± 10% over 7 runs) 
(Figure 2.3). This observation can likely be explained by the presence of small amounts 
of O2 dissolved in the liquid substrate brought into the glovebox. In contrast, sparging of 
the entire reaction mixture displaces even this small quantity of O2 from the solution.  
This discrepancy between sparging and glovebox conditions could presumably be 
eliminated by more careful degassing of liquid substrates prior to their use in the 
glovebox. Clearly, however, the simple sparging protocol is sufficient and is likely to be 


































MeOH, 12 h, rt
10 mol % Pd(NO3)2






Figure 2.3. Comparison of Dry/Degassed and Wet/Degassed MeOH for the Pd/Ir-
Catalyzed C–H Arylation of 7 
 
As described above, exclusion of O2 was found to improve the yield of the 
arylation reaction of both 9 and 7. Nevertheless, for arylpyridine 7, only about 80% of the 
total mass balance could be accounted for by summing the product and remaining starting 
material (Figure 2.3, entries 8–12, white bars). Analysis by GCMS and comparison to 
authentic materials suggests that the remainder of the mass balance can be attributed to 
several undesired side products. Figure 2.4 shows an annotated copy of a typical gas 
chromatogram for the Pd/Ir-catalyzed arylation reaction of 7 with [Ph2I]BF4. As 
indicated, side products resulting from arylation of the pyridine ring (A),26 diarylation 









10 mol % Pd(NO3)2
5 mol % Ir(ppy)2(dtbbpy)PF6
2 equiv [Ph2I]BF4
26 W lightbulb





by sparging with N2
Mass balance 


















Figure 2.4. Typical Gas Chromatogram of the Pd/Ir-Catalyzed Arylation of 7  
 
As shown in Table 2.1, the use of [Ph2I]OTf or [Ph2I]BF4 provided similar yields 
of pyrrolidinone product 10 under N2-sparging conditions. However, for other substrates 
such as arylpyridine 7, [Ph2I]OTf proved superior to [Ph2I]BF4 (Figure 2.5, 76% vs 56% 
GC yield for OTf– and BF4–, respectively). A more comprehensive screen of 
diphenyliodonium salts with substrate 7 confirmed that the yield of the transformation 
can be influenced by the oxidant counterion, although none of the other counterions 
screened were found to be superior to OTf– (Figure 2.5). Consequently, [Ph2I]OTf was 
























Figure 2.5. Oxidant Counterion Screen for the Pd/Ir-Catalyzed C–H Arylation of 7 
 
 
2.3  Substrate Scope 
With optimized reaction conditions in hand (Table 2.1), we next investigated the 
substrate scope of the reaction. Gratifyingly, a variety of aromatic substrates underwent 
room temperature C–H phenylation under the Pd/Ir-catalyzed conditions (Table 2.3). In 
addition to pyrrolidinones 9 and 11, other N-aryl amides were effective directing groups 
(entries 3 and 4). C-Aryl amides, such as benzamides 17 and 19, also underwent room 
temperature C–H phenylation, albeit in moderate yields (40% and 54%). The N,N-
disubstituted analog 21 provided phenylated product 22 in poor yield (9%), suggesting 
that C–H arylation is facilitated by the presence at least one N–H bond in this substrate 
class. 2-Arylpyridines 23 and 25 as well as ketoxime and aldoxime ethers 27 and 29 were 
also good substrates. The ability to use oxime ethers as directing groups is particularly 
notable, as these do not undergo C–H arylation with diaryliodonium reagents under the 


























10 mol % Pd(NO3)2
5 mol % Ir(ppy)2(dtbbpy)PF6
2 equiv [Ph2I]X
26 W lightbulb


















































































C H L C Ph
10 mol % Pd(NO3)2
5 mol % Ir(ppy)2(dtbbpy)PF6
2 equiv [Ph2I]OTf
26 W lightbulb

















aGeneral conditions: substrate (1 equiv), [Ph2I]OTf  (2 equiv),  Pd(NO3)2 (0.10 equiv), Ir(ppy)2(dtbbpy)PF6 (0.05 
equiv), MeOH, 26 W lightbulb, 15 h, rt, degassed by sparging with N2. b[Ph2I]BF4 was used as the oxidant. cwith 


















(9) (10) (21) (22)
(11) (12) (23) (24)
(13) (14) (25) (26)
(15) (16) (27) (28)
(17) (18) (29) (30)
(19) (20)
31 





2.4  Scope of Diaryliodonium Oxidants 
Diaryliodonium salts containing diverse aryl substituents were evaluated in this 
photocatalytic C–H arylation. As shown in Table 2.4, the highest yields were obtained 
with those bearing relatively electron neutral substituents (e.g., p-Cl, p-Br, p-CH3, o-CH3, 
entries 4–7). Nonetheless, oxidants possessing more strongly electron-donating and 
electron-withdrawing substituents were also effective. For example, C–H arylation with 
p-methoxyphenyl (entry 9) as well as p-, m-, and o-trifluoromethylphenyl (entries 1–3) 
reagents proceeded in moderate to good yields. Remarkably, even the highly sterically 
hindered mesityl group could be transferred, albeit in low yield (11%, entry 8). Notably, 
the analogous thermal reaction of [Mes2I]OTf with 9 did not provide detectable quantities 





















(toluene with 1.5 
equiv NaHCO3)
100 ºC, 15 h
(27) (28)
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2.5  Inhibition by Radical Scavengers and Chemoselectivity Studies 
We propose that the Ir/Pd-catalyzed photocatalytic C–H arylation proceeds via a 
fundamentally different mechanism than the analogous thermal reaction, despite the fact 
that the reactants and products are the same in both processes. A first piece of evidence to 
support this proposal is the reaction outcome in the presence of free radical scavengers 
(2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO) and galvinoxyl (Figure 2.6). As shown 
in Table 2.5, the thermal C–H arylation reaction is not inhibited by the addition of 25 mol 
% galvinoxyl or 100 mol % of TEMPO. With both radical scavengers, the reactions 
proceed to complete conversion and afford comparable yields (entries 1–3). In contrast, 







MeOH, 15 h, rt
10 mol % Pd(NO3)2
































aGeneral conditions: 9 (1 equiv),  [Ar2I]BF4 (2 equiv), Pd(NO3)2 (0.10 equiv), Ir(ppy)2(dtbbpy)PF6 (0.05 equiv), 
















dependent manner by galvinoxyl and TEMPO (entries 4–8). These results are consistent 
with the intermediacy of radicals in the latter but not the former reaction. 
 
 
Figure 2.6. Structures of Radical Scavengers TEMPO and Galvinoxyl 
 
 
Table 2.5. Effect of Radical Scavengers on the Pd/Ir-Catalyzed C–H Arylation of 23  
 
 
The chemoselectivity for arene transfer from unsymmetrical diaryliodonium salts 
of the type [Ar1–I–Ar2]+ was next explored. These reagents are known to display different 
chemoselectivity trends in different classes of reactions.27 For example, in metal-free 





10 mol % PdII
[Ph2I]BF4
radical scavenger
Conditions A:   Thermala































2 galvinoxyl 25% A
3 TEMPO 100% A





aThermal conditions A: 23 (1 equiv), [Ph2I]BF4 (1.1 equiv), Pd(OAc)2 
(0.10 equiv), AcOH (0.12 M in 23), 15 h, 100 º C. bPhotocatalytic 
conditions B: 23 (1 equiv), [Ph 2I]BF4 (2 equiv), Pd(NO 3)2 (0.10 
equiv), Ir(ppy)2(dtbbpy)PF6 (0.05 equiv), MeOH (0.2 M in 23), 26 W 
lightbulb, 15 h, rt, degassed by sparging with N2. cGC calibrated yield 
reported as % yield ± standard deviation.
H
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sterically hindered28c,29 aryl group is commonly observed. On the other hand, transfer of 
sterically bulky aryl groups tends to be disfavored in metal-catalyzed arylations, and 
there is variation among electronic trends between different metal-catalyzed 
transformations.27a 
 A number of mixed [Ph–I–Ar]BF4 reagents were prepared and the ratios of 
products resulting from phenyl versus aryl transfer were compared under the 
photocatalytic and thermal reaction conditions (Table 2.6). Under both sets of conditions, 
a modest preference was observed for transfer of the more electrophilic aryl group. Thus, 
p- and m-trifluoromethylphenyl are favored for transfer over phenyl under both sets of 
conditions (entries 1–4), while p-OMe is disfavored (entries 15 and 16). Additionally, a 
bulky ortho-disubstituted arene (mesityl) is disfavored for transfer under both the thermal 





















Table 2.6. Comparison of Chemoselectivity for Pd-Catalyzed C–H Arylation with Mixed 
Diaryliodonium Oxidants for Thermal and Photocatalytic Reaction Conditions 
 
 
Despite these similarities, differences in chemoselectivity for the two sets of 
reaction conditions arise in the case of aryl groups containing a single ortho substituent. 
Under thermal conditions, a less hindered Ph group is transferred preferentially over 
ortho-mono-substituted arenes, even when the latter aryl group is more electrophilic (e.g., 
Table 2.6, entry 5). In contrast, under photocatalytic reaction conditions, aryl groups with 
a single ortho-substituent are transferred more readily than phenyl (entries 6 and 12), 
aThermal conditions A: 9 (1 equiv), [ArR–I–Ph]BF4 (2 equiv), Pd(NO3)2 (0.10 equiv), 
NaHCO3 (1.5 equiv), toluene, 12 h, 100 º C. bPhotocatalytic conditions B: 9 (1 
equiv), [ArR–I–Ph]BF4 (2 equiv), Pd(NO3)2 (0.10 equiv), Ir(ppy)2(dtbbpy)PF6 (0.05 




1 equiv 9 N
O
+
Conditions A:   Thermala
Conditions B:   Photocatalyticb
entry R conditions
(10) (ArR product)





70% 1 : 1.52
40% 1 : 2.5
3 m-CF3
46% 1 : 1.54
49% 1 : 1.7
5 o-CF3
46% 1 : 3.66
18% 1 : 0.2
7 p-Cl
63% 1 : 1.18








78% 1 : 0.610
28% 1 : 1.2
11 o-CH3
81% 1 : 1.112
12% 1 : 0.9
13 Mes
65% 1 : 0.114
7% 1 : 0.0
15 p-OMe
61% 1 : 0.316






















even when transfer of the analogous para-substituted aryl group is disfavored relative to 
phenyl (e.g., entry 12 compared to entry 10). This trend is particularly pronounced with 
o-CF3 (entry 6). Whereas phenyl is transferred selectively under the thermal reaction 
conditions (10 : 33 = 1 : 0.2), selective transfer of the o-CF3C6H4 group occurs under the 
photocatalytic conditions to afford a 1 : 3.6 ratio of 10 : 33. Interestingly, the 
chemoselectivities observed for both the thermal and photocatalytic conditions are 
attenuated in an intermolecular competition experiment using two symmetrical 
diaryliodonium oxidants in one pot (Scheme 2.22). 
 
Scheme 2.22. Attenuation of Chemoselectivity Differences Between Thermal and 
Photocatalytic Reaction Conditions for Intermolecular Competition 
 
 
Thus, while chemoselectivities are generally modest under both sets of conditions, 
the selectivities under photocatalytic conditions do not always mirror those under the 
thermal reaction conditions, particularly when ortho substituents are present. These 
differences in chemoselectivity provide further support for divergent mechanistic 
pathways between the thermal and the photocatalytic reaction conditions.  
 
2.6  Proposed Reaction Mechanism 
For the described photocatalytic arylation, we preliminarily propose a reaction 
pathway that merges PdII/IV and IrIII/IV catalytic cycles. As shown in Scheme 2.23, ground 
state Ir3+ undergoes photoexcitation by visible light (step i), and the resultant Ir3+* 
complex can reduce Ar2I+ to generate Ar•, ArI, and Ir4+ (step ii).20,30 Ar• could then enter 
the Pd catalytic cycle by oxidizing cyclopalladated complex 40 (step iii). Complex 41 







Conditions A:   Thermal








B 32% : 55%




bond-forming reductive elimination from 42 would afford product 43 and regenerate Pd2+ 
(step v). Importantly, a number of other pathways are also possible and cannot be 
distinguished based on the current data. For example a PdI/III pathway could also be 
envisioned (Scheme 2.24). 
 





























































2.7  Comparison of Ph2I+ vs PhN2+ Reagents 
A related room temperature Pd/Ru catalyzed C–H arylation reaction previously 
reported from our lab was proposed to proceed via a mechanism similar to that shown in 
Scheme 2.21. However, this transformation used a different Ar• precursor (aryl 
diazonium salts), photocatalyst (Ru(bpy)3Cl2), Pd catalyst (Pd(OAc)2) and slightly 
different optimized reaction conditions. Thus, a final set of studies was conducted to 
compare these two processes.  
As illustrated in Table 2.7, the performance of the two systems is often 
comparable (e.g., for substrates 9 and 29). However, for benzamide substrates 17 and 19 
and ketoxime ether 27, the Pd/Ir/Ph2I+ protocol provided better yields of C–H 
phenylation. Conversely, the Pd/Ru/PhN2+ system performed better for acetanilide 13, 
and it is effective for hydroxyl oxime 45, a substrate class that undergoes decomposition 
under the Pd/Ir/Ph2I+ conditions. Overall, the room-temperature Pd/photocatalyzed C–H 



















Table 2.7. Comparison of Pd/Ir-Catalyzed C–H Phenylation with Ph2I+ vs Pd/Ru-




2.8  Conclusions 
In summary, a new photoredox Pd/Ir-catalyzed C–H arylation with 
diaryliodonium reagents has been described. The unusually low reaction temperature, the 
requirement for light and a photocatalyst, the inhibitory effect of radical scavengers, and 
the observed chemoselectivity trends are all consistent with a radical mechanism for this 

















































(9) (10) (21) (22)
(13) (14) (27) (28)
























aGC calibrated yield. bGeneral conditions: substrate (1 equiv), [Ph 2I]OTf (2 equiv), Pd(NO 3)2 (0.10 equiv), 
Ir(ppy)2(dtbbpy)PF6 (0.05 equiv), MeOH (0.2 M in substrate), 26 W lightbulb, 15 h, rt, degassed by sparging with 
N2. cGeneral conditions: substrate (1 equiv), [PhN2]BF4 (4 equiv), Pd(OAc)2 (0.10 equiv), Ru(bpy)3Cl2•6H2O (0.025 
equiv), MeOH (0.1 M in substrate), 26 W lightbulb, rt, 15 h, degassed by sparging with N 2. d[Ph2I]BF4 was the 
oxidant. eProduct 46 was not detected by GC, and only traces of 45 and 3-methylacetophenone were observed.
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analogous thermal reaction that requires a dramatically higher temperature (100 ºC) and 
is believed to proceed via an ‘ionic’ 2e– pathway.  
This example adds to a growing body of work suggesting that re-routing 
traditional metal-catalyzed transformations via radical pathways can offer major 
advantages in terms of reaction rates, substrate scope, and functional group tolerance.18,32 
 
2.9  Experimental Procedures and Characterization Data 
General Procedures 
NMR spectra were obtained on a Varian vnmrs 700 (699.76 MHz for 1H; 175.95 MHz 
for 13C; 658.43 for 19F), Varian vnmrs 500 (500.10 MHz for 1H; 125.75 MHz for 13C, 
470.56 MHz for 19F), Varian Inova 500 (499.90 MHz for 1H; 125.70 MHz for 13C), or a 
Varian MR400 (400.52 MHz for 1H; 100.71 for 13C, 376.87 MHz for 19F) spectrometer. 
1H NMR chemical shifts are reported in parts per million (ppm) relative to TMS, with the 
residual solvent peak used as an internal reference.  Multiplicities are reported as follows: 
singlet (s), doublet (d), doublet of doublets (dd), doublet of doublets of doublets (ddd), 
doublet of triplets (dt), triplet (t), triplet of doublets (td), triplet of triplets (tt), quartet (q), 
quintet (quin), multiplet (m), and broad resonance (br). IR spectra were obtained on a 
Perkin-Elmer Spectrum BX FT-IR spectrometer. Melting points were determined with a 
Mel-Temp 3.0, a Laboratory Devices Inc, USA instrument, and are uncorrected. HRMS 
data were obtained on a Micromass AutoSpec Ultima Magnetic Sector mass 
spectrometer. Gas chromatography was carried out on a Shimadzu 17A using a Restek 
Rtx®-5 (Crossbond 5% diphenyl – 95% dimethyl polysiloxane; 15 m, 0.25 mm ID, 0.25 
µm df) column. GC calibrated yields are reported relative to hexadecane as an internal 
standard. 
 
Materials and Methods. Substrates 1133 and 2334 were prepared according to literature 
procedures. Substrate 25 was prepared by a palladium-catalyzed Suzuki coupling 
between 2-methoxyboronic acid and 2-bromopyridine. Oxime ethers 27 and 29 were 
prepared by the reaction of the corresponding ketones with MeONH2•HCl in pyridine.35 
The remaining substrates were obtained from Aldrich (9, 17, and 21), Alfa Aesar (13 and 
15), or Acros (19) and were used as received. [Ph2I]BF4 and [Mes–I–Ph]BF4 were 
41 
prepared by the reaction of PhI(OAc)2 or MesI(OAc)2 with PhB(OH)2 in the presence of 
BF3•Et2O.36 [Ph2I]OTf and [Mes2I]OTf were prepared by the reaction of iodobenzene or 
iodomesitylene with mCPBA and benzene or mesitylene in the presence of TfOH.37 
Unsymmetrical [Ar–I–Ph]BF4 salts were prepared by the reaction of an aryl iodide with 
m-CPBA and PhB(OH)2 in the presence of BF3•Et2O.38 Symmetrical [Ar2I]BF4 salts were 
prepared by the reaction of an aryl iodide with m-CPBA and the corresponding 
arylboronic acid in the presence of BF3•Et2O.38 Pd(OAc)2, obtained from Pressure 
Chemical, and Pd(NO3)2 and Ru(bpy)3Cl2•6H2O, obtained from Strem, were used as 
received. Ir(ppy)339 and Ir(ppy)2(dtbbpy)PF640 were prepared according to literature 
procedures. Solvents were obtained from Fisher Chemical and used without further 
purification. Flash chromatography was performed on EM Science silica gel 60 (0.040–
0.063 mm particle size, 230–400 mesh) and thin layer chromatography was performed on 
Merck TLC plates pre-coated with silica gel 60 F254. 
 
Synthesis and Characterization of Products in Table 2.3 
General Procedure. Substrate (1 equiv), [Ph2I]BF4 or [Ph2I]OTf (2 equiv), 
Ir(ppy)2(dtbbpy)PF6 (0.05 equiv), and Pd(NO3)2•2H2O (0.10 equiv) were combined in 
MeOH in a 4 mL scintillation vial. For substrates containing N-acetyl moieties (noted 
below), MgO (1 equiv) was also included and appeared to help prevent substrate and/or 
product degradation. The reaction mixture was cooled in an ice bath (to prevent 
evaporation) and sparged with N2 using a submerged needle for 10 min, and the vial was 
then immediately sealed with a Teflon-lined cap. The vial was placed on a stir plate with 
two 26 W compact fluorescent light bulbs (one on either side of the vial about 5–8 cm 
away), and the reaction mixture was allowed to stir at room temperature for 15 h. The 
reaction mixture was diluted with EtOAc (50 mL) and washed with 10% aqueous Na2SO3 
(2 x 25 mL) and brine (1 x 25 mL). The combined aqueous layers were extracted with 
EtOAc (3 x 10 mL), and the organic layers were then combined, dried over MgSO4, 





Pyrrolidinone 10. The general procedure was followed utilizing 
substrate 9 (80.6 mg, 0.50 mmol, 1.0 equiv), [Ph2I]OTf (430 mg, 1.00 
mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 mmol, 0.05 
equiv), Pd(NO3)2•2H2O (13.3 mg, 0.05 mmol, 0.10 equiv), and 
MeOH (2.5 mL). Product 10 was obtained as a pale yellow oil (96.3 mg, 81% yield, Rf = 
0.17 in 20% hexanes/80% Et2O). 1H and 13C NMR data matched those reported in the 
literature.22  
 
Pyrrolidinone 12. The general procedure was followed utilizing 
substrate 11 (47.8 mg, 0.25 mmol, 1.0 equiv), [Ph2I]OTf (215 mg, 
0.50 mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (11.4 mg, 0.0125 mmol, 
0.05 equiv), Pd(NO3)2•2H2O (6.7 mg, 0.025 mmol, 0.10 equiv), and 
MeOH (1.8 mL). Product 12 was obtained as a pale yellow solid 
[62.5 mg, 94% yield, Rf = 0.10 in 20% hexanes/80% Et2O, mp = 72.9-74.7 ºC (lit.11 61–
64 ºC)]. 1H and 13C NMR data matched those reported in the literature.22 
 
Acetanilide 14. The general procedure was followed utilizing substrate 
13 (37.3 mg, 0.25 mmol, 1.0 equiv), [Ph2I]BF4 (184 mg, 0.50 mmol, 2 
equiv), Ir(ppy)2(dtbbpy)PF6 (11.4 mg, 0.0125 mmol, 0.05 equiv), 
Pd(NO3)2•2H2O (6.7 mg, 0.025 mmol, 0.10 equiv), and MeOH (1.25 
mL), with the addition of MgO (10.1 mg, 0.25 mmol, 1.0 equiv). 
Product 14 was obtained as a pale yellow solid [40.6 mg, 72% yield, Rf = 0.17 in 30% 
hexanes/70% Et2O, mp = 134.5-136.0 ºC (lit. 139-140 ºC)].13a 1H NMR (700 MHz, 
CD3CN): δ 7.64 (br s, 1H); 7.42–7.39 (multiple peaks, 2H); 7.35 (t, J = 7.4 Hz, 1H); 
7.32–7.31 (multiple peaks, 2H); 7.27 (d, J = 4.9 Hz, 2H); 7.17 (t, J = 4.9 Hz, 1H); 2.23 (s, 
3H); 1.85 (s, 3H). 13C{1H} NMR (176 MHz, CD3CN): δ 170.04; 141.30; 140.97; 138.16; 
134.58; 130.52; 129.67; 129.03; 128.72; 128.14; 128.05; 22.76; 18.54. IR (thin film, 
CH2Cl2) 3246, 3026, 2922, 1652, 1522 cm-1. HRMS [M+H]+ Calcd for C15H16NO: 













Acetylindoline 16. The general procedure was followed utilizing 
substrate 15 (80.5 mg, 0.50 mmol, 1.0 equiv), [Ph2I]BF4 (368 mg, 1.00 
mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 mmol, 0.05 
equiv), Pd(NO3)2•2H2O (26.6 mg, 0.100 mmol, 0.20 equiv), and 
MeOH (2.5 mL), with the addition of MgO (20.2 mg, 0.50 mmol, 1.0 
equiv). Product 16 was obtained as a pale yellow solid [51.7 mg, 44% yield, Rf = 0.30 in 
20% hexanes/80% Et2O, mp = 116.3-117.8 ºC (lit. 117-119 ºC)].10 1H and 13C NMR data 
matched those reported in the literature.10  
 
Benzamide 18. The general procedure was followed utilizing substrate 
17 (33.8 mg, 0.50 mmol,  1.0 equiv), [Ph2I]BF4 (368 mg, 1.00 mmol, 2 
equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 mmol, 0.05 equiv), 
Pd(NO3)2•2H2O (13.3 mg, 0.050 mmol, 0.10 equiv), and MeOH (2.5 
mL). Product 18 was obtained as a white solid (39 mg, 40% yield, Rf = 
0.26 in 1:1:1 benzene:CH2Cl2:Et2O, mp = 169.0-173.0 ºC). 1H NMR (700 MHz, CDCl3): 
δ 7.79 (d, J = 7.7 Hz, 1H), 7.50 (td, J = 7.7, 0.7 Hz, 1H), 7.46-7.42 (multiple peaks, 5H), 
7.39 (m, 1H), 7.37 (dd, J = 7.7, 0.7 Hz, 1H), 5.62 (br s, 1H), 5.25 (br s, 1H).  13C{1H} 
NMR (176 MHz, CDCl3): δ 171.21, 140.15, 139.80, 134.30, 130.54, 130.38, 129.08, 
128.77, 128.69, 127.93, 127.62. IR (thin film, CDCl3) 3383, 3178, 1653, 1643 cm-1. 
HRMS [M+H]+ Calcd for C13H12NO: 198.0913; Found: 198.0920. 
 
Benzamide 20. The general procedure was followed utilizing substrate 
19 (67.6 mg, 0.50 mmol, 1.0 equiv), [Ph2I]OTf (430 mg, 1.00 mmol, 2 
equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 mmol, 0.05 equiv), 
Pd(NO3)2•2H2O (13.3 mg, 0.05 mmol, 0.10 equiv), and MeOH (2.5 
mL). Product 20 was obtained as a pale yellow solid (56.7 mg, 54% 
yield, Rf = 0.27 in 20% hexanes/80% Et2O, mp = 164.5-166.8 ºC). 1H NMR (400 MHz, 
CDCl3): δ 7.69 (dd, J = 7.6, 1.6 Hz, 1H), 7.47 (td, J = 7.6, 1.2 Hz, 1H), 7.42-7.35 
(multiple peaks, 7H), 5.19 (br s, 1H), 2.67 (d, J = 4.8 Hz, 3H). 13C{1H} NMR (100 MHz, 











127.75, 127.59, 26.64. IR (thin film, CDCl3) 3286, 3060, 2936, 1636, 1540, 1313 cm-1. 
HRMS [M+H]+ Calcd for C14H14NO: 212.1070; Found: 212.1074. 
 
Benzamide 22. The general procedure was followed utilizing substrate 
21 (74.6 mg, 0.50 mmol, 1.0 equiv), [Ph2I]OTf (430 mg, 1.00 mmol, 2 
equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 mmol, 0.05 equiv), 
Pd(NO3)2•2H2O (13.3 mg, 0.05 mmol, 0.10 equiv), and MeOH (2.5 
mL). Product 22 was obtained as a yellow oil (9.8 mg, 9% yield, Rf = 
0.27 in 20% hexanes/80% Et2O). 1H NMR (400 MHz, CDCl3): δ 7.48-7.44 (multiple 
peaks, 3H), 7.42-7.32 (multiple peaks, 6H), 2.85 (s, 3H), 2.39 (s, 3H). 13C{1H} NMR 
(100 MHz, CDCl3): δ 171.33, 139.93, 138.67, 135.74, 129.30, 128.47, 128.36, 127.70, 
127.58, 127.41, 37.94, 24.53. Two aromatic 13C resonances are coincidentally 
overlapping. IR (thin film, CDCl3) 3057, 2924, 1624, 1394 cm-1. HRMS [M+H]+ Calcd 
for C15H16NO: 226.1226; Found: 226.1232. 
 
Pyridine 24. The general procedure was followed utilizing substrate 
23 (84.6 mg, 0.50 mmol, 1.0 equiv), [Ph2I]OTf (430 mg, 1.00 mmol, 2 
equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 mmol, 0.05 equiv), 
Pd(NO3)2•2H2O (13.3 mg, 0.050 mmol, 0.10 equiv), and MeOH (2.5 
mL). Product 24 was obtained as a clear viscous oil (76.0 mg, 62% 
yield, Rf = 0.09 in 90% hexanes/10% Et2O). 1H and 13C NMR data matched those 
reported in the literature.22 
 
Pyridine 26. The general procedure was followed utilizing substrate 
25 (92.6 mg, 0.50 mmol, 1.0 equiv), [Ph2I]OTf (430 mg, 1.00 mmol, 
2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 mmol, 0.05 equiv), 
Pd(NO3)2•2H2O (13.3 mg, 0.050 mmol, 0.10 equiv), and MeOH (2.5 
mL). Product 26 was obtained as a pale yellow solid [88.0 mg, 67% 
yield, Rf = 0.11 in 60% hexanes/40% Et2O, mp = 83.5-86.4 ºC (lit. 77.7-85.4 ºC)].22 1H 











Oxime ether 28. The general procedure was followed utilizing 
substrate 27 (81.6 mg, 0.50 mmol, 1.0 equiv), [Ph2I]OTf (430 mg, 1.00 
mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 mmol, 0.05 
equiv), Pd(NO3)2•2H2O (13.3 mg, 0.050 mmol, 0.10 equiv), and 
MeOH (2.5 mL). Product 28 was obtained as a colorless oil (71.4 mg, 
60% yield, Rf = 0.14 in 98% hexanes/2% Et2O). 1H NMR (700 MHz, CDCl3): δ 7.39–
7.36 (multiple peaks, 4H), 7.32 (m, 1H), 7.29 (d, J = 7.7 Hz, 1H), 7.23 (dd, J = 7.0, 0.7 
Hz, 1H), 7.20 (dd, J = 7.7, 0.7 Hz, 1H), 3.92 (s, 3H), 2.37 (s, 3H), 1.69 (s, 3H). 13C{1H} 
NMR (176 MHz, CDCl3): δ 156.52, 141.21, 140.97, 136.19, 136.07, 129.38, 129.34, 
128.13, 127.94, 127.63, 126.92, 61.62, 20.08, 16.56. IR (thin film, neat) 3060, 2936, 
1459, 1041 cm-1. HRMS [M+H]+ Calcd for C16H18NO: 240.1383; Found: 240.1387. 
 
Oxime ether 30. The general procedure was followed utilizing 
substrate 29 (74.6 mg, 0.50 mmol, 1.0 equiv), [Ph2I]OTf (430 mg, 1.00 
mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 mmol, 0.05 
equiv), Pd(NO3)2•2H2O (13.3 mg, 0.050 mmol, 0.10 equiv), and 
MeOH (2.5 mL). Product 30 was obtained as a colorless oil consisting 
of a ~1.5:1 mixture of oxime stereoisomers (64.7 mg, 57% yield, Rf = 0.28 (major) and 
0.14 (minor) in 6:1:0.2 hexanes/benzene/methylene chloride). Major Isomer: 1H NMR 
(700 MHz, C6D6): δ 8.26 (s, 1H); 7.22 (m, 2H), 7.09 (tt, J = 7.4, 1.4 Hz, 2H); 7.06-7.05 
(multiple peaks, 2H); 7.04-7.02 (multiple peaks, 2H); 3.76 (s, 3H), 2.62 (s, 3H). 13C{1H} 
NMR (100 MHz, CDCl3): δ 149.09, 143.18, 140.66, 137.83, 130.33, 129.83, 128.48, 
128.12, 127.84, 127.21, 61.85, 22.46. Two aromatic 13C resonances are coincidentally 
overlapping. IR (thin film, neat) 3059, 2935, 1460, 1048 cm-1. HRMS [M+H]+ Calcd for 
C15H16NO: 226.1226; Found: 226.1227. Minor Isomer: 1H NMR (700 MHz, C6D6): δ 
7.40 (d, J = 7.7 Hz, 2H); 7.24 (s, 1H); 7.19 (t, J = 7.7 Hz, 2H); 7.13-7.10 (multiple peaks, 
2H); 7.08 (t, J = 7.7 Hz, 1H); 6.98 (d, J = 7.7 Hz, 1H); 3.66 (s, 3H); 2.22 (s, 3H). 13C{1H} 
NMR (100 MHz, CDCl3): δ 147.58, 140.70, 140.66, 136.43, 130.19, 128.87, 128.84, 
128.74, 128.05, 127.36, 126.99, 61.79, 20.13. IR (thin film, CDCl3) 3059, 2935, 1460, 








Synthesis and Characterization of Products in Table 2.4 
General Procedure. Substrate (1 equiv), [Ar2I]BF4 (2 equiv), Ir(ppy)2(dtbbpy)PF6 (0.05 
equiv), and Pd(NO3)2•2H2O (0.10 equiv) were combined in MeOH in a 4 mL scintillation 
vial. The reaction mixture was cooled in an ice bath (to prevent evaporation) and sparged 
with N2 using a submerged needle for 10 min, and the vial was then immediately sealed 
with a Teflon-lined cap. The vial was placed on a stir plate with two 26 W compact 
fluorescent light bulbs (one on either side of the vial about 5–8 cm away), and the 
reaction mixture was allowed to stir at room temperature for 15 h. The reaction mixture 
was diluted with EtOAc (50 mL) and washed with 10% aqueous Na2SO3 (2 x 25 mL) and 
brine (1 x 25 mL). The combined aqueous layers were extracted with EtOAc (3 x 10 mL), 
and the organic layers were then combined, dried over MgSO4, filtered, concentrated, and 
purified by column chromatography on silica gel. 
 
Pyrrolidinone 31. The general procedure was followed utilizing 
substrate 9 (80.6 mg, 0.50 mmol, 1.0 equiv), [(p-CF3C6H4)2I]BF4 
(504 mg, 1.00 mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 
mmol, 0.05 equiv), Pd(NO3)2•2H2O (13.3 mg, 0.050 mmol, 0.10 
equiv), and MeOH (2.5 mL). Product 31 was obtained as a tan solid 
[106 mg, 69% yield, Rf = 0.17 in 20% hexanes/80% Et2O, mp = 87.6-89.2 ºC (lit. 86.1–
88.0 ºC)].22 1H and 13C NMR data matched those reported in the literature.22  
 
Pyrrolidinone 32. The general procedure was followed utilizing 
substrate 9 (80.6 mg, 0.50 mmol, 1.0 equiv), [(m-CF3C6H4)2I]BF4 
(504 mg, 1.00 mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 
mmol, 0.05 equiv), Pd(NO3)2•2H2O (13.3 mg, 0.050 mmol, 0.10 
equiv), and MeOH (2.5 mL). Product 32 was obtained as a tan solid 
[86.1 mg, 56% yield, Rf = 0.23 in 20% hexanes/80% Et2O, mp = 79.2-83.5  ºC]. 1H NMR 
(700 MHz, CDCl3): δ 7.64 (br s, 1H), 7.62 (d, J = 8.4 Hz, 1H), 7.60 (d, J = 7.7 Hz, 1H), 
7.53 (t, J = 7.7 Hz, 1H), 7.45 (m, 1H), 7.41–7.40 (multiple peaks, 2H), 7.33 (d, J = 7.7 
Hz, 1H), 3.28 (t, J = 7.0 Hz, 2H), 2.40 (t, J = 8.1 Hz, 2H), 1.91 (tt, J = 8.1, 7.0 Hz, 2H). 








JC–F = 32 Hz), 130.60, 129.25, 128.96, 128.30, 128.25, 124.99 (q, JC–F = 3.6 Hz), 124.21 
(q, JC–F = 3.8 Hz), 123.97 (q, JC–F = 272 Hz), 50.30, 30.93, 18.83. 19F NMR (376 MHz, 
CDCl3): δ –62.65 (s). IR (thin film, CDCl3) 2918, 1692, 1333, 1117 cm-1. HRMS [M+H]+ 
Calcd for C17H15F3NO: 306.1100; Found: 306.1110. 
 
Pyrrolidinone 33. The general procedure was followed utilizing 
substrate 9 (40.3 mg, 0.25 mmol, 1.0 equiv), [(o-CF3C6H4)2I]BF4 
(252 mg, 0.50 mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (11.4 mg, 
0.0125 mmol, 0.05 equiv), Pd(NO3)2•2H2O (6.7 mg, 0.025 mmol, 
0.10 equiv), and MeOH (1.25 mL). Product 33 was obtained as a 
white solid (35.0 mg, 46% yield, Rf = 0.13 in 20% hexanes/80% Et2O, mp = 61.8-63.9 
ºC). 1H NMR (700 MHz, CDCl3): δ 7.76 (d, J = 7.7 Hz, 1H), 7.54 (t, J = 7.7 Hz, 1H), 
7.49 (t, J = 7.7 Hz, 1H), 7.46 (td, J = 7.7, 1.4 Hz, 1H), 7.41 (d, J = 7.7 Hz, 1H), 7.36 (td, 
J = 7.4, 1.4 Hz, 1H), 7.33–7.32 (multiple peaks, 2H), 3.36 (ddd, J = 14.0, 7.7, 5.6 Hz, 
1H), 3.03 (ddd, J = 14.0, 8.4, 5.6 Hz, 1H), 2.40 (ddd, J = 16.4, 9.1, 6.3 Hz, 1H), 2.22 
(ddd, J = 16.4, 9.1, 6.3 Hz, 1H), 1.94 (m, 1H), 1.67 (m, 1H). 13C{1H} NMR (176 MHz, 
CDCl3): δ 175.57, 137.43, 136.99, 136.76, 132.08, 131.25, 131.05 (q, JC–F = 2.1 Hz), 
129.25, 128.28 (q, JC–F = 30 Hz), 128.08, 127.96, 127.17, 126.21 (q, JC–F = 5.3 Hz), 
124.06 (q, JC–F = 274 Hz), 49.90, 30.98, 19.05. 19F NMR (376 MHz, CDCl3): δ –57.09 
(s). IR (thin film, CDCl3) 2920, 1697, 1313, 1111 cm-1. HRMS [M+H]+ Calcd for 
C17H15F3NO: 306.1100; Found: 306.1112. 
 
Pyrrolidinone 34. The general procedure was followed utilizing 
substrate 9 (80.6 mg, 0.50 mmol, 1.0 equiv), [(p-ClC6H4)2I]BF4 (437 
mg, 1.00 mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 
mmol, 0.05 equiv), Pd(NO3)2•2H2O (13.3 mg, 0.050 mmol, 0.10 
equiv), and MeOH (2.5 mL). Product 34 was obtained as a tan solid 
[104 mg, 77% yield, Rf = 0.13 in 20% hexanes/80% Et2O, mp = 95.6-97.4 ºC (lit. 93.9-












Pyrrolidinone 35. The general procedure was followed utilizing 
substrate 9 (80.6 mg, 0.50 mmol, 1.0 equiv), [(p-BrC6H4)2I]BF4 (526 
mg, 1.00 mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 mmol, 
0.05 equiv), Pd(NO3)2•2H2O (13.3 mg, 0.050 mmol, 0.10 equiv), and 
MeOH (2.5 mL). Product 35 was obtained as a pale yellow oil (125 
mg, 79% yield, Rf = 0.13 in 20% hexanes/80% Et2O). 1H NMR (500 MHz, CDCl3): δ 
7.54 (d, J = 8.5 Hz, 2H), 7.44–7.35 (multiple peaks, 3H) 7.33 (d, J = 7.5 Hz, 1H), 7.27 (d, 
J = 8.5 Hz, 2H), 3.27 (t, J = 7.0 Hz, 2H), 2.44 (t, J = 8.0 Hz, 2H), 1.93 (tt, J = 8.0, 7.0 Hz, 
2H). 13C{1H} NMR (126 MHz, CDCl3): δ 175.61, 138.48, 138.01, 136.18, 131.56, 
130.61, 130.00, 128.95, 128.40, 128.18, 121.87, 50.26, 31.09, 18.94. IR (thin film, neat) 
2879, 1680, 1402 cm-1. HRMS [M+H]+ Calcd for C16H15BrNO: 316.0332; Found: 
316.0340. 
 
 Pyrrolidinone 36. The general procedure was followed utilizing 
substrate 9 (80.6 mg, 0.50 mmol, 1.0 equiv), [(p-MeC6H4)2I]BF4 (396 
mg, 1.00 mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 mmol, 
0.05 equiv), Pd(NO3)2•2H2O (13.3 mg, 0.050 mmol, 0.10 equiv), and 
MeOH (2.5 mL). Product 36 was obtained as a tan solid (109.8 mg, 
87% yield, Rf = 0.17 in 20% hexanes/80% Et2O, mp = 78.6-80.4 ºC). 1H NMR (700 
MHz, CDCl3): δ 7.40-7.35 (multiple peaks, 3H), 7.31 (d, J = 7.3 Hz, 1H), 7.27 (d, J = 8.0 
Hz, 2H), 7.20 (d, J = 8.0 Hz, 2H), 3.22 (t, J = 6.9 Hz, 2H), 2.43 (t, J = 8.0 Hz, 2H), 2.39 
(s, 3H), 1.88 (tt, J = 8.0, 6.9 Hz, 2H). 13C{1H} NMR (176 MHz, CDCl3): δ 175.61, 
139.52, 137.28, 136.27, 136.16, 130.86, 129.12, 128.34, 128.30, 128.18, 127.98, 50.06, 
31.20, 21.18, 18.97. IR (thin film, CDCl3) 3026, 2920, 1694, 1487, 1407, 1301 cm-1. 
HRMS [M+H]+ Calcd for C17H18NO: 252.1383; Found: 252.1391. 
 
Pyrrolidinone 37. The general procedure was followed utilizing 
substrate 9 (80.6 mg, 0.50 mmol, 1.0 equiv), [(o-MeC6H4)2I]BF4 
(396 mg, 1.00 mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 












equiv), and MeOH (2.5 mL). Product 37 was obtained as a pale yellow oil (107 mg, 85% 
yield, Rf = 0.20 in 20% hexanes/80% Et2O). NMR (500 MHz, CDCl3): δ 7.40 (ddd, J = 
7.7, 7.0, 1.4 Hz, 1H), 7.36 (dd, J = 8.4, 1.4 Hz, 1H), 7.34 (td, J = 7.7, 1.4 Hz, 1H), 7.27–
7.24 (multiple peaks, 3H), 7.19 (m, 1H), 7.16 (d, 7.0 Hz, 1H), 3.23 (ddd, J = 9.1, 8.4, 5.6 
Hz, 1H), 3.09 (ddd, J = 9.1, 7.7, 5.6 Hz, 1H) 2.32 (m, 2H), 2.15 (s, 3H), 1.82 (m, 1H), 
1.75 (m, 1H). 13C{1H} NMR (126 MHz, CDCl3): δ 175.10, 138.89, 138.60, 136.96, 
135.88, 131.11, 130.13, 129.39, 128.3, 128.1, 127.72, 127.29, 125.47, 49.94, 31.15, 
19.93, 19.02. IR (thin film, neat) 2952, 1696, 1398 cm-1. HRMS [M+H]+ Calcd for 
C17H18NO: 252.1383; Found: 252.1392. 
 
Pyrrolidinone 38. The general procedure was followed utilizing 
substrate 9 (40.3 mg, 0.25 mmol, 1.0 equiv), [Mes2I]OTf (257 mg, 
0.50 mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (11.3 mg, 0.0125 mmol, 
0.05 equiv), Pd(NO3)2•2H2O (6.7 mg, 0.025 mmol, 0.10 equiv), and 
MeOH (1.25 mL). Product 38 was obtained as a white solid (8 mg, 
11% yield, Rf = 0.17 in 96% CH2Cl2/4% Et2O, mp = 121.2-123.8 ºC). 1H NMR (700 
MHz, CDCl3): δ 7.44–7.39 (multiple peaks, 2H), 7.34 (td, J = 7.5, 1.5 Hz, 1H), 7.13 (dd, 
J = 7.5, 1.2 Hz, 1H), 6.92 (s, 2H), 3.12 (t, J = 6.9 Hz, 2H), 2.36 (t, J = 8.0 Hz, 2H), 2.34 
(s, 3H), 1.98 (s, 6H), 1.80 (tt, J = 8.0, 6.9 Hz, 2H). 13C{1H} NMR (176 MHz, CDCl3): δ 
174.82, 137.32, 137.16, 137.01, 136.23, 135.62, 131.27, 128.25, 128.06, 127.97, 127.33, 
49.16, 31.35, 21.06, 20.41, 19.07. IR (thin film, CH2Cl2) 2918, 1699, 1398, 1301 cm-1. 
HRMS [M+H]+ Calcd for C19H22NO: 280.1699; Found: 280.1705. 
 
Pyrrolidinone 39. The general procedure was followed utilizing 
substrate 9 (80.6 mg, 0.50 mmol, 1.0 equiv), [(p-OMeC6H4)2I]BF4 
(428 mg, 1.00 mmol, 2 equiv), Ir(ppy)2(dtbbpy)PF6 (22.8 mg, 0.025 
mmol, 0.05 equiv), Pd(NO3)2•2H2O (13.3 mg, 0.050 mmol, 0.10 
equiv), and MeOH (2.5 mL). Product 39 was obtained as a tan 
viscous oil (54.3 mg, 41% yield, Rf = 0.07 in 20% hexanes/80% Et2O). 1H and 13C NMR 











Experimental Details for Table 2.5 
Ionic/Thermal Procedure for Reactions in Table 2.5 (entries 1–3). Substrate 23 (8.5 
mg, 0.050 mmol, 1 equiv), [Ph2I]BF4 (20.2 mg, 0.055 mmol, 1.1 equiv), Pd(OAc)2 (1.1 
mg, 0.005 mmol, 0.10 equiv), and galvinoxyl (0 or 5.3 mg; 0 or 0.0125 mmol; 0 or 0.25 
equiv) or TEMPO (0 or 7.8 mg; 0 or 0.050 mmol; 0 or 1.0 equiv) were combined in 
AcOH (0.42 mL) in a 4 mL scintillation vial. The reaction was heated to 100 ºC for 15 h, 
then quenched with 10% aqueous Na2SO3 (0.25 mL), diluted with EtOAc (3.5 mL), and 
analyzed by GC-FID. GC calibrated yields are reported relative to hexadecane as an 
internal standard. The yields reported in Table 2.5 are the averages of three separate 
trials. These conditions are similar to those reported previously for 2-arylpyridine 
substrates;10 however, the catalyst loading was increased to 10% (instead of 5%) to more 
closely resemble the conditions of the photocatalytic/radical trials. 
 
Radical/Photocatalytic Procedure for Reactions in Table 2.5 (entries 4–8). Substrate 
23 (8.5 mg, 0.050 mmol, 1 equiv), [Ph2I]BF4 (36.8 mg, 0.100 mmol, 2 equiv), 
Ir(ppy)2(dtbbpy)PF6 (2.3 mg, 0.0025 mmol, 0.05 equiv), Pd(NO3)2•2H2O (1.3 mg, 0.005 
mmol, 0.10 equiv), and galvinoxyl (0, 2.1, or 5.3 mg; 0, 0.005, or 0.0125 mmol; 0, 0.10, 
or 0.25 equiv) or TEMPO (0, 3.9, or 7.8 mg; 0, 0.025, or 0.050 mmol; 0, 0.50, or 1.0 
equiv) were combined in MeOH (0.25 mL) in a 4 mL scintillation vial. The reaction 
mixture was cooled in an ice bath (to prevent evaporation) and sparged with N2 using a 
submerged needle for 1 min, and the vial was then immediately sealed with a Teflon-
lined cap. The vial was placed on a stir plate with two 26 W compact fluorescent light 
bulbs (one on either side of the vial about 5–8 cm away), and the reaction mixture was 
allowed to stir at room temperature for 15 h. Reactions were then quenched with 10% 
aqueous Na2SO3 (0.25 mL), diluted with EtOAc (3.5 mL), and analyzed by GC-FID. GC 
calibrated yields are reported relative to hexadecane as an internal standard. The yields 
reported in Table 2.5 are the averages of three separate trials. 
 
Experimental Details for Table 2.6 and Scheme 2.22 
Radical/Photocatalytic Procedure for Reactions in Table 2.6 (even-numbered 
entries). Substrate 9 (8.1 mg, 0.050 mmol, 1 equiv), [Ar–I–Ph]BF4 (0.100 mmol, 2 
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equiv), Ir(ppy)2(dtbbpy)PF6 (2.3 mg, 0.0025 mmol, 0.05 equiv), and Pd(NO3)2•2H2O (1.3 
mg, 0.005 mmol, 0.10 equiv) were combined in MeOH (0.25 mL) in a 4 mL scintillation 
vial. The reaction mixture was cooled in an ice bath (to prevent evaporation) and sparged 
with N2 using a submerged needle for 1 min, and the vial was then immediately sealed 
with a Teflon-lined cap. The vial was placed on a stir plate with two 26 W compact 
fluorescent light bulbs (one on either side of the vial about 5–8 cm away), and the 
reaction mixture was allowed to stir at room temperature for 15 h. Reactions were then 
quenched with 10% aq. Na2SO3 (0.25 mL), diluted with EtOAc (3.5 mL), and analyzed 
by GC-FID. GC calibrated yields are reported relative to hexadecane as an internal 
standard. 
 
Ionic/Thermal Procedure for Reactions in Table 2.6 (odd-numbered entries). 
Substrate 9 (8.1 mg, 0.050 mmol, 1 equiv), [ArI–Ph]BF4 (0.100 mmol, 2 equiv), 
Pd(OAc)2 (1.1 mg, 0.005 mmol, 0.10 equiv), and NaHCO3 (6.3 mg, 0.075 mmol, 1.5 
equiv) were combined in toluene (0.42 mL). The reaction was heated to 100 ºC for 15 h, 
then quenched with 10% aq. Na2SO3 (0.25 mL), diluted with EtOAc (3.5 mL), and 
analyzed by GC-FID. GC calibrated yields are reported relative to hexadecane as an 
internal standard. These conditions are similar to the thermal conditions reported 
previously for substrate 1;10 however, the equivalents of oxidant were increased to 2 
(instead of 1.5) and the catalyst loading was increased to 10% (instead of 5%) to more 
closely resemble the conditions of the photocatalytic/radical trials. 
 
Experimental Details for Table 2.7 
PhN2+ procedure.22 Substrate (0.050 mmol, 1 equiv), Pd(OAc)2 (1.1 mg, 0.005 mmol, 
0.10 equiv), Ru(bpy)3Cl2•6H2O (0.94 mg, 0.00125 mmol, 0.025 equiv), and [PhN2]BF4 
(38.4 mg, 0.200 mmol, 4 equiv) were combined in MeOH (500 µL) in a 4 mL 
scintillation vial. The reaction mixture was cooled in an ice bath (to prevent evaporation) 
and sparged with N2 using a submerged needle for 1 min, and the vial was then 
immediately sealed with a Teflon-lined cap. The vial was placed on a stir plate with two 
26 W compact fluorescent light bulbs (one on either side of the vial about 5–8 cm away), 
and the reaction mixture was allowed to stir at room temperature for 15 h. Reactions were 
52 
then quenched with 10% aq. Na2SO3 (0.25 mL), diluted with EtOAc (3.5 mL), and 
analyzed by GC-FID. GC calibrated yields are reported relative to hexadecane as an 
internal standard. 
 
Ph2I+ procedure. GC calibrated yields were obtained from the reactions described above 
for Table 2.3 and are reported relative to hexadecane as an internal standard. 
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Pd-Catalyzed Radical-Mediated C–H Alkylation Using Potassium 
Alkyltrifluoroborates  
 
3.1  Background and Significance 
Carbon–alkyl bonds are indispensible structural elements in organic compounds. 
Nevertheless, mild and general strategies for incorporating alkyl groups into complex 
molecules remain elusive. Diverse C–alkyl coupling reactions can be effected with 
nucleophilic organometallic alkylating agents (e.g., alkyl Grignards and alkyllithiums);1 
however, many of these reagents are too reactive for late stage applications. The use of 
strongly basic nucleophiles is avoided in Suzuki-Miyaura cross-coupling reactions that 
employ alkylboron reagents in conjunction with a palladium catalyst (Scheme 3.1).2 This 
strategy is powerful, yet it carries a number of limitations that include the following: (1) 
the substrate (1) must be prefunctionalized with a halide or pseudohalide, (2) each 
substrate/alkyl combination typically requires extensive optimization with respect to 
additives and ancillary ligands, (3) reagents are usually air-sensitive and often moisture-
sensitive, and (4) stoichiometric base is required. 
 
Scheme 3.1. Suzuki-Miyaura Cross-Coupling with Alkylboron Reagents 
 
 
An alternative Pd-catalyzed C–H activation/alkylation sequence addresses the 
first of these limitations by precluding the requirement for halogenated substrates. This 
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strategy could be particularly appealing for late stage derivatization of complex 
molecules; in such situations it may not be feasible (or desirable) to carry a halogen 
substituent through several steps or to regioselectively introduce a halide into the 
substrate at a late stage. Over the past few years, a limited number of examples of ligand-
directed PdII-catalyzed C–H alkylations have been reported using alkylboron reagents.3–14 
These transformations are believed to proceed through PdII/Pd0 catalytic cycles (Scheme 
3.2) involving (i) C–H activation at PdII, (ii) transmetallation of the alkyl group from 
boron to palladium, (iii) C–C bond-forming reductive elimination, and (iv) reoxidation of 
Pd0 to PdII.  
 




Within this mechanistic manifold, ligand-directed C–H methylation using 
methylboronic acid or trimethylboroxine has been demonstrated with pyridines and 
pyrazoles (Scheme 3.3),3 carboxylic acids (Scheme 3.4),4 2-pyridylsulfonyls (Scheme 



























Although the installation of longer-chain alkyls has proven more challenging, 
pyridine- (Scheme 3.6),3 methyl hydroxamic acid- (Scheme 3.7),5 and N-
(perfluoroaryl)amide-containing substrates7,9 (Scheme 3.8) have been functionalized with 
ethyl-, n-butyl-, i-butyl, n-hexyl-, phenethyl-, cyclohexylmethyl-, and cyclopropyl 
boronic acid or trifluoroborate reagents. 
 




Scheme 3.7. Methyl Hydroxamic Acid-Directed sp3 C–H Alkylation with Alkylboronic 






Scheme 3.8. N-(Perfluoroaryl)benzamide -Directed C–H Alkylation of Cyclopropanes 
with Alkyltrifluoroborates and Ag2CO37 
 
 
A key challenge associated with Pd-catalyzed C–alkyl bond formation is the 
propensity for undesired reaction pathways (Scheme 3.9), such as proto-deboronation 
(path A) or Pd-catalyzed β-hydride elimination (path C), which compete with the desired 
cross-coupling (path B).2,3 To date, the efforts to develop and improve C–H alkylation 
reactions have focused on identifying promoters for each sequential step of the PdII/Pd0 
catalytic cycle shown in Scheme 3.2. This strategy, largely advanced by Yu and 
coworkers,3–6,8,9 aims to increase the rate of the desired transformation relative to the 
rates of undesired mechanistic pathways. 
 





For example, benzoquinone is included in all reported protocols for Pd-catalyzed 
C–H alkylation with alkylboron reagents. This additive is believed to promote reductive 
elimination,3,13,15 and it may also act as a cooxidant.3 Silver salts are usually employed, 
serving as oxidants and purportedly promoting transmetallation.3 Careful optimization 
has led to the identification of ligands that promote the alkylation of certain substrates. 
For instance, 2,2,5,5-tetramethyltetrahydrofuran was used as the reaction solvent for the 
sp3-C–H alkylation of O-methyl hydroxamic acids (Scheme 3.4). It was hypothesized that 
this highly substituted ether serves as a bulky ligand for Pd to slow the rate of undesired 
homocoupling and β-hydride elimination.5  
As exemplified in Schemes 3.3–3.8, efforts to identify promoters have resulted in 
several elegant examples of PdII/Pd0-catalyzed C–H alkylation with alkylboron reagents. 
Nevertheless, current methodologies are characterized by a number of key limitations 
similar to those of traditional Suzuki-Miyaura cross-coupling reactions. Importantly, no 
set of reaction conditions is general for more than one type of directing group (the low-
yielding pyrazole example in Scheme 3.3 is the sole exception shown to proceed under 
the same conditions as another substrate class). Instead, extensive optimization of base, 
oxidants, and solvents has been necessary for each transformation. Furthermore, a 
minimum reaction temperature of 70 ºC has been reported,5,8 and higher temperatures 
(100–120 ºC) are more common. The requirement for elevated temperatures, in addition 
to the need for superstoichiometric base, renders the current methodology impractical for 
substrates with sensitive functional groups. In light of all these limitations, the 
identification of more general and efficient promoters would be necessary to develop 
improved protocols for C–H alkylation via a PdII/Pd0 mechanistic manifold. 
We envisioned a new strategy that would effect the desired transformation 
through an alternative alkyl radical-mediated pathway (Scheme 3.10). In contrast to 
PdII/Pd0-catalysis, the proposed strategy would replace the traditional transmetallation 
step with a 1 e– oxidation of PdII by alkyl• (step ii). Although transmetallation from boron 
can be slow in PdII/Pd0-catalyzed C–C bond-forming reactions, literature precedent 
suggests that the reaction between carbon-centered radicals and palladacycles can be 
extremely fast.16–18 Furthermore, reductive elimination is expected to be more facile from 
a high valent Pd–alkyl intermediate (2 or 3, step iv-A or iii-B) than from a PdII–alkyl 
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species. Finally, β-hydride elimination (an unproductive reaction pathway in this case) is 
much less facile from octahedral high valent Pd–alkyl complexes than from PdII–alkyl 
species.19 
 
Scheme 3.10. Envisioned Alkyl Radical-Mediated Pd-Catalyzed C–H Alkylation 
 
 
To develop the proposed transformation, we sought to identify a suitable system 
for generating alkyl radicals that would be compatible with cyclopalladation. A number 
of radical-mediated Pd-catalyzed C–H arylation16 and acylation17 reactions have been 
reported by our group and others using benzoic acids,16a aryldiazonium salts,16b  
diaryliodonium salts,16c diethylazodicarboxylates,17a and aldehydes17b–d as radical 
precursors. However, none of these reagent classes are practical sources of analogous 
alkyl radicals. For instance, although aryldiazonium and diaryliodonium salts are 
commonplace, the corresponding alkyl reagents are typically too unstable to isolate.20  
Molander and coworkers recently reported the use of potassium 
alkyltrifluoroborates as precursors to alkyl radicals for the alkylation of electron-deficient 
heteroarenes (Scheme 3.11).21,22 This transformation is believed to involve oxidation of 
alkyl–BF3K to alkyl• by a MnIII reagent. The intermediacy of alkyl radicals is supported 
by the observed regioselectivity, which is consistent with a radical aromatic substitution 
mechanism in which alkylation occurs at the more electron-deficient 2- and 4-positions of 
the pyridine ring (trifluoroacetic acid is used as an additive to generate a more 
electrophilic pyridinium species).23 This selectivity stands in contrast to that of 
electrophilic aromatic substitution (e.g., Friedel-Crafts alkylation), in which 
functionalization occurs at the most nucleophilic positions of an aromatic ring.  
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Scheme 3.11. Alkylation of Electron-Deficient Heteroarenes with Alkyl Radicals 
Generated from Alkyltrifluoroborates and Mn(OAc)321 
 
 
Inspired by this precedent, we hypothesized that Pd-catalyzed C–H activation 
could be coupled with MnIII-mediated alkyl–BF3K 1 e– oxidation to provide a net C–H 
alkylation (Scheme 3.12). Encouragingly, numerous C–H functionalization reactions 
have been documented in acetic acid,24 the same solvent used by Molander and 
coworkers in conjunction with Mn(OAc)3. This precedent suggests compatibility between 
the conditions required for C–H activation and alkyl–BF3K oxidation. Furthermore, 
alkyltrifluoroborates are attractive reagents for C–H alkylation because (1) they are 
readily prepared from inexpensive commercial starting materials, and (2) they are 
typically air- and moisture-stable crystalline solids that are convenient to handle.25 
 




Although an attractive strategy, several possible undesired processes could 
impede the development of the proposed Pd-catalyzed ligand-directed C–H alkylation 
reaction. In particular, two potential side reactions are unique to this approach. First, 
although pyridines are highly effective directing groups for diverse C–H 
functionalizations, heterocycles such as these might undergo uncatalyzed Minisci-type 
alkylation (vide supra) in the presence of alkyl radicals. Second, C–OAc bond-forming 
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reductive elimination could occur from high-valent Pd intermediates in competition with 
the desired C–alkyl bond formation. Analogous ligand-directed Pd-catalyzed formation 
of C–H acetoxylated products has been described numerous times under conditions 
involving strong oxidants, especially in the presence of acetic acid.26 As such, reaction 
conditions must be developed under which the rate of C–H alkylation outcompetes the 
rates of these undesired processes. 
  
3.2  Reaction Optimization 
 Our initial experiments were directed toward assessing the feasibility of the 
unprecedented steps of the envisioned catalytic cycle, namely, those that occur after 
cyclopalladation (Scheme 3.10). We thus began by examining the stoichiometric reaction 
of cyclopalladated complex 4 with MeBF3K in the presence of Mn(OAc)3. Excitingly, 
after 6 h at room temperature in AcOH/H2O (1:1), 40% yield of methylated product 5 
was obtained (GC calibrated yield, Scheme 3.13). This result indicates that methyl 
radicals, putatively generated by 1 e– oxidation of MeBF3K, react with palladacycle 4 
under these conditions to effect C–C bond formation. 
 
Scheme 3.13. Reaction of Cyclopalladated Complex 4 With MeBF3K and Mn(OAc)3 
 
 
With this promising stoichiometric result in hand, we next turned to the catalytic 
reaction. We were pleased to find that methylation of substrate 6 occurred under 
analogous conditions in the presence of 10 mol % Pd(OAc)2, albeit in low yield (Table 
3.1, entry 1, 9%). Not surprisingly, the addition of 1 equiv TFA did not substantially 
improve the yield of the transformation (entry 2), as protonation of the pyridine directing 
group is not a productive step in the envisioned catalytic cycle. However, changing the 
oxidant from Mn(OAc)3 to MnF3 doubled the yield of the catalytic reaction to 22% (entry 
3). A further increase in yield was observed when the reaction temperature was raised 
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slightly to 40 ºC (entry 4). Finally, after screening a number of solvents, we found that 
the use of a solvent mixture of trifluoroethanol (TFE)/acetic acid/water (8:1:1) resulted in 
a high yield of 5 (entry 5). 
 
Table 3.1. Optimization of the Pd-Catalyzed C–H Methylation with MeBF3K and MnIII a 
 
 
Interestingly, the methylation reaction does not proceed in trifluoroethanol alone 
(entry 6). Small quantities of both water and AcOH were necessary to achieve optimum 
yields (compare entries 6–8 with entry 5; see section 3.9 for further details). Although the 
best results were obtained at 40 ºC, running the reaction at room temperature was only 
slightly detrimental to the reaction yield (entry 9), and increasing the reaction 
temperature to 50 ºC offered no further advantage (entry 10). Finally, both methylboronic 
acid (entry 11) and trimethylboroxine (entries 12 and 13) performed nearly as well as the 
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corresponding trifluoroborate, although these classes of reagents are not as convenient to 
prepare and handle as trifluoroborate salts.25  
Importantly, no methylation occurs in the absence of Pd, providing support for a 
Pd-catalyzed process (Table 3.2, entry 2). When MnIII is excluded from the reaction, no 
methylated product (5) is detected (entry 3). Finally, in the absence of MeBF3K, 
significant quantities of acetoxylated product 8 are observed (entry 4). 
 




It is noteworthy that Minisci-type methylation of the pyridine ring (7) was not 
detected under any conditions, even when Pd was excluded from the reaction. This 
observation was encouraging; however, pyridine alkylation with alkyl–BF3K has only 
been demonstrated with alkyl–BF3K reagents that produce 2º, longer-chain 1º, and 
heteroatom-stabilized 1º radicals.21 As such, the absence of pyridine-methylation 
products in this control reaction did not rule out the possibility of competing pyridine 





3.3  Methylation Scope 
The optimal conditions were applied to the C–H methylation of other arylpyridine 
derivatives as well as diverse anilide substrates (Table 3.3). Products derived from the C–
H methylation of acetanilide (12, 14, 16, and 18), pyrrolidinone (20), acetylindoline (22), 
and tetrahydroacetylquinoline (24) derivatives were all obtained in good to excellent 
isolated yields at 25–40 ºC. Furthermore, the presence of an aryl iodide functional group 
was well tolerated under these mild reaction conditions (18).  
 
Table 3.3. Substrate Scope for the Pd-Catalyzed Radical Mediated Methylationa 
 
C H L C MeL





25–40 ºC, 3 h






















































entry substrate product % yieldb
aConditions: substrate (1 equiv), Pd(OAc)2 (0.10 equiv), MeBF3K (2 equiv), MnF3(4 equiv), AcOH (2 equiv), 
TFE/H2O (9:1, 0.067 M in substrate), 40 ºC, 3 h. bIsolated yield. cReaction solvent was TFE/H2O/AcOH (8:1:1); 
this corresponds to approximately 26 equiv AcOH. dReaction was run at room temperature.
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A limitation to the current methodology is that electron-deficient substrates 
display low reactivity under the optimized conditions. Table 3.4 depicts a number of 
additional substrates that were evaluated for the methylation reaction under conditions 
similar to those optimized for 6. Methylated products were identified by GCMS, and the 
GC yields presented are uncalibrated. Particularly poor reactivity was observed with 
substrates containing electron-withdrawing substituents (entries 6–9). Further studies will 
be needed to explain the poor efficiency of this substrate class; however, electron 
withdrawing substituents are expected to slow the rate of cyclopalladation by making the 
directing group less basic and/or by making the C–H bond less nucleophilic (step i, 
Scheme 3.10).27 Additionally, the PdII center formed by cyclopalladation of more electron 
deficient substrates would have a less negative redox potential, and thus likely undergo 
less facile oxidation by alkyl• (step ii, Scheme 3.10). 
 




Interestingly, 3ʹ′-methoxy substituted arylpyridine 25 displayed very different 
reactivity than the analogous 2ʹ′-substituted substrate 9 (Scheme 3.14). When 25 was 
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subjected to the reaction conditions, only ~5% of methylated product 26 was observed. 
Instead, the major products were consistent with the structures of 28 and 29 by GCMS 
analysis.  
 




 Additional substrates containing diverse directing groups were screened for the 
methylation reaction, but they yielded less than 10% of the corresponding methylated 
products as detected by GC. These substrates are summarized in Figure 3.1. 
 
 
Figure 3.1. Substrates Screened That Provided <10% Yield of Methylated Product by 




























3.4  Alkyl Scope 
A wide variety of other 1º alkyl groups were installed using the corresponding 
alkyltrifluoroborate salts (Table 3.5). Alkylation of both arylpyridine 6 and acetanilide 11 
with ethyl, n-butyl, and n-hexyl groups proceeded efficiently to afford 30, 31, 32, and 40. 
The sterically hindered neopentyl group was introduced in 40% yield (34), and alkyl 
chains bearing phenyl, ester, ketone, and trifluoromethyl substituents were compatible 





























































































aConditions: substrate (1 equiv), Pd(OAc)2 (0.10 equiv), alkyl–BF3K (2 equiv), MnF3 (4 equiv), TFE/H2O/AcOH 
(8:1:1, 0.067 M in substrate), 40 ºC, 3–6 h. bIsolated yield. c4 equiv alkyl–BF3K and 3 equiv MnF3 were used. 
dSolvent was TFE/AcOH/H2O (4.5:4.5:1). esolvent was TFE/H2O (9:1) with 2 equiv AcOH. fSolvent was TFE/H2O 















In contrast to the 1º alkyltrifluoroborates shown in Table 3.5, 2º alkyl–BF3K 
reagents did not perform well under the reaction conditions. The use of cyclopropyl–
BF3K yielded no detectable products, and the reaction between arylpyridine 41 and 
cyclohexyltrifluoroborate afforded a mixture of the desired product 42 and the Molander-
type undirected alkylation product 43 (Table 3.6, entry 1). Unlike 43, product 42 was not 
detected in the control reaction without Pd (entry 2), suggesting that 42 is formed by a 
Pd-catalyzed process. A second competing side product is acetoxylated product 44, 
which requires both Pd and Mn, but not CyBF3K, for formation. The observed side 
products provide insight into the mechanism of the current transformation (see section 
3.6), and the results shown in Table 3.6 demonstrate the feasibility of Pd-catalyzed C–H 
alkylation with 2º alkylboron reagents. However, further optimization of the reaction 
conditions will be necessary to achieve high-yielding transformations using 2º 
alkyltrifluoroborates. 
 




The use of a primary alkyltrifluoroborate containing an α-heteroatom (45) 
resulted in the formation of only Molander-type products (Scheme 3.15). Additionally, 
several alkyltrifluoroborates were screened that did not afford any detectable quantities of 
the desired alkylated product (Figure 3.2). 
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Figure 3.2. Alkyltrifluoroborate Reagents that Afforded no Detectable C–H Alkylation 
Products 
  
The observed trends in reactivity of different alkyltrifluoroborates can be 
summarized as follows. Alkylation with MeBF3K tends to afford high yields of 
methylated products (e.g., 81% isolated yield of 5). The use of 1º alkyltrifluoroborates 
results in modest to good yields of alkylated products, although the yields tend to be 
lower than methylation (25–77% isolated yield, Table 3.5). In contrast, use of 
alkyltrifluoroborates that generate 2º or resonance-stabilized alkyl radicals (e.g., 
cyclohexyl, benzyl, benzyloxymethyl) leads to none or very little of the desired products 
(<10% yield). 
 
3.5  Proposed Radical-Mediated Reaction Mechanism 
In contrast to previous reports of PdII/Pd0-catalyzed C–H alkylation with 
alkylboron reagents, the dramatically lower temperatures required for this PdII/MnIII-
mediated transformation are consistent with a fundamentally different operating 
mechanism for this reaction. One possible PdII/PdIII/PdIV mechanism (Scheme 3.16) could 
involve (i) 1 e– oxidation of alkyl–BF3K by MnIII to generate alkyl radical 46, (ii) 1 e– 
oxidation of palladacycle 47 by 46 to afford PdIII–alkyl species 48, (iii) 1 e– oxidation of 
48 by a second equivalent of MnIII to provide PdIV–alkyl species 49, and finally (iv) C–C 
N N
10 mol % Pd(OAc)2
2.5 equiv MnF3
10% H2O in AcOH
















bond-forming reductive elimination to generate the alkylated product 50 and a PdII 
species that undergoes cyclometallation with 6 to regenerate 47. A related PdII/PdIII/PdI 
catalytic cycle could also be envisioned. 
 
Scheme 3.16. Proposed PdII/PdIII/PdIV Mechanism for the Alkylation Reaction 
 
 
 Several pieces of evidence support the intermediacy of alkyl radicals in this 
transformation. These points are discussed in sections 3.6–3.8 and include: (1) the 
observation of Molander-type alkylated side products in the reaction of arylpyridine 
substrate 6, (2) the trends in reactivity of different alkyltrifluoroborates, and (3) the lack 
of reactivity seen with traditional 2 e– oxidants. 
 
3.6  Evidence for an Alkyl Radical-Mediated Mechanism: Molander-Type Side 
Products 
As illustrated by Table 3.6 and Scheme 3.15, Molander-type pyridine alkylation 
products are observed when CyBF3K or BnOCH2BF3K salts are employed. Notably, we 
have also observed these Molander-type side products in Pd-free control reactions using 
alkyltrifluoroborates that normally afford higher yields of the desired C–H alkylated 
products in the presence of Pd. For instance, pyridine-alkylated products 51 are observed 
in the Pd-free control reaction with PhCH2CH2BF3K (Table 3.7, entry 2). These results 
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suggest that alkyl radicals are present under reaction conditions that are relevant to our 
catalytic system. 
 
Table 3.7. Observation of Undirected Pyridine-Alkylated Products with Phenethyl–BF3K 
 
 
In contrast, this type of non-directed alkylation is not reported as a side reaction 
under the conditions developed by Yu and coworkers for arylpyridine C–H alkylation.3  
Furthermore, in our hands, these products were not observed even in the absence of Pd 
(Scheme 3.17). The observation of undirected pyridine-alkylated products in our system, 
but not in Yu’s, is consistent with a mechanism involving alkyl radicals in the former 
system, but not in the latter.  
 













































aBased on calibrated GC yield relative to hexadecane as standard. bGC calibrated 
yield relative to hexadecane as standard cGC yield using calibration for 33, relative 
to hexadecane as standard.
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3.7  Evidence for an Alkyl Radical-Mediated Mechanism: Reactivity Trends of 
Alkytrifluoroborates 
A second piece of evidence supporting the proposed radical-mediated mechanism 
is provided by the observed trends in reactivity of different alkyltrifluoroborates. These 
trends are consistent with steps involving alkyl–BF3K acting as a reductant for MnIII (step 
i, Scheme 3.16) and an alkyl radical serving as an oxidant for PdII (step ii, Scheme 3.16) 
Specifically, the yields of C–H alkylated products track with the redox potentials of the 
corresponding RBF3K reagents and R• intermediates (Table 3.8). The majority of the 
alkyltrifluoroborates that were used successfully are expected to provide alkyl radicals 
with redox potentials similar to ethyl• (entry 3).28 
 




As shown in Table 3.8, substituted sp3 carbon-centered radicals are characterized 
by lower redox potentials than that of methyl• (i.e., substituted alkyl• is less easily 
reduced than Me•).28 Alkyl radicals substituted with resonance stabilizing moieties (e.g., 
heteroatoms) have even lower redox potentials (e.g., entries 4, 6, 7, and 9). By extension, 
the corresponding substituted alkyl–BF3K species should have lower redox potentials 
than MeBF3K (i.e., substituted alkyl–BF3K are more easily oxidized than MeBF3K).  
Taking these redox trends into consideration, it is expected that stabilizing 
substituents on the alkyl radical may have the following effects on the reaction pathway: 
(1) the rate of reaction between alkyl• and the intermediate palladacycle could be slowed 
(step ii in Scheme 3.16), allowing competing side reactions of alkyl• to occur; and (2) the 
rate of radical generation (step i in Scheme 3.16) may be accelerated, particularly when 
alkyl is substituted with a stabilizing heteroatom(s). The latter effect could be detrimental 
to the overall yield of the desired transformation because only 10 mol % of palladacycle 
47 can be in solution at any given time to participate in step ii of the catalytic cycle. A 
large excess of alkyl• relative to 47 would likely be consumed by unproductive side 
processes (e.g., those shown in Scheme 3.18).  
 
Scheme 3.18. Examples of Side Reactions of Alkyl• that Could Compete with Step ii of 
the Proposed Catalytic Cycle 
 
81 
If alkyl–BF3K (and the resultant alkyl•) is consumed rapidly at the start of the 
reaction by unproductive processes, the observation of products similar to those detected 
in control reactions without alkyl–BF3K would be expected (assuming that an excess of 
MnIII is present). (Such products would also be expected in a converse scenario; namely, 
if alkyl–BF3K is stable toward oxidation by MnIII, allowing MnIII to instead participate in 
undesired side reactions). As shown in Section 3.2, acetoxylated arylpyridine 8 is the 
main product observed upon subjection of 6 to the reaction conditions in the absence of 
an alkyl–BF3K reagent (Table 3.2, entry 4 in Section 3.2). Indeed, this product (8) was 
also detected in significant quantities when cyclopropyl–BF3K was used as the alkylating 
reagent, and none of the desired C–H functionalized product was formed (Scheme 3.19). 
Based on redox potentials, cyclopropyl–BF3K is expected to produce a radical that is a 
poor oxidant (E0 = 0.05 V, Table 3.8), resulting in a slow step ii. As such, cyclopropyl–
BF3K may be quickly consumed early into the reaction without generating any of the 
desired C–H functionalized product. A number of mechanisms for formation of side 
product 8 could be envisioned. Scheme 3.20 illustrates one possible reaction pathway 
involving oxidation of PdII by MnIII (instead of by cyclopropyl•) followed by C–O bond-
forming reductive elimination from a PdIV complex. 
 





Scheme 3.20. Possible Mechanism for Formation of Acetoxylated Product 8 
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In summary, the observed trends in reactivity of the alkyltrifluoroborates are 
consistent with a hypothesis that, as redox potentials of alkyl–BF3K (or alkyl•) become 
less positive, the rate of step (ii) in the proposed reaction mechanism (Scheme 3.16) 
becomes less favorable relative to the rates of unproductive side reactions. Importantly, 
the observed correlation between alkyl radical redox potentials and reaction yields does 
not provide conclusive evidence to support or refute the proposed reaction mechanism. 
Detailed studies will be needed to elucidate the origin of the observed correlation, and to 
investigate the contribution of other factors to the observed trends in reactivity. For 
instance, many of the putative Pd–alkyl intermediates could undergo competing β-
hydride elimination, a process that is not possible from Pd–methyl intermediates. The 
olefin moiety in allyltrifluoroborate may participate in divergent Pd-catalyzed reactions. 
Lastly, factors such as the nucleophicility and the sterics of the alkyl radicals, as well as 
the rates of reductive elimination from a Pd–alkyl species, may contribute to the observed 
trends. 
 
3.8  Evidence for an Alkyl Radical-Mediated Mechanism: Results of Screening 
Alternative Oxidants 
A number of oxidants were screened for the methylation reaction of 6 in the 
optimized solvent system (Table 3.9). Other manganese salts besides MnF3 were 
ineffective, including those in higher and lower oxidation states (entries 3, 5, and 6). 
Importantly, oxidants that have been used for C–H alkylation under a proposed PdII/Pd0 
catalytic cycle3–9 were also ineffective under our conditions (entries 8–11). However, 
potassium persulfate promoted the desired transformation, albeit in poor yield (entries 11 
and 12). This peroxide oxidant has been used previously in conjunction with catalytic 
AgNO3 or FeS to promote aryl• formation from arylboronic acids.29 The ineffectiveness 
of all oxidants screened, except those previously shown to generate carbon-centered 
radicals from organoboron species, is consistent with the hypothesis of a radical-mediated 





Table 3.9. Oxidant Screen for the Pd-Catalyzed C–H Alkylation Reaction 
 
 
3.9  Discussion of the Roles of Acetic Acid and Water 
As shown in Section 3.2, both acetic acid and water were found to be necessary 
components of the reaction mixture. It is believed that water improves the solubility of 
the trifluoroborate salt in the reaction solvent. For instance, at least ~50 equiv H2O were 











40 ºC, 6 h
oxidant % conversionb,c % yieldbentry
1 MnF3 100 89
2 Mn(OAc)3 10 0
3 Mn(OAc)2 7 0
4 Mn2O3 0 0
5 MnO2 6 0
9 Ag2CO3 7 0
12 tBuOOH 22 0
13 K2S2O8 100 9
6 KMnO4 21 0
8 benzoquinone 11 0
aConditions: 6 (8.5 mg, 0.050 mmol, 1 equiv), Pd(OAc)2 (1.1 mg, 0.005 mmol, 
0.10 equiv), MeBF 3K (12.2 mg, 0.100 mmol, 2 equiv), oxidant (4 equiv), 
TFE/H2O/AcOH (8:1:1, 0.067 M in 6), 6 h. bBased on calibrated GC yield 
relative to hexadecane as standard. cIn cases with high conversion but low yield 
of methylated product 5, 6 may undergo a high oxidation-state Pd-catalyzed 
homodimerization process, which has been previously publlshed in reference 
31. The product of homodimerization is difficult to observe and quantify by GC 
because it appears as a broad peak in the baseline.
(5)(6)
14 K2S2O8 + 0.2 equiv AgNO3 100 10
7 PhI(O2CCF3)2 38 0
11 Ag2O + 0.5 equiv benzoquinone 4 0




Figure 3.3. Yield of Methylated Product 20 in the Presence of Varying Equivalents of 
Water 
 
Acetic acid (or other carboxylic acid additives) was also necessary for the 
alkylation reactions; however, the optimal equivalents of AcOH varied with different 
substrates. For arylpyridine 6, the highest yields of 5 were obtained when 10–30 equiv 
AcOH were included in the reaction mixture (Figure 3.4). In contrast, the best yields of 



























































































Further studies will be necessary to elucidate the role of acid in this reaction. We 
tentatively hypothesize that it may be involved in cyclopalladation or with modulating the 
activity of MnF3.  
 
3.10  C–H Arylation with Potassium Aryltrifluoroborates 
In collaboration with my colleague Cydney Seigerman, we have found that the 
use of aryltrifluoroborates under conditions similar to the C–H alkylation conditions can 
provide C–H arylated products (Scheme 3.21). Pd-catalyzed C–H arylation reactions 
using arylboronic acid derivatives have been previously reported at both elevated (70–
110 ºC)4–7,9,32 and mild (≤40 ºC)8,33 reaction temperatures through putative PdII/Pd0 
catalytic cycles. We believe that the C–H arylation in the presence of MnIII proceeds 
through a high oxidation-state Pd-catalyzed mechanism; however, insufficient evidence is 
currently available to distinguish between a radical or an ionic reaction mechanism. 
 
Scheme 3.21. Pd-Catalyzed C–H Arylation with Aryltrifluoroborates and Mn(OAc)3 
 
 
3.11  Conclusions and Outlook 
This chapter describes a Pd-catalyzed ligand directed C–H alkylation using 
alkyltrifluoroborate reagents in conjunction with MnF3. This new approach is highly 
complementary to previously reported methodologies for C–H alkylation. Unlike earlier 
examples, this reaction does not require the use of high temperatures or stoichiometric 
bases or silver salts. Alkylation proceeds under remarkably mild temperatures (25–40 ºC) 
with short reaction times (2–6 h). Pyridine- and amide-containing aryl substrates can be 
alkylated with methyl and a variety of 1º alkyl groups in good to excellent yields. 
Furthermore, aryltrifluoroborates can be used under similar reaction conditions to provide 
C–H arylated products.  
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Several pieces of evidence support an alkyl radical-mediated reaction mechanism 
for the alkylation reaction. This evidence includes: (1) the observation of non-directed 
pyridine-alkylation side products in control reactions without Pd, (2) the trends in 
reactivity observed with different alkyltrifluoroborates, and (3) the ineffectiveness of 
traditional 2 e– oxidants for this transformation.  
 
3.12  Experimental Procedures and Characterization Data 
General Procedures 
 NMR spectra were obtained on a Varian vnmrs 700 (699.76 MHz for 1H; 175.95 MHz 
for 13C) or a Varian MR400 (400.52 MHz for 1H; 100.71 for 13C, 376.87 MHz for 19F) 
spectrometer. 1H and 13C NMR chemical shifts are reported in parts per million (ppm) 
relative to TMS, with the residual solvent peak used as an internal reference. 
Multiplicities are reported as follows: singlet (s), doublet (d), doublet of doublets (dd), 
doublet of doublets of doublets (ddd), doublet of triplets (dt), triplet (t), triplet of doublets 
(td), triplet of triplets (tt), quartet (q), quintet (quin), multiplet (m), and broad resonance 
(br). IR spectra were obtained on a Perkin-Elmer Spectrum BX FT-IR spectrometer. 
Melting points were determined with a Mel-Temp 3.0, a Laboratory Devices Inc, USA 
instrument, and are uncorrected. HRMS data were obtained on a Micromass AutoSpec 
Ultima Magnetic Sector mass spectrometer. Gas chromatography was carried out on a 
Shimadzu 17A using a Restek Rtx®-5 (Crossbond 5% diphenyl – 95% dimethyl 
polysiloxane; 15 m, 0.25 mm ID, 0.25 µm df) column. GC calibrated yields are reported 
relative to hexadecane as an internal standard. 
 
Materials and Methods. Substrate 6 was prepared by a literature procedure.34 Substrate 
9 was prepared by a palladium-catalyzed Suzuki coupling between 2-methoxyboronic 
acid and 2-bromopyridine. The remaining substrates were obtained from Aldrich (15 and 
19), Acros (11), Alfa Aesar (13), Lancaster Synthesis (21), or TCI America (23). n-
BuBF3K and EtBF3K were obtained from Aldrich, and all other potassium 
trifluoroborates were obtained from Frontier Chemical. MnF3 and Pd(OAc)3 were 
obtained Alfa Aesar and Pressure Chemical, respectively. Trifluoroethanol was obtained 
from TCI America, and all other solvents were from Fisher Chemical. All commercial 
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substrates, reagents, and solvents were used as received without further purification. 
Flash chromatography was performed on EM Science silica gel 60 (0.040–0.063 mm 
particle size, 230–400 mesh) and thin layer chromatography was performed on Merck 
TLC plates pre-coated with silica gel 60 F254. 
 
Synthesis and Characterization of Methylated Products in Table 3.3 
General Procedures  
Method A: To a solution of substrate (1 equiv), Pd(OAc)2 (0.10 equiv), and potassium 
methyltrifluoroborate (2 equiv) in TFE/H2O/AcOH (8:1:1, 0.067 M with respect to 
substrate) in a scintillation vial was added MnF3 (4 equiv). The vial was sealed with a 
Teflon-lined cap, and the mixture was stirred at 40 °C for 2-6 h. The reaction was 
quenched with 10 wt % aqueous Na2SO3 (0.5 times the volume of total solvent), and then 
the reaction mixture was poured into a saturated solution of aqueous NaHCO3 and diluted 
by 10-fold with EtOAc or Et2O. The organic layer was washed twice with aqueous 
NaHCO3, and the combined aqueous layers were extracted three times with EtOAc or 
Et2O. The combined organic layers were washed with brine, dried over MgSO4, and 
concentrated to afford the crude product, which was then purified by column 
chromatography. 
 
Method B: To a solution of substrate (1 equiv), Pd(OAc)2 (0.10 equiv), potassium 
methyltrifluoroborate (2 equiv), and AcOH (2 equiv) in TFE/H2O (9:1, 0.067 M with 
respect to substrate) in a scintillation vial was added MnF3 (4 equiv). The vial was sealed 
with a Teflon-lined cap, and the mixture was stirred at 25 or 40 °C for 2-6 h. The reaction 
was quenched with 10 wt % aqueous Na2SO3 (0.5 times the volume of total solvent), and 
then the reaction mixture was poured into a saturated solution of aqueous NaHCO3 and 
diluted by 10-fold with EtOAc or Et2O. The organic layer was washed twice with 
aqueous NaHCO3, and the combined aqueous layers were extracted three times with 
EtOAc or Et2O. The combined organic layers were washed with brine, dried over 




Aryl Pyridine 5. Method A was followed using substrate 6 (84.6 mg, 
0.50 mmol, 1.0 equiv), Pd(OAc)2, (11.2 mg, 0.050 mmol, 0.10 equiv), 
MeBF3K (122 mg, 1.00 mmol, 2 equiv), and MnF3 (224 mg, 2.00 mmol, 
4 equiv) in TFE/H2O/AcOH (8:1:1; 7.5 mL total) at 40 ºC for 3 h. Product 5 was obtained 
as a pale yellow oil (74.1 mg, 81% yield, Rf = 0.22 in 80% hexanes/20% Et2O). 1H NMR 
(700 MHz, CDCl3): δ 8.72 (ddd, J = 4.9, 1.9, 1.2 Hz, 1H), 7.76 (td, J = 7.8, 1.9 Hz, 1H), 
7.26 (ddd, J = 7.8, 4.9, 1.2 Hz, 1H), 7.23 (dt, J = 7.8, 1.2 Hz, 1H), 7.19 (t, J = 7.6 Hz, 
1H), 7.10 (d, J = 7.6 Hz, 2H), 2.04 (s, 6H). 13C{1H} NMR (176 MHz, CDCl3): δ 159.9, 
149.7, 140.5, 136.2, 135.7, 127.8, 127.5, 124.4, 121.6, 20.2. HRMS [M+H]+ Calcd for 
C13H14N: 184.1121; Found: 184.1121. 
 
Aryl Pyridine 10. Method A was followed using substrate 9 (92.6 mg, 
0.50 mmol, 1.0 equiv), Pd(OAc)2, (11.2 mg, 0.050 mmol, 0.10 equiv), 
MeBF3K (122 mg, 1.00 mmol, 2 equiv), and MnF3 (224 mg, 2.00 mmol, 
4 equiv) in TFE/H2O/AcOH (8:1:1; 7.5 mL total) at 40 ºC for 3 h. Product 10 was 
obtained as a pale yellow oil (69.3 mg, 70% yield, Rf = 0.20 in 60% hexanes/40% Et2O). 
1H NMR (700 MHz, CDCl3): δ 8.72 (ddd, J = 4.9, 1.9, 1.1 Hz, 1H), 7.73 (td, J = 7.6, 1.9 
Hz, 1H), 7.29 (dt, J = 7.8, 1.1 Hz, 1H), 7.25 (dd, J = 8.2, 7.7 Hz, 1H), 7.24 (ddd, J = 7.5, 
4.9, 1.1 Hz, 1 H), 6.89 (d, J = 7.7 Hz, 1H), 6.83 (d, J = 8.2 Hz, 1H), 3.71 (s, 3H), 2.08 (s, 
3H). 13C{1H} NMR (176 MHz, CDCl3): δ 157.2, 157.0, 149.4, 137.9, 135.8, 129.9, 
128.8, 125.5, 122.6, 121.6, 108.4, 55.7, 19.8. HRMS [M+H]+ Calcd for C13H14NO: 
200.1070; Found: 200.1070. 
 
Acetanilide 12. Method B was followed using substrate 11 (74.6 mg, 
0.50 mmol, 1.0 equiv), Pd(OAc)2, (11.2 mg, 0.050 mmol, 0.10 equiv), 
MeBF3K (122 mg, 1.00 mmol, 2 equiv), MnF3 (224 mg, 2.00 mmol, 4 
equiv), and AcOH (57 µL, 1.00 mmol, 2.0 equiv) in TFE/H2O (9:1; 7.5 
mL total) at room temperature for 3 h. Product 12 was obtained as a white solid [78.2 mg, 
96% yield, Rf = 0.27 in 50% hexanes/50% EtOAc, mp = 137.0–138.3 ºC (lit.35 138–141 
ºC)]. 1H NMR (700 MHz, CD3CN, major rotamer): δ 7.77 (br s, 1H), 7.34 (s, 1H), 7.08 
(d, J = 7.8 Hz, 1H), 6.90 (d, J = 7.8 Hz, 1H), 2.27 (s, 3H), 2.17 (s, 3H), 2.07 (s, 3H). 
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13C{1H} NMR (176 MHz, CD3CN, major rotamer): δ 169.5, 137.2, 126.7, 121.1, 129.1, 
126.8, 126.0 23.8, 21.0, 17.6. IR (thin film, CH2Cl2) 3278, 2922, 1657 cm-1. HRMS 
[M+H]+ Calcd for C10H14NO: 164.1070; Found: 164.1070. 
 
Acetanilide 14. Method B was followed using substrate 13 (74.6 mg, 
0.50 mmol, 1.0 equiv), Pd(OAc)2, (11.2 mg, 0.050 mmol, 0.10 equiv), 
MeBF3K (122 mg, 1.00 mmol, 2 equiv), MnF3 (224 mg, 2.00 mmol, 4 
equiv), and AcOH (57 µL, 1.00 mmol, 2.0 equiv) in TFE/H2O (9:1; 7.5 
mL total) at 40 ºC for 3 h. Product 14 was obtained as a white solid [58.7 mg, 72% yield, 
Rf = 0.19 in 50% hexanes/50% EtOAc, mp = 166.6–170.2 ºC (lit.36 176–177 ºC)]. 1H 
NMR (700 MHz, CD3CN, major rotamer): δ 7.70 (br s, 1H), 7.08–7.06 (multiple peaks, 
3H), 2.17 (s, 6H), 2.07 (s, 3H). 13C{1H} NMR (176 MHz, CD3CN, major rotamer): δ 
169.4, 136.8, 136.1, 128.7, 127.7, 22.9, 18.4. IR (thin film, CH2Cl2) 3233, 3044, 1648 
cm-1. HRMS [M+H]+ Calcd for C10H14NO: 164.1070; Found: 164.1071. 
 
Acetanilide 16. Method B was followed using substrate 15 (82.6 mg, 
0.50 mmol, 1.0 equiv), Pd(OAc)2, (11.2 mg, 0.050 mmol, 0.10 equiv), 
MeBF3K (122 mg, 1.00 mmol, 2 equiv), MnF3 (224 mg, 2.00 mmol, 4 
equiv), and AcOH (57 µL, 1.00 mmol, 2.0 equiv) in TFE/H2O (9:1; 7.5 
mL total) at 40 ºC for 3 h. Product 16 was obtained as a white solid [43.6 mg, 53% yield, 
Rf = 0.16 in 50% hexanes/50% EtOAc, mp = 124.1–124.4 ºC (lit.37 123 ºC)]. 1H NMR 
(700 MHz, CD3CN, major rotamer): δ 7.59 (br s, 1H), 7.14 (dd, J = 8.2, 7.5 Hz, 1H), 6.83 
(d, J = 8.2 Hz, 1H), 6.82 (d, J = 7.5 Hz, 1H), 3.77 (s, 3H), 2.15 (s, 3H), 2.05 (s, 3H). 
13C{1H} NMR (176 MHz, CDCl3): δ 169.5, 155.8, 138.1, 128.1, 126.0, 123.0, 109.7, 
56.3, 23.1, 18.3. IR (thin film, CH2Cl2) 3252, 3004, 2935, 2837, 1660 cm-1. HRMS 
[M+H]+ Calcd for C10H14NO2: 180.1019; Found: 180.1020. 
 
Acetanilide 18. Method B was followed using substrate 17 (137.5 mg, 
0.50 mmol, 1.0 equiv), Pd(OAc)2, (11.2 mg, 0.050 mmol, 0.10 equiv), 
MeBF3K (122 mg, 1.00 mmol, 2 equiv), MnF3 (224 mg, 2.00 mmol, 4 
equiv), and AcOH (57 µL, 1.00 mmol, 2.0 equiv) in TFE/H2O (9:1; 7.5 





yield, Rf = 0.25 in 50% hexanes/50% EtOAc, mp = 211.4–213.3 ºC (lit.38 212–214 ºC)]. 
1H NMR (700 MHz, DMSO-d6): δ 9.26 (s, 1H), 7.64 (s, 1H), 7.39 (s, 1H), 2.29 (s, 3H), 
2.12 (s, 3H), 2.04 (s, 3H). 13C{1H} NMR (176 MHz, DMSO-d6): δ 168.2, 139.6, 138.0, 
136.8, 131.2, 126.1, 96.0, 27.0, 23.3, 16.8. IR (thin film, CH2Cl2) 3286, 1654 cm-1. 
HRMS [M+H]+ Calcd for C10H13INO: 290.0036; Found: 290.0038. 
 
Pyrrolidinone 20. Method B was followed using substrate 19 (80.6 mg, 
0.50 mmol, 1.0 equiv), Pd(OAc)2, (11.2 mg, 0.050 mmol, 0.10 equiv), 
MeBF3K (122 mg, 1.00 mmol, 2 equiv), MnF3 (224 mg, 2.00 mmol, 4 
equiv), and AcOH (57 µL, 1.00 mmol, 2.0 equiv) in TFE/H2O (9:1; 7.5 mL total) at 40 ºC 
for 2 h. Product 20 was obtained as a pale yellow oil (63.8 mg, 73% yield, Rf = 0.16 in 
50% hexanes/50% EtOAc). 1H NMR (700 MHz, CDCl3): δ 7.27 (m, 1H), 7.23–7.22 
(multiple peaks, 2H), 7.14 (m, 1H), 3.73 (t, J = 7.1 Hz, 2H), 2.58 (t, J = 8.1 Hz, 2H), 2.24 
(s, 3H), 2.23 (m, 2H). 13C{1H} NMR (176 MHz, CDCl3): δ 174.3, 137.4, 135.5, 131.2, 
127.9, 126.8, 126.6, 50.7, 31.2, 19.1, 17.9. IR (thin film, neat) 2956, 1682 cm-1. HRMS 
[M+H]+ Calcd for C11H14NO: 176.1070; Found: 176.1069. 
 
Acetylindoline 22. Method B was followed using substrate 21 (80.6 mg, 
0.50 mmol, 1.0 equiv), Pd(OAc)2, (11.2 mg, 0.050 mmol, 0.10 equiv), 
MeBF3K (122 mg, 1.00 mmol, 2 equiv), MnF3 (224 mg, 2.00 mmol, 4 
equiv), and AcOH (57 µL, 1.00 mmol, 2.0 equiv) in TFE/H2O (9:1: 7.5 mL total) at 40 ºC 
for 2 h. Product 22 was obtained as a white solid [72.7 mg, 83% yield, Rf = 0.34 in 50% 
hexanes/50% EtOAc, mp = 86.9–88.1 ºC (lit.39 89–90 ºC)].  1H NMR (700 MHz, 
CD3CN): δ 7.08 (t, J = 4.4 Hz, 1H), 7.00–6.99 (multiple peaks, 2H), 4.04 (t, J = 7.6 Hz, 
2H), 3.00 (t, J = 7.6 Hz, 2H), 2.20 (s, 3H), 2.19 (s, 3H). 13C{1H} NMR (176 MHz, 
CD3CN): δ 169.5, 143.0, 136.1, 130.1, 129.5, 125.7, 122.7, 51.9, 30.5, 24.0, 20.8. IR 
(thin film, CH2Cl2) 2920, 1666 cm-1. HRMS [M+H]+ Calcd for C11H14NO: 176.1070; 
Found: 176.1068. 
 
Tetrahydroquinoline 24. Method B was followed using substrate 23 
(87.6 mg, 0.50 mmol, 1.0 equiv), Pd(OAc)2, (11.2 mg, 0.050 mmol, 0.10 









mmol, 4 equiv), and AcOH (57 µL, 1.00 mmol, 2.0 equiv) in TFE/H2O (9:1; 7.5 mL 
total) at 40 ºC for 2 h. Product 24 was obtained as a pale yellow oil (70.0 mg, 74% yield, 
Rf = 0.38 in 50% hexanes/50% EtOAc). 1H NMR (700 MHz, C6D6, major rotamer): δ 
6.89 (t, J = 7.6 Hz, 1H), 6.83 (d, J = 7.6 Hz, 1H), 6.74 (d, J = 7.6 Hz, 1H), 4.93 (ddd, J = 
12.8, 9.2, 5.9 Hz, 1H), 2.51 (ddd, J = 12.8, 8.4, 5.8 Hz, 1H), 2.15 (ddd, J = 14.7, 6.2, 3.3 
Hz, 1H), 2.10 (ddd, J = 14.7, 10.9, 6.7 Hz, 1H), 1.95 (s, 3H), 1.83 (m, 1H), 1.73 (s, 3H), 
1.14 (m, 1H). 13C{1H} NMR (176 MHz, CDCl3, major rotamer): δ 170.9, 139.8, 137.3, 
133.1, 128.9, 126.5, 125.2, 41.4, 26.6, 24.0, 21.3, 17.6. IR (thin film, neat) 2946, 1650 
cm-1. HRMS [M+H]+ Calcd for C12H16NO: 190.1226; Found: 190.1229. 
 
 
Synthesis and Characterization of Alkylated Products in Table 3.5 
General Procedures 
Method A: To a solution of substrate (1 equiv), Pd(OAc)2 (0.10 equiv), and potassium 
alkyltrifluoroborate (2–4 equiv) in TFE/H2O/AcOH (8:1:1 or 4.5:1:4.5, 0.067 M with 
respect to substrate) in a scintillation vial was added MnF3 (3–4 equiv). The vial was 
sealed with a Teflon-lined cap, and the mixture was stirred at 40 °C for 2-6 h. The 
reaction was quenched with 10 wt % aqueous Na2SO3 (0.5 times the volume of total 
solvent), and then the reaction mixture was poured into a saturated solution of aqueous 
NaHCO3 and diluted by 10-fold with EtOAc or Et2O. The organic layer was washed 
twice with aqueous NaHCO3, and the combined aqueous layers were extracted three 
times with EtOAc or Et2O. The combined organic layers were washed with brine, dried 
over MgSO4, and concentrated to afford the crude product, which was then purified by 
column chromatography. 
 
Method B: To a solution of substrate (1 equiv), Pd(OAc)2 (0.10 equiv), potassium 
alkyltrifluoroborate (2 equiv), and AcOH (1 or 2 equiv) in TFE/H2O (9:1, 0.067 or 0.133 
M with respect to substrate) in a scintillation vial was added MnF3 (4 equiv). The vial 
was sealed with a Teflon-lined cap, and the mixture was stirred at 25 or 40 °C for 2-6 h. 
The reaction was quenched with 10 wt % aqueous Na2SO3 (0.5 times the volume of total 
solvent), and then the reaction mixture was poured into a saturated solution of aqueous 
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NaHCO3 and diluted by 10-fold with EtOAc or Et2O. The organic layer was washed 
twice with aqueous NaHCO3, and the combined aqueous layers were extracted three 
times with EtOAc or Et2O. The combined organic layers were washed with brine, dried 
over MgSO4, and concentrated to afford the crude product, which was then purified by 
column chromatography. 
 
Aryl Pyridine 30. Method A was followed using substrate 6 (84.6 
mg, 0.50 mmol, 1.0 equiv), Pd(OAc)2 (11.2 mg, 0.050 mmol, 0.10 
equiv), EtBF3K (136 mg, 1.00 mmol, 2 equiv), and MnF3 (224 mg, 
2.00 mmol, 4 equiv) in TFE/H2O/AcOH (8:1:1; 7.5 mL total) at 40 ºC for 3 h. Product 30 
was obtained as a pale yellow oil (73.8 mg, 75% yield, Rf = 0.26 in 80% hexanes/20% 
Et2O).  1H NMR (700 MHz, CDCl3): δ 8.72 (ddd, J = 5.0, 1.6, 1.0 Hz, 1H), 7.75 (td, J = 
7.6, 1.7 Hz, 1H), 7.27–7.23 (multiple peaks, 3H), 7.14 (d, J = 7.3 Hz, 1H), 7.10 (d, J = 
7.3 Hz, 1H), 2.35 (br m, 2H), 2.02 (s, 3H), 1.03 (t, J = 7.3 Hz, 3H). 13C{1H} NMR (176 
MHz, CDCl3): δ 159.8, 149.6, 141.9, 140.0, 136.1, 135.8, 128.0, 127.4, 125.8, 124.6, 
121.6, 26.5, 20.2, 15.4. HRMS [M+H]+ Calcd for C14H16N: 198.1277; Found: 198.1276. 
 
Aryl Pyridine 31. Method A was followed using substrate 6 (42.3 
mg, 0.25 mmol, 1.0 equiv), Pd(OAc)2 (5.6 mg, 0.025 mmol, 0.10 
equiv), nBuBF3K (164 mg, 1.00 mmol, 4 equiv), and MnF3 (84 mg, 
0.75 mmol, 3 equiv) in TFE/H2O/AcOH (8:1:1; 3.75 mL total) at 40 ºC for 6 h. Product 
31 was obtained as a pale yellow oil (43.2 mg, 77% yield, Rf = 0.30 in 80% hexanes/20% 
Et2O). 1H NMR (700 MHz, CDCl3): δ 8.71 (ddd, J = 4.8, 1.8, 1.2 Hz, 1H), 7.75 (td, J = 
7.7, 1.8 Hz, 1H), 7.26 (ddd, J = 7.7, 4.8, 1.2 Hz, 1H), 7.24 (dt, J = 7.7, 1.2 Hz, 1H), 7.22 
(t, J = 7.6 Hz, 1H), 7.12 (d, J = 7.6 Hz, 1H), 7.09 (d, J = 7.6 Hz, 1H), 2.32 (t, J = 7.9 Hz, 
2H), 2.02 (s, 3H), 1.38 (br m, 2H), 1.16 (sext, J = 7.4 Hz, 2H), 0.74 (t, J = 7.4 Hz, 3H). 
13C{1H} NMR (176 MHz, CDCl3): δ 159.8, 149.5, 140.6, 140.2, 136.0, 135.8, 127.9, 
127.4, 126.6, 124.7, 121.6, 33.3, 33.1, 22.5, 20.3, 13.7. HRMS [M+H]+ Calcd for 








Aryl Pyridine 32. Method A was followed using substrate 6 
(42.3 mg, 0.25 mmol, 1.0 equiv), Pd(OAc)2 (5.6 mg, 0.025 
mmol, 0.10 equiv), n-hexylBF3K (192 mg, 1.00 mmol, 4 equiv), 
and MnF3 (84 mg, 0.75 mmol, 3 equiv) in TFE/H2O/AcOH (8:1:1; 3.75 mL total) at 40 
ºC for 6 h. Product 32 was obtained as a pale yellow oil (39.0 mg, 62% yield, Rf = 0.35 in 
80% hexanes/20% Et2O).  1H NMR (700 MHz, CDCl3): δ 8.71 (ddd, J = 4.7, 1.9, 1.2 Hz, 
1H), 7.75 (td, J = 7.7, 1.9 Hz, 1H), 7.27–7.24 (multiple peaks, 3H), 7.13 (d, J = 7.6 Hz, 
1H), 7.09 (d, J = 7.6 Hz, 1H), 2.31 (t, J = 8.1 Hz, 2H), 2.02 (s, 3H), 1.39 (br m, 2H), 1.18 
(sext, J = 7.3 Hz, 2H), 1.15-1.09 (multiple peaks, 4H), 0.81 (t, J = 7.2 Hz, 3H) 13C{1H} 
NMR (176 MHz, CDCl3): δ 159.8, 149.5, 140.7, 140.2, 136.0, 135.8, 127.9, 127.4, 126.6, 
124.6, 121.6, 33.4, 31.4, 31.0, 29.1, 22.4, 20.3, 14.0. HRMS [M+H]+ Calcd for C18H24N: 
254.1903; Found: 254.1906. 
 
Aryl Pyridine 33. Method A was followed using substrate 6 (84.6 
mg, 0.50 mmol, 1.0 equiv), Pd(OAc)2 (11.2 mg, 0.050 mmol, 0.10 
equiv), potassium phenethyltrifluoroborate (212 mg, 1.00 mmol, 2 
equiv), and MnF3 (224 mg, 2.00 mmol, 4 equiv) in TFE/H2O/AcOH 
(8:1:1; 7.5 mL total) at 40 ºC for 6 h. Product 33 was obtained as a pale yellow oil (67.0 
mg, 49% yield, Rf = 0.23 in 80% hexanes/20% Et2O).  1H NMR (700 MHz, CDCl3): δ 
8.75 (ddd, J = 5.00, 1.6, 1.0 Hz, 1H), 7.75 (td, J = 7.7, 1.6 Hz, 1H), 7.29 (ddd, J = 7.5, 
5.0, 1.0 Hz, 1H), 7.25 (t, J = 7.6 Hz, 1H), 7.20-7.18 (multiple peaks, 3H), 7.16-7.12 
(multiple peaks, 3H), 6.92 (d, J = 7.7 Hz, 2H), 2.71 (br m, 2H), 2.63 (t, J = 8.5 Hz, 2H), 
2.05 (s, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 159.6, 149.6, 142.1, 140.3, 139.6, 
136.2, 136.0, 128.24, 128.20, 128.0, 127.8, 126.7, 125.7, 124.7, 121.8, 37.8, 36.0, 20.3. 
HRMS [M+H]+ Calcd for C20H20N: 274.1590; Found: 274.1596. 
 
Aryl Pyridine 34. Method A was followed using substrate 6 (42.3 mg, 
0.25 mmol, 1.0 equiv), Pd(OAc)2 (5.6 mg, 0.025 mmol, 0.10 equiv), 
potassium neopentyltrifluoroborate (178 mg, 1.00 mmol, 4 equiv), and 
MnF3 (84 mg, 0.75 mmol, 3 equiv) in TFE/H2O/AcOH (4.5:1:4.5; 3.75 








yield, Rf = 0.32 in 80% hexanes/20% Et2O). 1H NMR (700 MHz, CDCl3): δ 8.71 (ddd, J 
= 4.7, 1.7, 1.2 Hz, 1H), 7.72 (td, J = 7.6, 1.8 Hz, 1H), 7.24-7.23 (multiple peaks, 2H), 
7.20 (t, J = 7.5 Hz, 1H), 7.14 (d, J = 7.5 Hz, 1H), 7.12 (d, J = 7.5 Hz, 1H), 2.46 (s, 2H), 
2.04 (s, 3H), 0.71 (s, 9H). 13C{1H} NMR (176 MHz, CDCl3): δ 160.1, 149.2, 141.2, 
137.5, 136.0, 135.6, 129.2, 127.9, 127.0, 125.9, 121.4, 45.6, 32.4, 29.9, 20.8. HRMS 
[M+H]+ Calcd for C17H22N: 240.1747; Found: 240.1748. 
 
Aryl Pyridine 35. Method B was followed using substrate 6 
(84.6 mg, 0.50 mmol, 1.0 equiv),  Pd(OAc)2 (11.2 mg, 0.050 
mmol, 0.10 equiv), potassium 3-trifluoroboratopropionate ethyl 
ester (208 mg, 1.00 mmol, 2 equiv), MnF3 (224 mg, 2.00 mmol, 
4 equiv), and AcOH (57 µL, 1.00 mmol, 2 equiv) in TFE/H2O (9:1; 7.5 mL total) at 40 ºC 
for 6 h. Product 35 was obtained as a pale yellow oil (62.4 mg, 46% yield, Rf = 0.23 in 
80% hexanes/20% Et2O). 1H NMR (700 MHz, CDCl3): δ 8.72 (ddd, J = 4.9, 1.8, 0.9 Hz, 
1H), 7.77 (td, J = 7.8, 1.8 Hz, 1H), 7.28-7.26 (multiple peaks, 2H), 7.23 (t, J = 7.5 Hz, 
1H), 7.134 (d, J = 7.5 Hz, 1H), 7.131 (d, J = 7.5 Hz, 1H), 4.04 (q, J = 7.2 Hz, 2H), 2.67 
(br m, 2H), 2.42 (br m, 2H), 2.02 (s, 3H)1.18 (t, J = 7.2 Hz, 3H). 13C{1H} NMR (176 
MHz, CDCl3): δ 173.0, 159.3, 149.7, 140.3, 138.4, 136.3, 136.1, 128.1, 126.5, 124.6, 
121.9, 60.2, 35.5, 28.7, 20.3, 14.1. Two aromatic 13C resonances are coincidentally 
overlapping. IR (thin film, neat) 2980, 1728 cm-1. HRMS [M+H]+ Calcd for C17H20NO2: 
270.1489; Found: 270.1493. 
 
Aryl Pyridine 36. Method B was followed using substrate 6 (84.6 
mg, 0.50 mmol, 1.0 equiv), Pd(OAc)2 (11.2 mg, 0.050 mmol, 0.10 
equiv), potassium 3,3,3-trifluoropropane-1-trifluoroborate (204 mg, 
1.00 mmol, 2 equiv), MnF3 (224 mg, 2.00 mmol, 4 equiv), and 
AcOH (29 µL, 0.50 mmol, 1 equiv) in TFE/H2O (9:1; 3.75 mL total) at 40 ºC for 6 h. 
Product 36 was obtained as a pale yellow oil (33.8 mg, 25% yield, Rf = 0.30 in 80% 
hexanes/20% Et2O). 1H NMR (700 MHz, CDCl3): δ 8.73 (ddd, J = 5.0, 1.8, 0.9 Hz, 1H), 
7.79 (td, J = 7.7, 1.8 Hz, 1H), 7.30 (ddd, J = 7.7, 5.0, 1.1 Hz, 1H), 7.27-7.25 (multiple 








m, 2H), 2.05 (s, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 158.9, 149.8, 140.4, 137.0, 
136.4, 126.3, 128.6, 128.4, 126.6, 126.5 (q, 1JC–F = 277 Hz) 124.5, 122.1, 35.3 (q, 2JC–F = 
28 Hz), 26.2 (q, 3JC–F = 3 Hz), 20.3. 19F NMR (376 MHz, CDCl3): δ –67.20 (t, J = 11.0 
Hz). HRMS [M+H]+ Calcd for C15H15F3N: 266.1151; Found: 266.1157. 
 
Aryl Pyridine 37. Method A was followed using substrate 6 
(84.6 mg, 0.50 mmol, 1.0 equiv), Pd(OAc)2 (11.2 mg, 0.050 
mmol, 0.10 equiv), potassium 5-oxohexyltrifluoroborate (206 
mg, 1.00 mmol, 2 equiv), and MnF3 (224 mg, 2.00 mmol, 4 
equiv) in TFE/H2O/AcOH (8:1:1; 7.5 mL total) at 40 ºC for 6 h. Product 37 was obtained 
as a pale yellow oil (40.2 mg, 30%, Rf = 0.19 in 60% benzene/20% CH2Cl2/20% Et2O). 
1H NMR (700 MHz, CDCl3): δ 8.71 (ddd, J = 4.9, 1.7, 1.1 Hz, 1H), 7.76 (td, J = 7.6, 1.7 
Hz, 1H), 7.27 (ddd, J = 7.6, 4.9, 1.1 Hz, 1H), 7.23 (dt, J = 7.6, 1.1 Hz, 1H), 7.22 (t, J = 
6.9 Hz, 1H), 7.11-7.09 (multiple peaks, 2H), 2.33 (br t, J = 7.4 Hz, 2H), 2.26 (br m, 2H), 
2.05 (s, 3H), 2.01 (s, 3H), 1.42-1.41 (multiple peaks, 4H) 13C{1H} NMR (176 MHz, 
CDCl3): δ 209.0, 159.7, 149.5, 140.1, 139.9, 136.1, 135.9, 128.0, 127.6, 126.5, 124.7, 
121.7, 43.4, 33.2, 30.5, 29.8, 23.6, 20.3. IR (thin film, neat) 2934, 1711 cm-1. HRMS 
[M+H]+ Calcd for C18H22NO: 268.1696; Found: 268.1701. 
 
Acetanilide 38. Method B was followed using substrate 11 
(37.3 mg, 0.25 mmol, 1.0 equiv), Pd(OAc)2, (5.6 mg, 0.025 
mmol, 0.10 equiv), n-hexylBF3K (96 mg, 0.50 mmol, 2 equiv), 
MnF3 (112 mg, 1.00 mmol, 4 equiv), and AcOH (29 µL, 0.50 
mmol, 2.0 equiv) in TFE/H2O (9:1; 3.75 mL total) at 40 ºC for 3 h. Product 38 was 
obtained as a white solid (42.1 mg, 72% yield, Rf = 0.50 in 50% hexanes/50% EtOAc, 
mp = 113.4–114.7 ºC). 1H NMR (700 MHz, CD3CN, major rotamer): δ 7.73 (br s, 1H), 
7.27 (s, 1H), 7.09 (d, J = 7.6 Hz, 1H), 6.94 (d, J = 7.6 Hz, 1H), 2.52 (t, J = 7.7 Hz, 2H), 
2.27 (s, 3H), 2.06 (s, 3H), 1.50 (quin, J = 7.7 Hz, 2H), 1.35-1.29 (multiple peaks, 6H), 
0.89 (t, J = 7.0 Hz, 3H). 13C{1H} NMR (176 MHz, CD3CN, major rotamer): δ 169.8, 






(thin film, CH2Cl2) 3273, 2925, 1654 cm-1. HRMS [M+H]+ Calcd for C15H24NO: 
234.1852; Found: 234.1857. 
 
Acetanilide 39. Method B was followed using substrate 11 
(37.3 mg, 0.25 mmol, 1.0 equiv), Pd(OAc)2, (5.6 mg, 0.025 
mmol, 0.10 equiv), potassium 3-trifluoroboratopropionate 
ethyl ester (104 mg, 0.50 mmol, 2 equiv), MnF3 (112 mg, 1.00 
mmol, 4 equiv), and AcOH (29 µL, 0.50 mmol, 2.0 equiv) in TFE/H2O (9:1; 3.75 mL 
total) at 40 ºC for 3 h. Product 39 was obtained as a white solid (37.2 mg, 60% yield, Rf = 
0.25 in 50% hexanes/50% EtOAc, mp = 109.5–110.1 ºC). 1H NMR (700 MHz, CD3CN, 
major rotamer): δ 8.10 (br s, 1H), 7.30 (s, 3H), 7.11 (d, J = 7.8 Hz, 1H), 6.95 (d, J = 7.8 
Hz, 1H), 4.07 (q, J = 7.1 Hz, 2H), 2.81 (t, J = 7.7 Hz, 2H), 2.56 (t, J = 7.7 Hz, 2H), 2.27 
(s, 3H), 2.08 (s, 3H), 1.18 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (176 MHz, CD3CN, major 
rotamer): δ 173.3, 168.8, 136.4, 135.8, 131.5, 129.4, 126.4, 126.2, 60.3, 34.5, 25.4, 22.9, 
20.0, 13.5. IR (thin film, CH2Cl2) 3277, 1716, 1654 cm-1. HRMS [M+H]+ Calcd for 
C14H20NO3: 250.1438; Found: 250.1440. 
 
Acetanilide 40. Method B was followed using substrate 11 (74.6 
mg, 0.50 mmol, 1.0 equiv), Pd(OAc)2 (11.2 mg, 0.050 mmol, 
0.10 equiv), potassium phenethyltrifluoroborate (212 mg, 1.00 
mmol, 2 equiv), MnF3 (224 mg, 2.00 mmol, 4 equiv), and AcOH 
(57 µL, 0.50 mmol, 2.0 equiv) in TFE/H2O (9:1; 7.5 mL total) at room temperature for 3 
h. Product 40 was obtained as a white solid (68.4 mg, 54% yield, Rf = 0.41 in 50% 
hexanes/50% EtOAc, mp = 144.4–145.9 ºC). 1H NMR (700 MHz, CD3CN, major 
rotamer): δ 7.66 (s, 1H), 7.28 (t, J = 7.4 Hz, 2H), 7.24 (s, 1H), 7.21 (d, J = 7.4 Hz, 2H), 
7.19 (t, J = 7.4 Hz, 1H), 7.11 (d, J = 7.7 Hz, 1H), 6.95 (d, J = 7.7 Hz, 1H), 2.83-2.82 
(multiple peaks, 4H), 2.28 (s, 3H), 2.05 (s, 3H). 13C{1H} NMR (176 MHz, CD3CN, 
major rotamer): δ 169.8, 143.0, 137.0, 136.7, 125.6, 133.6, 130.4, 129.9, 129.4, 129.3, 
129.2, 127.4, 126.8, 37.0, 33.7, 23.8, 20.9. IR (thin film, CH2Cl2) 3273, 3024, 2926, 1655 
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Asymmetric Pd-Catalyzed Chiral Ligand-Directed Alkene 
Dioxygenation 
 
4.1  Background and Significance  
Alkene difunctionalization reactions are synthetically valuable transformations 
that introduce two functional groups and up to two new stereocenters into a substrate. 
Dioxygenation is particularly widely studied, and several catalytic and non-catalytic 
strategies for alkene dihydroxylation have emerged including the Woodward 
dihydroxylation (Scheme 4.1, path A),1 the Prévost reaction (path B),2 epoxidation/ring-
opening (path C),3 and metal mediated syn-dihydroxylation reactions (path D).4,5  
 
Scheme 4.1. Strategies for Alkene Dioxygenation 
 
 
Of these strategies, Sharpless’ osmium-catalyzed asymmetric dihydroxylation has 
proven particularly valuable, and has a reputation for being a reliable route to syn vicinal 
diols (Scheme 4.2).4 A related Os-catalyzed aminohydroxylation reaction provides access 
to chiral 1,2-amino alcohols in an analogous fashion (Scheme 4.3).4c,6 
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Scheme 4.3. Sharpless Osmium-Catalyzed Aminohydroxylation6a 
 
 
Despite the significance of these methodologies, osmium catalysis remains 
limited. Most importantly, the ability to extend this approach toward the installation of 
diverse nucleophiles beyond hydroxyl/hydroxyl and hydroxyl/amine has not been 
demonstrated. Furthermore, control over the regioselectivity of aminohydroxylation (e.g., 
2 vs 3, Scheme 4.3) is challenging and highlights the need for an alternative strategy for 
installing two non-identical nucleophiles across an alkene. Lastly, the toxicity of osmium 
is often cited as a drawback to these transformations. 
A vast amount of literature on palladium catalysis, and particularly the recent 
surge of work involving high-oxidation-state Pd,7 has opened the door to considering this 
versatile metal as a powerful alternative catalyst for alkene difunctionalization 
transformations.8 Whereas OsVIII catalysis involves concerted syn addition of two 
heteroatoms across an alkene (intermediate 1, Scheme 4.2), Pd reacts with olefins by a 
fundamentally different mechanism that forms each new carbon–X bond in a discrete step 
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(Scheme 4.4).8 This feature of palladium catalysis provides an opportunity to control the 
regioselectivity of alkene difunctionalization with non-identical nucleophiles.  
 
Scheme 4.4. General Mechanism of Pd-Catalyzed Alkene Difunctionalization 
 
 
The use of high-oxidation state Pd catalysis for alkene difunctionalization (instead 
of PdII/Pd0 catalysis) is particularly attractive. Although PdII–alkyl species like 4 tend to 
undergo facile β-hydride elimination, analogous PdIV intermediates are often resistant to 
this decomposition pathway. As such, oxidative interception of the PdII–alkyl 
intermediate 4 generated by nucleopalladation (Scheme 4.5, path A) could suppress 
formation of undesired Wacker-type side products (5, path B). Additionally, there is 
significant precedent for a large variety of bond constructions at PdIV, including the 
formation of C–O, C–N, C–C, and C–halogen linkages. For these reasons, a high-
oxidation state Pd-catalyzed mechanistic manifold could provide a powerful approach to 
achieving a diverse scope of alkene difunctionalizations. 
 
Scheme 4.5. Alkene Difunctionalization by High-Oxidation-State Palladium Catalysis 
 
 
Indeed, numerous Pd-catalyzed oxidative alkene difunctionalization reactions 
have been developed in recent years, including dioxygenations,9 aminooxygenations,10 
aminoarylations,11 diaminations,12 aminofluorinations,13 chloroaminations,14 
arylhalogenations,15 and cyclopropanations.16 These transformations often proceed with 
good selectivity for either syn or anti addition of the vicinal groups. However, the 
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stereoselective formation of non-racemic difunctionalized products by high-oxidation-
state Pd-catalysis has remained largely elusive. A single example of asymmetric alkene 
difunctionalization via PdII/PdIV catalysis utilizes chiral SPRIX ligands and produces 
chiral nonracemic cyclopropanes (Scheme 4.6).16d 
 
Scheme 4.6. Asymmetric PdII/PdIV-Catalyzed Oxidative Cyclization of Enynes 
 
 
One attractive approach for achieving asymmetric Pd-catalyzed alkene 
difunctionalization would involve the use of a chiral directing group. Analogous chiral 
directing group-based strategies have been successfully employed by Yu and coworkers 
to achieve asymmetric C–H bond oxidation via high-oxidation-state Pd catalysis (Scheme 
4.7).17,18 In a similar fashion, we envisioned that a chiral directing ligand (L* in substrate 
6, Scheme 4.8) could potentially relay stereochemical information to the stereocenter(s) 
formed upon alkene difunctionalization (product 8) via a chiral palladacycle intermediate 
7. 
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In addition to providing stereocontrol, the use of this ligand-directed strategy 
could accelerate the rate of Pd-catalyzed alkene difunctionalization by bringing the Pd 
center proximal to the target olefin. Dong and coworkers have shown that simple 
palladium salts like Pd(OAc)2 and PdCl2(MeCN)2 do not effect any detectable 
dioxygenation of alkene 9 with PhI(OAc)2 at 50 ºC after 16 h (Scheme 4.9).9a Instead, 
both Dong (Scheme 4.9) and Shi9c (Scheme 4.10) found that the use of ancillary BINAP 
or NHC ligands was necessary to achieve any reactivity with Pd(OAc)2, and good yields 
of dioxygenated product 10 were only obtained with cationic Pd triflate salts. In contrast, 
we expected that the increased reactivity of a directing-group-containing substrate (6, 
Scheme 4.8) might enable the use of simple Pd salts for alkene diacetoxylation with 
PhI(OAc)2. As such, we chose to focus our initial studies on alkene dioxygenation with 
PhI(O2CR)2 oxidants, using the work by Dong and Shi as a benchmark for testing the 
effectiveness of the envisioned directing group strategy. 
 
Scheme 4.9. Diacetoxylation of an Undirected Substrate with PhI(OAc)2 using a Cationic 





Scheme 4.10. Diacetoxylation of an Undirected Substrate with PhI(OAc)2 Using a 
Cationic Pd(NHC) Triflate Salt9c 
 
 
For the work described in this chapter, we focused on the use of chiral oxime 
ethers as directing groups for asymmetric alkene dioxygenation (13, Scheme 4.11). These 
directing groups were selected based on several key criteria: (1) oxime ethers are known 
to be effective directing ligands for other Pd-catalyzed reactions,19 (2) the substrates can 
easily be prepared from an allyl alcohol 11 and a chiral ketone 12 (Scheme 4.11, step i), 
(3) the chiral auxiliary could potentially be cleaved off at a later stage (step iii) and (4) 
diverse chiral non-racemic ketones are readily available. 
 








4.2  Reaction Optimization 
Diacetoxylation of substrate 14 using a PdII catalyst and PhI(OAc)2 was found to 
proceed in a variety of solvents at relatively mild temperatures (25–50 ºC), and numerous 
PdII salts were effective catalysts for this transformation (Table 4.1). These observations 
stand in contrast to the work by Dong and Shi, in which cationic Pd complexes and acidic 
solvents were necessary to obtain good yields of the diacetoxylated products (vide supra). 
As such, these results provide evidence in support of the hypothesis that a directing group 
can facilitate Pd-catalyzed alkene difunctionalization. 
 
Table 4.1. Solvent and Catalyst Optimization for Pd-Catalyzed Ligand Directed 
Diacetoxylation of 14 
 
 
In our system, the highest yields of product 15 were obtained in dry aromatic 
solvents like benzene, toluene, and chlorobenzene (Table 4.1, entries 7, 8, and 10). 
Although PdCl2(PhCN)2 and Pd(OAc)2 afforded comparable results with 15 (entries 10 
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and 11) subsequent studies on chiral substrates revealed that the use of PdCl2(PhCN)2 
provided better stereocontrol (see section 4.13 for details).  
Furthermore, we found that PhI(OBz)2 could essentially be used essentially 
interchangeably with PhI(OAc)2 to afford the analogous dibenzoylated products. The 
dibenzoylated products offer the advantage of facile visualization on TLC plates. 
Additionally, we later found that diastereomeric dibenzoylated products are easier to 
differentiate by NMR spectroscopy than their diacetoxylated counterparts. For these 
reasons, much of the work presented in this chapter utilizes PhI(OBz)2 instead of 
PhI(OAc)2. For instance, we examined the Pd-catalyzed dioxygenation of achiral oxime 
ether substrate 16 with PhI(OBz)2. Using PdCl2(MeCN)2 as catalyst, this transformation 
proceeded in 59% isolated yield under mild conditions (8 h at 50 ºC in toluene, Scheme 
4.12). 
 




4.3  Control Reactions 
We next sought confirmation that the dioxygenation reaction was proceeding 
through a Pd-catalyzed pathway. Notably, Gade and coworkers have recently 
demonstrated metal-free TfOH-catalyzed alkene diacetoxylation with PhI(OAc)2 
(Scheme 4.13).20,21 Their work provided evidence that the reactions in Schemes 4.99a and 
4.109c using cationic Pd triflate salts, as well as related diacetoxylation reactions using 






Scheme 4.13. Metal-Free TfOH-Catalyzed Alkene Diacetoxylation with PhI(OAc)220 
 
 
We hypothesized that an analogous acid-catalyzed pathway was not feasible in 
our system because of the presence of a basic nitrogen in the oxime ether substrate. 
However, because the envisioned chiral ligand-directed alkene difunctionalization relies 
on the involvement of a palladium catalyst to achieve absolute stereocontrol, it was 
important to rule out the possibility of a competing acid-catalyzed reaction pathway. 
Evidence for the role of Pd, rather than H+, as the active catalyst is presented in Table 
4.2. Importantly, no dioxygenation was observed in the absence of Pd under our reaction 
conditions, even upon the addition of 5–10 mol % TfOH or BF3•OEt2 (see section 4.13 
for further details). 
 
Table 4.2. Control Reactions for the Dibenzoylation of 16 a,b 
 
 
Finally, support for the role of the oxime ether directing ligand is provided in 
Scheme 4.14. Like 16, substrate 18 contains an olefin that is allylic to an oxygen atom. 
112 
Unlike 16, however, 18 does not include a good ligand for palladium. As expected, 
substrate 18 was completely unreactive under the optimized conditions. This observation 
indicates that the oxime ether moiety in 16 is necessary to enable alkene 
difunctionalization under our reaction conditions. 
 




4.4  Syn Diastereoselectivity and Reaction Mechanism 
Several mechanistic pathways for the described dioxygenation reaction can be 
imagined (Scheme 4.15) involving either trans (paths A and B) or cis oxypalladation 
(paths C and D), and direct (paths A and C) or SN2-type reductive elimination (paths B 
and D). In an achiral system, these four pathways would lead to two possible products 
resulting from overall syn or anti addition.  
 




Previous reports have indicated that each of these pathways is possible in the 
context of Pd-catalyzed alkene difunctionalization reactions.8 However, to achieve an 
asymmetric difunctionalization with high stereochemical fidelity, it is important that a 
single reaction pathway is dominant. If two pathways are competing, asymmetric 
induction is likely to be eroded. Thus, in order to assess the feasibility of developing an 
asymmetric transformation, we examined the stereospecificity of dioxygenation of achiral 
cis and trans alkene substrates 19 and 22. In this system, only two dibenzoylated products 
are possible (threo product 20 and erythro product 21). Poor selectivity between 20 and 
21 could suggest the existence of competing reaction pathways. Gratifyingly, under the 
optimal conditions, dioxygenation of both alkenes proceeded with high (~10:1) 
selectivity for the syn addition product (Schemes 4.16 and 4.17).  
 




Scheme 4.17. Syn Selective Dibenzoylation of trans Alkene Substrate 22 
 
 
The relative stereochemistry of the two products was determined by deprotection 
of 20 and 21 to the corresponding diols (Scheme 4.18) and spectroscopic comparison to 
an authentic sample of 23 prepared by Os-catalyzed syn dihydroxylation23 of 19 (Scheme 
4.19). 
114 




Scheme 4.19. Preparation of Authentic Erythro Diol 23 by Os-Catalyzed Syn 




4.5  Use of Chiral Auxiliaries Derived from Commercial Ketones 
With these results in hand, we next examined chiral oxime auxiliaries. A series of 
terminal (allyl) oxime ethers 24–30 were prepared from commercially available chiral 
ketones containing diverse patterns of α-substitution (Table 4.3). The E and Z oxime 
isomers of the same parent ketone provide significantly different steric environments for 
a coordinated Pd center. Therefore, the E and Z diastereomers were separated and studied 
individually when possible (substrates 24, 25, 27, and 28). Importantly, a new 
stereocenter is created upon dioxygenation of these chiral substrates, and the resulting 
products are diastereomers. Thus, control over absolute stereochemistry is reported as a 








Table 4.3. Dibenzoylation with Chiral Auxiliaries Derived from Commerical Ketonesa 
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Oxime stereoisomers 24 and 25 reacted under our standard Pd-catalyzed 
dioxygenation conditions to afforded two spectroscopically different sets of products. 
These results indicate that the oxime ether is configurationally stable under the reaction 
conditions. The stereocenter at the α position of the auxiliary is expected to be in closer 
proximity to the coordinated Pd center in 25 relative to 24. Consistent with this proposal, 
25 reacts to form 32 in modest 63:37 dr, while 24 yields 31 with essentially no selectivity 
(dr = 52:48). These results demonstrate that the steric environment created by the chiral 
oxime auxiliary significantly impacts the stereochemical outcome of the dibenzoylation. 
In keeping with the trend observed with 24 and 25, the dr’s obtained with 
substrates derived from other commercial chiral ketones showed a significant correlation 
with the steric environment at the α-position of the oxime. For example, the 
diastereoselectivity of the reaction of 26 was lower than seen with 25. This may be 
rationalized based on the fact that the 3º-α stereocenter of 26 is tied back into a bicyclic 
scaffold. Improved diastereoselectivity (75:25) was observed in 27, which contains a 4º-α 
stereocenter. However, the overall yield was low, likely due to the highly conjested steric 
environment proximal to the oxime. Consistent with this proposal, the other oxime 
isomer (28) afforded dioxygenated product in lower dr (66:34) but with higher yield. An 
even bulkier 4º-α group (29) resulted in dramatically decreased reactivity, and no 
dioxygenated product was observed. Among the substrates in Table 4.3, the best balance 
between reactivity and selectivity appeared to be found with 30, which features β-
branching adjacent to the 3º-α substituent. 
 
4.6  Use of Auxiliaries Derived from 8-Substituted Menthone 
We next sought to improve on the selectivity seen with 30 by preparing a number 
of 8-substituted menthone derivatives to use as auxiliaries. Excitingly, the addition of a 
third methyl group to the β-position of the ketone (38) provided a substantial 
improvement in stereoselectivity (dr = 86:14 for 43, compared to 74:26 for 37). The 
selectivity remained unchanged with additional mono-substitution at the γ position (39 
and 40). As seen in Table 4.4, however, reaction yields began to decline as the steric bulk 
of the auxiliary increased (compare 45 and 47 to 44). The highest selectivity was seen 
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with 42, which has a 3º carbon at the γ position, albeit with only moderate yield of 
dibenzoylated product 47. 
 





4.7  E/Z Stereochemical Assignment of Oxime Ether Substrates 
Most of the oxime ether substrates in Tables 3 and 4 were isolated as single 
isomers, presumably with an E configuration. This geometry should be 
thermodynamically favored, as it places the bulkier α group trans to the oxime ether N–O 
bond. However, the oxime ethers prepared from α-thujone (24 and 25) and camphor (27 
and 28) were isolated as two distinct isomers. In each case, the major isomer was 
expected to be the E stereoisomer. This assignment was confirmed spectroscopically by 
comparing the chemical shifts of the α carbons (from 13C NMR spectra) and the α 
methylene or methine protons (from 1H NMR) of the two isomers. Literature precedent 
indicates that the chemical shifts of the α carbons should be further upfield when cis to 
the N–O bond than when trans (resulting from steric compression).24 Conversely, the 
chemical shifts of the α methylene or methine protons should be further downfield when 
cis to the N–O bond than when trans (resulting from shielding by the lone pair on 
nitrogen, Figure 4.1).25  
 
 
Figure 4.1. Relative Chemical Shifts of α Protons and Carbons of E and Z Oximes24,25 
 
Proton and carbon assignments for substrates 24, 25, 27, and 28 were made using 
standard 2D NMR techniques (COSY, HSQC, and HMBC). The relative chemical shifts 
of the α carbons were consistent with the assigned E or Z configurations of these 
substrates (Figure 4.2). Additionally, for both sets of substrates, at least one of the α 
protons followed the expected trend. It is believed that the deviation from the literature 
trend seen with H2a in 24 and 25 is a result of the rigid cyclic conformation of the 
119 
substrate. It is likely that the geometry of 24 permits only one of H2a or H2b to experience 
a shielding effect by the lone pair on the oxime nitrogen. 
 
 
Figure 4.2. Chemical Shifts of α Carbons and Protons of 24, 25, 27, and 28 
 
4.8  Quantification of Diastereomeric Ratios 
For the products in Tables 4.3 and 4.4, diastereomeric ratios were obtained from 
13C NMR spectra. This method of analysis was chosen because, for the majority of the 
products isolated, 1H NMR peaks corresponding to the minor product were fully or 
partially overlapping with peaks corresponding to the major product, making isomer ratio 
determination by 1H NMR integration impossible in most cases. In contrast, for all of the 
products isolated, a large number of the peaks in the 13C NMR spectra corresponding to 
the minor product were distinguishable from the peaks corresponding to the major 
product. Each minor product peak, when distinguishable, appeared as a smaller peak 
immediately to the left or right of the major product peak, representing the analogous 
carbon in the opposite diastereomer. Thus, diastereomeric ratios were obtained from the 
relative integrations of major product peaks and minor product peaks representing 
analogous carbons.  
Although 13C NMR is not generally used to obtain quantitative integrations, we 
hypothesized that analogous carbon nuclei on two diastereomers would have identical or 
nearly identical relaxation times. If so, 13C NMR integrations could be used 
quantitatively. To test this hypothesis, we acquired 13C NMR spectra of 43 using 
relaxation delays of 10 s and 0.10 s (default). As expected, the ratio of integrations of 
major and minor peaks for analogous carbons did not change with relaxation delay (ratio 
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= 85.5 : 13.5 for both experiments). (The ratio of integrations between peaks representing 
different carbons did change, as is typical.) Thus the 13C NMR spectra used to obtain 
quantitative integrations were acquired with the default relaxation delay (0.10 s), 
allowing satisfactory spectra to be obtained within a reasonable length of time. A 
minimum of two sets of peaks in the 13C NMR spectra (chosen for having the best 
separation) were integrated to confirm that the ratio was consistent. In the few instances 
where it was possible, integrations from 1H NMR spectra were also used to confirm the 
results of 13C integrations. 
Notably, chiral GC and HPLC were initially explored to obtain dr values (the 
diastereomeric products typically did not separate using achiral columns). While these 
methods often allowed observation of two distinct products, reliable integration by GC 
was not possible as a result of broad peak shapes and poor separation. This may be due in 
part to the high molecular weight of the products; typically very long run times (e.g., 90 
min) were necessary to obtain separation. Although chiral HPLC provided better 
separation in some cases, it did not prove general for the majority of the products. 
 
4.9  Identification of Side Products 
In many cases, the yield of the dioxygenation reaction was relatively poor. This 
can be accounted for, in part, by the formation of several side products analogous to those 
isolated from the diacetoxylation reaction of substrate 16 with PhI(OAc)2 (Scheme 4.20). 
Although these side products have not all been fully characterized, 1H NMR analysis 
suggests that they include monoacetoxylated alkene 49, diastereomeric triacetoxylated 










Scheme 4.20. Side Products Isolated from the Diacetoxylation Reaction of 16 
 
 
Resubjection of 48 to the reaction conditions did not result in the formation of any 
of these side products. This result suggests that side products 49–53 are not derived from 
48.  
 
4.10  Preliminary Results with Additional Directing Groups  
In addition to the chiral ketone auxiliaries presented in Tables 4.3 and 4.4, a 
number of auxiliaries derived from other non-commercial chiral ketones and aldehydes 
were prepared and are described in this section. These auxiliaries did not provide as high 
levels of selectivity as the substrates in Table 4.4, and so full characterization of the 
substrates and products was not pursued. However, studies of these auxiliaries provide 
two important pieces of information about these reactions. First, unlike ketoxime ethers, 
aldoxime ethers appear to be prone to E/Z isomerization under the optimized reaction 
conditions. Second, branching at positions that are remote to the C=N (δ and farther) does 
not appear to have a substantial influence on the stereoselectivity of the dioxygenation 
reaction. 
Subjection of aldoximes 54 and 55 to the reaction conditions with PhI(OAc)2 
resulted in the formation of four distinct diacetoxylated products (analyzed by chiral 
HPLC). This stands in contrast to the typical set of 2 products seen with the ketoxime 
ether substrates in Tables 4.3 and 4.4. The products resulting from diacetoxylation of 54 
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and 55 are expected to be the four diastereomers shown in Schemes 4.21 and 4.22. These 
results suggest that aldoxime substrates are not configurationally stable under the 
dioxygenation conditions. 
 




Scheme 4.22. Diacetoxylation of Aldoxime 55 to Afford Four Diastereomeric Products 
 
 
In an effort to systematically vary the sterics of an oxime ether auxiliary, we 
prepared several derivatives of ketoxime ether 56 substituted at the β-oxygen. Table 4.5 
lists the yields and approximate dr’s for the diacetoxylation of these substrates with 
PhI(OAc)2. Based on the consistently low selectivities with these auxiliaries, it appears 







Table 4.5. Diacetoxylation of Derivatives of Oxime Ether 56 
 
 
Early on in our studies, before determining that ketoxime ethers are 
configurationally stable under the dioxygenation conditions, we were interested in 
exploring substrates derived from C2 symmetric ketones. Such substrates would consist 
of a single isomer regardless of any dynamic isomerization. Substrate 57 was prepared by 
Ir-catalyzed asymmetric hydrogenation of dibenzylidenecyclohexanone26 followed by 
conversion to the allyl oxime ether. Diacetoxylation of 57 proceeded in relatively poor 
yield with 71:29 dr, and further optimization of this transformation was not pursued 




Scheme 4.23. Diacetoxylation of C2-Symmetric Substrate 57 
 
 
4.11 Substituted Alkene Substrates 
The previous sections described dioxygenation of terminal (allyl) or simple 
internal (crotyl) alkenes. In addition to these substrates, more highly substituted alkenes 
were also tested under the dioxygenation conditions. As detailed below, these substrates 
presented significant challenges in terms of reactivity, site-selectivity, and/or 
chemoselectivity; therefore, furthur exploration of the use of such substrates has not yet 
been pursued, and the products of the attempted dioxygenation reactions have not been 



















Table 4.6. Efforts Toward Dioxygenation of Substituted Alkene Substrates 
 
 
In the case of entry 3, we observed a significant amount of a triacetoxylated 
product. To test whether dibenzoylated product 58 was undergoing a third oxygenation, 
we resubjected 58 to the reaction conditions. However, conversion to 59 was not 
observed from 58, suggesting that 58 is not an intermediate in the reaction pathway that 
forms 59 (Scheme 4.24).  
 




4.12  Conclusions and Outlook 
In summary, the results presented in this chapter demonstrate that a chiral 
directing group can facilitate Pd-catalyzed alkene difunctionalization with control over 
the absolute stereoselectivity of the transformation. Preliminary results indicate that this 
directing group strategy also allows for site selective functionalization of proximal 
olefins in the presence of remote alkenes (Scheme 4.25). 
 
Scheme 4.25. Site Selective Functionalization of Diene 60 
 
 
Conceptually, this approach could prove quite powerful if it can be extended to 
the use of diverse nucleophiles. Efforts thus far to apply the developed reaction 
conditions toward the asymmetric dioxygenation of disubstituted alkenes (crotyl oxime 
ethers of achiral ketones) have resulted in erosion of control over relative stereochemistry 
(syn vs anti difunctionalization). Consequently, further optimization will be necessary to 
broaden the scope of this work. 
 
4.13  Experimental Procedures and Characterization Data 
General Procedures and Materials and Methods 
NMR spectra were obtained on a Varian vnmrs 700 (699.76 MHz for 1H; 175.95 MHz 
for 13C), Varian vnmrs 500 (500.10 MHz for 1H; 125.75 MHz for 13C), Varian Inova 500 
(499.90 MHz for 1H; 125.70 MHz for 13C), or a Varian MR400 (400.52 MHz for 1H; 
100.71 for 13C) spectrometer. 1H and 13C NMR chemical shifts are reported in parts per 
million (ppm) relative to TMS, with the residual solvent peak used as an internal 
reference. Multiplicities are reported as follows: singlet (s), doublet (d), doublet of 
doublets (dd), doublet of doublet of doublets (ddd), doublet of doublet of doublet of 
doublets (dddd), triplet (t), quartet (q), quintet (quin), sextet (sext), septet (sept), doublet 
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of triplets (dt), doublet of doublet of triplets (ddt), doublet of triplet of doublets (dtd), 
doublet of quartets (dq), triplet of triplets (tt), quartet of doublets (qd), multiplet (m), and 
broad resonance (br).  IR spectra were obtained on a Perkin-Elmer Spectrum BX FT-IR 
spectrometer. HRMS data were obtained on a Micromass AutoSpec Ultima Magnetic 
Sector mass spectrometer. Gas chromatography was carried out on a Shimadzu 17A 
using a Restek Rtx®-5 (Crossbond 5% diphenyl – 95% dimethyl polysiloxane; 15 m, 
0.25 mm ID, 0.25 µm df) column. Chiral gas chromatography was carried out on a 
Shimadzu 17A using an Agilent Cyclosil-B [30% hepatkis (2,3-di-O-methyl-6-O-t-butyl 
dimethylsilyl)-β-cyclodextrin in DB-1701; 30 m, 0.25 mm ID, 0.25µm df) column. 
Chiral HPLC was performed on a Varian Prostar 210 HPLC using a Daicel Chiralcel 20 
µm silica (46 x 500 mm) column. 
 
Materials and Methods. Commercial ketones were obtained from Aldrich [4-heptanone, 
(–)-(α)-thujone, (1R)-(+)-nopinone, (–)-menthone, and (1R)-(+)-camphor], Acros [(R)-
(+)-2-(2ʹ′-carbomethoxyethyl)-2-methylcyclohexanone], or Mallinckrodt (cyclohexanone) 
and used as received. (+)-Dihydrocarvone was obtained from Acros as a mixture of 
(2R,5R) and (2R,5S) diasteromers, and the major isomer (2R,5R) was isolated by column 
chromatography (Rf = 0.14 and 0.10 in 96% hexanes/4% diethyl ether for the major and 
minor isomers, respectively) prior to use. (R)-(+)-Pulegone was obtained from Acros and 
was used as received to prepare ketones 62–66. PdCl2(PhCN)227 and PhI(OBz)228 were 
prepared according to literature procedures. Toluene was purified using an Innovative 
Technology (IT) solvent purification system composed of activated alumina, copper 
catalyst, and molecular sieves. Flash chromatography was performed on EM Science 
silica gel 60 (0.040-0.063 mm particle size, 230-400 mesh) and thin layer 
chromatography was performed on Merck TLC plates pre-coated with silica gel 60 F254.  
 
Synthesis and Characterization of Allyl Oxime Ether Substrates in Schemes 4.12 and 4.25 
and Table 4.3  
General Procedure. Ketone and O-allyl hydroxylamine hydrochloride were combined in 
pyridine in a scintillation vial. The vial was sealed with a Teflon-lined cap, and the 
mixture was heated to 80 °C for 30 min and then stirred at room temperature overnight. 
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The reaction mixture was diluted by 5-fold with EtOAc or Et2O and washed with 20% 
aqueous AcOH (5 x equal volume to the organic layer) to remove pyridine. The organic 
layer was then neutralized with aqueous NaHCO3, washed with brine, dried over MgSO4, 
and concentrated to yield the oxime ether. Where noted, some oxime ethers were 
obtained as mixtures of E and Z stereoisomers. In these cases, the major (E) stereoisomer 
and the minor (Z) stereoisomer were obtained in isomerically pure form following 
column chromatography.  
 
Oxime Ether 16. The general procedure was followed using 
cyclohexanone (1.00 g, 10.2 mmol, 1.0 equiv), O-allyl hydroxylamine 
hydrochloride (1.34 g, 12.2 mmol, 1.2 equiv), and pyridine (4.4 mL). 
Oxime ether 16 was obtained as a colorless oil (1.37 g, 88% yield). 1H 
NMR (700 MHz, CDCl3): δ 5.99 (ddt, J = 17.5, 10.5, 5.6 Hz, 1H), 5.29 (dd, J = 17.5, 1.4 
Hz, 1H), 5.19 (dd, J = 10.5, 1.4 Hz, 1H), 4.52 (d, J = 5.6 Hz, 2H), 2.48 (t, J = 6.0 Hz, 
2H), 2.20 (t, J = 6.3 Hz, 2H), 1.67 (quin, J = 6.0 Hz, 2H), 1.62–1.57 (multiple peaks, 4H). 
13C{1H} NMR (176 MHz, CDCl3): δ 160.6, 134.6, 116.9, 74.0, 32.2, 27.0, 25.8, 25.7, 
25.3. IR (thin film, neat) 2932, 2860, 1449 cm-1. HRMS [M+H]+ Calcd for C9H15NO: 
154.1226; Found: 154.1221. 
 
Oxime Ethers 24 and 25. The general procedure was followed using (–)-(α)-thujone 
(428 mg, 2.81 mmol, 1 equiv), O-allyl hydroxylamine hydrochloride (370 mg, 3.37 
mmol, 1.2 equiv), and pyridine (1.2 mL) affording the products as a colorless oil 
consisting of an ~2 : 1 mixture of E/Z stereoisomers (545 mg, 94% yield). E and Z 
isomers were obtained in isomerically pure form following column chromatography (Rf = 
0.22 and 0.21 for Z and E isomers, respectively, in 2:1:0.1 hexanes/benzene/CH2Cl2). 
HRMS electrospray (m/z): [M+H]+ calcd for C13H22NO (mixture of oxime isomers), 
208.1696; found, 208.1698. 
Major (E) Isomer (25): 1H NMR (700 MHz, CDCl3): δ  5.97 (ddt, J = 
17.3, 10.6, 5.5 Hz, 1H), 5.26 (ddt, J = 17.3, 1.7, 1.7 Hz, 1H), 5.18 (ddt, 
J = 10.6, 1.7, 1.3 Hz, 1H), 4.50 (m, 2H), 2.66 (d, J = 17.9 Hz, 1H), 
2.65 (m, 1H), 2.39 (app dt, J = 17.9, 1.9 Hz, 1H), 1.33 (sept, J = 6.8 
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Hz, 1H), 1.16 (d, J = 7.2 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H), 0.93 (d, J = 6.8 Hz, 3H), 0.91 
(dd, J = 8.0, 3.9 Hz, 1H), 0.53 (ddd, J = 8.0, 5.3, 2.2. Hz, 1H), 0.04 (dd, J = 5.3, 3.9 Hz, 
1H). 13C{1H} NMR (176 MHz, CDCl3): δ 168.3, 134.4, 117.1, 74.4, 40.8, 32.3, 31.5, 
28.9, 26.8, 21.5, 20.0, 19.7, 16.8. IR (thin film, neat): 2958, 1454 cm-1. 
Minor (Z) Isomer (24): 1H NMR (700 MHz, CDCl3): δ 5.94 (ddt, J = 
17.3, 10.6, 5.4 Hz, 1H), 5.24 (ddt, J = 17.3, 1.6. 0.6 Hz, 1H), 5.16 
(ddt, J = 10.6, 1.6, 0.6 Hz, 1H), 4.48 (m, 2H), 3.07 (qd, J = 7.0, 1.7 
Hz, 1H), 2.58 (d, J = 16.5 Hz, 1H), 2.27 (d, J = 16.5 Hz, 1H), 1.36 
(sept, J = 6.8 Hz, 1H), 1.11 (d, J = 7.2 Hz, 3H), 0.97 (d, J = 6.8 Hz, 3H), 0.91 (d, J = 6.8 
Hz, 3H), 0.906 (dd, J = 8.0, 3.9 Hz, 1H), 0.50 (ddd, J = 8.0, 5.1, 1.7 Hz, 1H), 0.03 (dd, J 
= 4.6, 4.1 Hz, 1H). 13C{1H} NMR (176 MHz, CDCl3): δ 167.7, 134.7, 116.7, 74.2, 37.5, 
32.2, 31.9, 30.2, 26.9, 20.0, 19.8, 17.4, 15.8. IR (thin film, neat): 2957, 1457 cm-1. 
 
Oxime Ether 26. The general procedure was followed using  (1R)-
(+)-nopinone (829 mg, 6.00 mmol, 1 equiv), O-allyl hydroxylamine 
hydrochloride (986 mg, 9.00 mmol, 1.5 equiv), and pyridine (2.6 
mL) affording the product as a colorless oil consisting of an ~8 : 1 
mixture of E/Z stereoisomers (1.09 g, 94% yield). The E isomer (26) was obtained in 
isomerically pure form following column chromatography (Rf = 0.26 in 3:3:0.2 
hexanes/benzene/CH2Cl2). 1H NMR (700 MHz, CDCl3): δ 5.98 (ddt, J = 17.3, 10.6, 5.5 
Hz, 1H), 5.28 (ddt, J = 17.3, 2.7, 1.4 Hz, 1H), 5.18 (ddt, J = 10.5, 2.7, 1.4 Hz, 1H), 4.52 
(ddd, J = 5.5, 1.4, 1.4 Hz, 2H), 2.77 (ddd, J = 19.8, 9.8, 2.6 Hz, 1H), 2.59, (dd, J = 5.6, 
5.6 Hz, 1H), 2.48–2.42 (multiple peaks, 2H), 2.06 (m, 1H), 1.93 (m, 1H), 1.87 (m, 1H), 
1.37 (d, J = 10.6 Hz, 1H), 1.27 (s, 3H), 0.81 (s, 3H). 13C{1H} NMR (176 MHz, CDCl3): 
δ 164.8, 134.8, 116.7, 74.1, 48.1, 40.6, 40.5, 27.3, 25.6, 22.2, 22.1, 18.7. IR (thin film, 
neat): 2918, 1458 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C12H20NO, 
194.1539; found, 194.1543. 
 
Oxime Ethers 27 and 28. The general procedure was followed using (1R)-(+)-camphor 
(761 mg, 5.00 mmol, 1 equiv), O-allyl hydroxylamine hydrochloride (822 mg, 7.50 
mmol, 1.5 equiv), and pyridine (2.2 mL) affording the products as a colorless oil 
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consisting of an ~1.7 : 1 mixture of E/Z stereoisomers (888 mg, 86% yield). E and Z 
isomers were obtained in isomerically pure form following column chromatography (Rf = 
0.18 and 0.08 for E and Z isomers, respectively, in 98% hexanes/2% Et2O).  
Major (E) Isomer (27): 1H NMR (700 MHz, CDCl3): δ 5.98 (ddt, 
J = 17.3, 10.6, 5.4 Hz, 1H), 5.26 (ddt, J = 17.3, 1.5, 1.5  Hz, 1H), 
5.16 (ddt, J = 10.6, 1.5, 1.5 Hz, 1H), 4.53 (ddd, J = 5.4, 1.5, 1.5 
Hz, 2H), 2.50 (ddd, J = 17.9, 4.4, 3.3 Hz, 1H), 2.01 (d, J = 17.9 Hz, 1H), 1.87 (dd, J = 
4.4, 4.4 Hz, 1H), 1.82 (m, 1H), 1.69 (m, 1H), 1.44 (m, 1H), 1.22 (m, 1H), 1.00 (s, 3H), 
0.90 (s, 3H), 0.78 (s, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 169.6, 134.8, 116.7, 
74.1, 51.7, 48.1, 43.7, 33.8, 32.8, 27.3, 19.5, 18.5, 11.2. IR (thin film, neat): 2956, 1456 
cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C13H22NO, 208.1696; found, 
208.1697.  
Minor (Z) Isomer (28): 1H NMR (700 MHz, CDCl3): δ 5.96 (ddt, J = 
17.3, 10.6, 5.3 Hz, 1H), 5.27 (d, J = 17.3 Hz, 1H), 5.16 (d, J = 10.6 
Hz, 1H), 4.44 (d, 5.3 Hz, 2H), 2.49 (ddd, J = 16.3, 3.7, 3.7 Hz, 1H), 
1.90 (d, J = 16.3 Hz, 1H), 1.85–1.81 (multiple peaks, 2H), 1.64–1.58 
(multiple peaks, 2H), 1.32 (s, 3H), 1.27 (m, 1H), 0.90 (s, 3H), 0.84 (s, 3H). 13C{1H} 
NMR (176 MHz, CDCl3): δ 166.1, 134.8, 116.3, 74.2, 55.0, 48.7, 43.9, 36.6, 32.8, 27.3, 
20.4, 18.2, 14.2. IR (thin film, neat): 2956, 1453 cm-1. HRMS electrospray (m/z): [M+H]+ 
calcd for C13H22NO, 208.1696; found, 208.1698. 
 
Oxime Ether 29. The general procedure was followed using 
(R)-(+)-2-(2ʹ′-carbomethoxyethyl)-2-methylcyclohexanone 
(500 mg, 2.52 mmol, 1 equiv), O-allyl hydroxylamine 
hydrochloride (414 mg, 3.78 mmol, 1.5 equiv), and pyridine 
(1.1 mL) affording 29 as a colorless oil consisting of a single (E) stereoisomer (529 mg, 
83% yield).  1H NMR (700 MHz, CDCl3): δ 5.98 (ddt, J = 17.3, 10.6, 5.6 Hz, 1H), 5.25 
(d, J = 17.3 Hz, 1H), 5.17 (d, J = 10.6 Hz, 1H), 4.51 (d, J = 5.6 Hz, 2H), 3.65 (s, 3H), 
2.77 (ddd, J = 14.5, 5.4, 5.4 Hz, 1H), 2.34 (ddd, J = 16.4, 11.2, 5.4 Hz, 1H), 2.22–2.15 
(multiple peaks, 2H), 2.07 (ddd, J = 13.8, 11.2, 5.1 Hz, 1H), 1.67–1.57 (multiple peaks, 
5H), 1.46 (m, 2H), 1.06 (s, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 174.7, 163.0, 
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134.7, 116.9, 74.2, 51.5, 39.8, 39.7, 32.9, 29.1, 25.8, 24.0, 21.5, 21.1. IR (thin film, neat): 
2936, 1737, 1436 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C14H24NO3, 
254.1751; found, 254.1753. 
Oxime Ether 30. The general procedure was followed using (–)-
menthone (1.23 g, 8.00 mmol, 1 equiv), O-allyl hydroxylamine 
hydrochloride (1.32 g, 12.00 mmol, 1.5 equiv), and pyridine (3.5 
mL) affording 30 as a colorless oil consisting of a single (E) 
stereoisomer (1.31 g, 78% yield).  1H NMR (400 MHz, CDCl3): δ 5.99 (ddt, J = 17.3, 
10.5, 5.6 Hz, 1H), 5.26 (ddt, J = 17.3, 1.6, 1.6 Hz, 1H), 5.16 (ddt, J = 10.5, 1.3, 1.3 Hz, 
1H), 4.52 (ddd, J = 5.6, 1.6, 1.3 Hz, 2H), 2.84 (ddd, J = 13.3, 4.3, 1.3 Hz, 1H), 2.12 (app 
octet, J = 6.7 Hz, 1H), 1.87–1.73 (multiple peaks, 5H), 1.40 (m, 1H), 1.14 (m, 1H), 0.95 
(d, J = 6.6 Hz, 3H), 0.90 (d, J = 6.7 Hz, 6H). 13C{1H} NMR (100.7 MHz, CDCl3): δ 
161.0, 135.1, 116.6, 74.0, 48.5, 32.1, 32.05, 32.04, 26.6, 26.5, 21.5, 21.0, 19.4. IR (thin 
film, neat): 2955, 1457 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C13H24NO, 
210.1852; found, 210.1852. 
 
Oxime Ether 60. The general procedure was followed using 
(2R,5R)-dihydrocarvone (300  mg, 1.97 mmol, 1.0 equiv), O-allyl 
hydroxylamine hydrochloride (324 mg, 2.96 mmol, 1.5 equiv), and 
pyridine (0.85 mL). Oxime ether 60 was obtained as a colorless oil 
consisting of a single (E) stereoisomer (403 mg, 99% yield). 1H NMR (700 MHz, 
CDCl3): δ 6.02 (ddt, J = 17.3, 10.5, 5.6 Hz, 1H), 5.29 (ddt, J = 17.3, 1.7, 1.7 Hz, 1H), 
5.19 (ddt, J = 10.5, 1.7, 1.3 Hz, 1H), 4.75 (app s, 2H), 4.55 (ddd, J = 5.6, 1.7, 1.3 Hz, 
2H), 3.38 (ddd, J = 13.6, 3.9, 2.1 Hz, 1H), 2.20 (m, 1H), 2.08 (app tt, J = 12.1, 3.6 Hz, 
1H), 1.96 (app dq, J = 12.9, 3.6 Hz, 1H), 1.86 (m ,1H), 1.75 (s, 3H), 1.63 (dd, J = 13.4, 
12.7 Hz, 1H), 1.43 (app qd, J = 12.9, 3.6 Hz, 1H), 1.26 (app qd, J = 12.6, 3.4 Hz, 1H), 
1.11 (d, J = 6.6 Hz, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 161.9, 148.7, 134.8, 
116.8, 109.2, 74.2, 44.8, 37.3, 35.4, 30.9, 30.0, 20.7, 16.4. IR (thin film, neat) 2968, 




Synthesis and Characterization of Crotyl Oxime Ether Substrates in Schemes 4.16 and 
4.17 
Oxime Ether 21. Substrate 21 was prepared by the reaction sequence 
depicted in Scheme 4.26 involving (1) conversion of 2-butyn-1-ol to 
the corresponding hydroxylamine via the intermediate propargyloxy 
phthalimide (2) condensation of the hydroxylamine with 
cyclohexanone, and (3) alkyne reduction to the cis alkene with Schwartz’ reagent. The 
final product 21 was isolated as a colorless oil (33% from cyclohexanone, Rf = 0.21 in 
95% hexane/5% Et2O). 1H NMR (700 MHz, CDCl3): δ 5.68 (m, 1H), 5.63 (m, 1H), 4.59 
(d, J = 6.3 Hz, 2H), 2.46 (t, J = 6.3 Hz, 2H), 2.20 (t, J = 6.3 Hz, 2H), 1.69 (d, J = 6.4 Hz, 
3H), 1.67 (m, 2H), 1.61–1.57 (multiple peaks, 4H). 13C{1H} NMR (176 MHz, CDCl3): δ 
160.4, 127.9, 126.3, 68.8, 32.2, 27.0, 25.8, 25.7, 25.2, 13.3. IR (thin film, neat) 2929, 
2858, 1448 cm-1. HRMS [M+H]+ Calcd for C10H18NO: 168.1383; Found: 168.1382. 
 
Scheme 4.26. Synthesis of cis-Crotyl Oxime Ether 21 
 
 
Oxime Ether 22. Substrate 22 was prepared by the reaction sequence 
depicted in Scheme 4.27 involving (1) LAH reduction of 2-butyn-1-
ol, (2) conversion of the trans-crotyl alcohol to the corresponding 
hydroxylamine via the intermediate allyloxy phthalimide, and (3) 
condensation of the hydroxylamine with cyclohexanone. The final product 22 was 
isolated as a colorless oil (42% from cyclohexanone, Rf = 0.21 in 95% hexane/5% Et2O). 
133 
1H NMR (700 MHz, CDCl3): δ 5.75 (m, 1H), 5.66 (m, 1H), 4.45 (dd, J = 6.2, 1.1 Hz, 
2H), 2.47 (t, J = 6.3 Hz, 2H), 2.20 (t, J = 6.3 Hz, 2H), 1.72 (dd, J = 6.5, 1.1 Hz, 3H), 1.67 
(m, 2H), 1.63–1.58 (multiple peaks, 4H). 13C{1H} NMR (176 MHz, CDCl3): δ 160.2, 
129.6, 127.2, 73.9, 32.2, 27.0, 25.8, 25.7, 25.4, 17.9. IR (thin film, neat) 2929, 2858, 
1449 cm-1. HRMS [M+H]+ Calcd for C10H18NO: 168.1383; Found: 168.1381. 
 




Synthesis and Characterization of Allyl Oxime Ether Substrates in Table 4.4 
General Procedure. 8-Substituted menthone derivatives 62, 63, 64, and 65 were 
prepared by a literature prep involving the conjugate addition of methyl, ethyl, isobutyl, 
or phenyl Grignard to (R)-(+)-pulegone in the presence of cat. CuBr (Scheme 4.28).29 8-
Isopropyl menthone 66 was prepared by the conjugate addition of iPrLi (2 equiv) to (R)-
(+)-pulegone (1 equiv) in the presence of CuCN (1 equiv) and BF3•Et2O (3 equiv) at –78 
ºC (Scheme 4.29). The resulting 8-substituted menthone derivatives were then refluxed in 
H2O/EtOH with KOH to enhance the ratio of  the desired thermodynamic trans (2S,5R) 











Scheme 4.29. Synthesis 8-Isopropyl Menthone 66 
 
 
The enantiomerically pure (2S,5R) ketones 62–66 and O-allyl hydroxylamine 
hydrochloride were combined in pyridine in a scintillation vial. The vial was sealed with 
a Teflon-lined cap, and the mixture was heated to 80 °C for 30 min and then stirred at 
room temperature overnight. The reaction mixture was diluted by 5-fold with EtOAc or 
Et2O and washed with 20% aqueous AcOH (5 x equal volume to the organic layer) to 
remove pyridine. The organic layer was then neutralized with aqueous NaHCO3, washed 
with brine, dried over MgSO4, and concentrated to yield the oxime ether, which was 
further purified by column chromatography to remove residual impurities from the 
ketone synthesis steps. In all cases, the oxime ether products were isolated as a single 
oxime stereoisomer (E). 
 
Oxime Ether 38.  The general procedure was followed using 8-
methylmenthone 62 (500 mg, 2.97 mmol, 1.0 equiv), O-allyl 
hydroxylamine hydrochloride (456 mg, 4.16 mmol, 1.4 equiv), and 
pyridine (1.3 mL). Oxime ether 38 was obtained as a colorless oil 
(545 mg, 82% yield, Rf = 0.47 in 99% hexanes/1% Et2O). 1H NMR (700 MHz, CDCl3): δ 
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6.00 (ddt, J = 17.3, 10.5, 5.6 Hz, 1H), 5.25 (ddt, J = 17.3, 3.2, 1.0 Hz, 1H), 5.16 (ddt, J = 
10.5, 3.2, 1.0 Hz, 1H), 4.52 (ddd, J = 5.6, 1.0, 1.0 Hz, 2H), 3.15 (ddd, J = 12.9, 4.5, 1.7 
Hz, 1H), 1.98 (app dq, J = 12.9, 4.0 Hz, 1H), 1.84 (dd, J = 11.6, 4.3 Hz, 1H), 1.80 (m, 
1H), 1.64 (m, 1H), 1.41 (dd, J = 12.9, 11.3 Hz, 1H), 1.35 (app qd, J = 12.5, 3.6 Hz, 1H), 
1.06 (m, 1H), 1.03 (s, 9H), 0.95 (d, J = 6.5 Hz, 3H). 13C{1H} NMR (176 MHz, CDCl3): 
δ 160.5, 135.3, 116.7, 74.1, 53.1, 34.6, 34.2, 33.4, 32.8, 28.4, 28.3, 22.2. IR (thin film, 
neat): 2952, 1457 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C14H26NO, 
224.2009; found, 224.2006. 
 
Oxime Ether 39. The general procedure was followed using 8-
ethylmenthone 63 (300 mg, 1.65 mmol, 1.0 equiv), O-allyl 
hydroxylamine hydrochloride (270 mg, 2.47 mmol, 1.5 equiv), and 
pyridine (0.72 mL). Oxime ether 39 was obtained as a colorless oil 
(230 mg, 59% yield, Rf = 0.47 in 99% hexanes/1% Et2O). 1H NMR (700 MHz, CDCl3): δ 
6.00 (ddt, J = 17.3, 10.4, 5.6 Hz, 1H), 5.25 (ddt, J = 17.3, 2.1, 1.3 Hz, 1H); 5.16 (ddt, J = 
10.4, 2.1, 1.3 Hz, 1H), 4.51 (ddd, J = 5.6, 1.3, 1.3 Hz, 2H), 3.16 (ddd, J =12.9, 4.6, 1.7 
Hz, 1H), 1.93–1.90 (multiple peaks, 2H), 1.80 (m, 1H), 1.68–1.61 (multiple peaks, 2H), 
1.41 (dd, J = 12.9, 11.3 Hz, 1H), 1.39–1.30 (multiple peaks, 2H), 1.06 (m, 1H), 1.01 (s, 
3H), 0.95 (d, J = 7.0 Hz, 3H), 0.94 (s, 3H), 0.76 (t, J = 7.5 Hz, 3H). 13C{1H} NMR (176 
MHz, CDCl3): δ 160.6, 135.4, 116.6, 74.1, 50.3, 35.2, 34.8, 34.3, 33.5, 33.1, 28.0, 25.4, 
24.5, 22.3, 8.2. IR (thin film, neat): 2954, 2918, 1457 cm-1. HRMS electrospray (m/z): 
[M+H]+ calcd for C15H28NO, 238.2165; found, 238.2163. 
 
Oxime Ether 40. The general procedure was followed using 
8-iso-butylmenthone 64 (175 mg, 0.83 mmol, 1.0 equiv), O-
allyl hydroxylamine hydrochloride (109 mg, 1.00 mmol, 1.2 
equiv), and pyridine (0.36 mL). Oxime ether 40 was obtained 
as a colorless oil (134 mg, 61% yield, Rf = 0.40 in 99% hexanes/1% Et2O). 1H NMR (700 
MHz, CDCl3): δ 6.00 (ddt, J = 17.3, 10.5, 5.6, 1H), 5.25 (ddt, J = 17.3, 3.3, 1.7 Hz, 1H), 
5.16 (ddt, J = 10.5, 3.3, 1.2 Hz, 1H), 4.51 (ddd, J = 5.6, 1.7, 1.2 Hz, 2H), 3.17 (ddd, J = 
12.8, 4.5, 1.2 Hz, 1H), 1.95 (app. dq, J = 12.7, 3.7 Hz, 1H), 1.92 (dd, J = 11.3, 4.0 Hz, 
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1H), 1.80 (m, 1H), 1.66–1.58 (multiple peaks, 3H), 1.37 (dd, J = 12.8, 11.6 Hz, 1H), 1.36 
(m, 1H), 1.24 (dd, J = 13.8, 5.2 Hz, 1H), 1.06 (m, 1H), 1.04 (s, 3H), 0.99 (s, 3H), 0.95 (d, 
J = 6.5 Hz, 3H), 0.90 (d, J = 6.6 Hz, 3H), 0.88 (d, J = 6.6, 1H). 13C{1H} NMR (176 
MHz, CDCl3): δ 160.6, 135.4, 116.7, 74.1, 51.8, 49.1, 35.9, 34.9, 34.5, 33.6, 28.2, 26.6, 
25.6, 25.5, 24.0, 22.3. Two 13C resonances are coincidentally overlapping. IR (thin film, 
neat): 2953, 2926, 1457 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C17H32NO, 
266.2478; found, 266.2471. 
 
Oxime Ether 41. The general procedure was followed using 
8-phenylmenthone 65 (515 mg, 2.2 mmol, 1.0 equiv), O-allyl 
hydroxylamine hydrochloride (368 mg, 3.36 mmol, 1.5 equiv), 
and pyridine (1 mL). Oxime ether 41 was obtained as a 
colorless oil (359 mg, 56% yield, Rf = 0.62 in 95% hexanes/5% Et2O). 1H NMR (700 
MHz, CDCl3): δ 7.36 (dd, J = 8.5, 1.1 Hz, 2H), 7.27 (dd, J = 8.5, 7.3 Hz, 2H), 7.25 (tt, J 
= 7.3, 1.1. Hz, 1H), 5.90 (ddt, J = 17.3, 10.5, 5.7 Hz, 1H), 5.22 (ddt, J = 17.3, 3.0, 1.3 Hz, 
1H), 5.14 (ddt, J = 10.5, 3.0, 1.3 Hz, 1H), 4.43 (ddd, J = 5.7, 1.3, 1.3 Hz, 2H), 3.11 (ddd, 
J = 13.3, 4.5, 1.8 Hz, 1H), 2.44 (dd, J =11.8, 4.2 Hz, 1H), 1.70 (m, 1H), 1.65 (app. dq, J = 
13.0, 3.8 Hz, 1H), 1.58 (m, 1H), 1.51 (s, 3H), 1.43 (s, 3H), 1.37 (dd, J = 13.3, 11.4 Hz, 
1H), 1.34 (m, 1H), 0.99 (m, 1H), 0.92 (d, J = 6.5 Hz, 3H). 13C{1H} NMR (176 MHz, 
CDCl3): δ 159.5, 150.6, 135.3, 127.7, 126.0, 125.1, 116.7, 74.1, 53.0, 40.1, 34.6, 34.2, 
33.3, 28.7, 26.5, 25.2, 22.2. IR (thin film, neat): 2950, 2924, 1457 cm-1. HRMS 
electrospray (m/z): [M+H]+ calcd for C19H28NO, 286.2165; found, 286.2172. 
 
Oxime ether 42. The general procedure was followed using 8-
iso-propylmenthone 66 (500 mg, 2.55 mmol, 1.0 equiv), O-allyl 
hydroxylamine hydrochloride (419 mg, 3.82 mmol, 1.5 equiv), 
and pyridine (1.1 mL). Oxime ether 42 was obtained as a 
colorless oil (283 mg, 44% yield, Rf = 0.38 in 99% hexanes/1% Et2O). 1H NMR (700 
MHz, CDCl3): δ 5.99 (ddt, J = 17.3, 10.5, 5.6 Hz, 1H), 5.24 (ddt, J = 17.3, 3.4, 1.7 Hz, 
1H), 5.16 (ddt, J = 10.5, 3.4, 1.2 Hz, 1H), 4.51 (ddd, J = 5.6, 1.7, 1.2 Hz, 2H), 3.18 (ddd, 
J = 12.8, 4.7, 1.7 Hz, 1H), 2.23 (app septet, J = 6.9 Hz, 1H), 2.04 (dd, J = 11.8, 4.0 Hz, 
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1H), 1.94 (app dq, J = 13.0, 3.7 Hz, 1H), 1.81 (m, 1H), 1.66 (m, 1H), 1.40 (dd, J = 12.2, 
11.3 Hz, 1H), 1.36 (dddd, J = 12.6, 12.6, 12.6, 4.1 Hz, 1H), 1.06 (dddd, J = 12.6, 12.6, 
12.6, 3.6 Hz, 1H), 0.97 (s, 3H), 0.96 (d, J = 6.5 Hz, 3H), 0.81 (s, 3H), 0.80 (d, J = 6.8 Hz, 
3H), 0.74 (d, J = 6.8 Hz, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 160.9, 135.4, 116.6, 
74.1, 50.1, 37.5, 35.0, 34.6, 33.9, 32.4, 28.5, 22.3, 20.4, 20.1, 17.34, 17.30. IR (thin film, 
neat): 2960, 1925, 1457 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C16H30NO, 
252.2322; found, 252.2313. 
 
Synthesis and Characterization of Dioxygenated Products in Schemes 4.12 and 4.25 and 
Tables 4.3 and 4.4 
General Procedure. Substrate (1 equiv), PdCl2(PhCN)2 (0.05 equiv), and PhI(OBz)2 (2 
or 3 equiv) were combined in dry toluene in a 4 mL or 20 mL scintillation vial and sealed 
with a Teflon-lined cap. Reactions were stirred at 50 ºC for 8 h, then diluted with EtOAc 
and washed with 10% aqueous Na2SO3 and brine. The combined aqueous layers were 
extracted with EtOAc, and the organic layers were then combined, dried over MgSO4, 
filtered, concentrated, and purified by column chromatography on silica gel to afford the 
products as a mixture of diastereomers (indistinguishable by TLC; all product-containing 
column fractions were combined for final yields and dr determination). The ratio of 
diastereomers was determined by 13C NMR integrations and, when possible, confirmed 
by 1H NMR. In all cases, complete 1H and 13C NMR data are reported for the major 
product isomer. In addition, the distinct resonances associated with the minor isomer are 
reported for both the 1H and 13C NMR spectra (many of the peaks for the minor isomer 
are overlapping with those of the major isomer). 
 
Oxime Ether 17. The general procedure was followed using 
substrate 16 (76.6 mg, 0.50 mmol, 1 equiv), PdCl2(PhCN)2 
(9.6 mg, 0.025 mmol, 0.05 equiv), PhI(OBz)2 (446 mg, 1.00 
mmol, 2 equiv), and dry toluene (4.2 mL). Compound 17 
was isolated in 59% yield as a colorless oil (Rf = 0.14 in 
79% hexanes/20% Et2O/1% Et3N). 1H NMR (700 MHz, 
CDCl3): δ 8.06 (d, J = 7.9 Hz, 2H), 8.03 (d, J = 7.9 Hz, 2H), 7.56 (t, J = 7.3 Hz, 1H), 7.55 
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(t, J = 7.3 Hz, 1H), 7.44 (dd, J = 7.9, 7.3 Hz, 2H), 7.42 (dd, J = 7.9, 7.3 Hz, 2H), 5.73 
(dtd, J = 6.2, 5.6, 3.6 Hz, 1H), 4.67 (dd, J = 12.0, 3.6 Hz, 1H), 4.58 (dd, J = 12.0, 6.2 Hz, 
1H), 4.38 (d, J = 5.6 Hz, 2H), 2.42 (m, 2H), 2.15 (m, 2H), 1.63 (m, 2H) 1.57–1.55 
(multiple peaks, 4H). 13C{1H} NMR (176 MHz, CDCl3): δ 166.2, 165.8, 161.5, 133.09, 
133.06, 130.0, 129.9, 129.8, 129.7, 128.4, 128.3, 71.3, 70.7, 63.6, 32.0, 26.9, 25.7, 25.6, 
25.3. IR (thin film, neat): 2934, 1722, 1451 cm-1. HRMS electrospray (m/z): [M+H]+ 
calcd for C23H26NO5, 396.1805; found, 396.1808. 
 
Oxime Ether 20. The general procedure was followed using 
substrate 22 (83.6 mg, 0.50 mmol, 1 equiv), PdCl2(PhCN)2 
(9.6 mg, 0.025 mmol, 0.05 equiv), PhI(OBz)2 (446 mg, 1.00 
mmol, 2 equiv), and dry toluene (4.2 mL). Compound 20 was 
isolated in 53% yield as a colorless oil (Rf = 0.15 in 84% 
hexanes/15% Et2O/1% Et3N) with diastereomeric ratio 
threo:erythro ~ 10 : 1 as measured by 13C NMR. Major (Threo) Isomer: 1H NMR (700 
MHz, CDCl3): δ 8.08 (d, J = 7.9 Hz, 2H), 8.05 (d, J = 7.9 Hz, 2H), 7.55 (t, J = 7.2 Hz, 
1H), 7.54 (t, J = 7.2 Hz, 1H), 7.43 (dd, J = 7.9, 7.2 Hz, 2H), 7.42 (dd, J = 7.9, 7.2 Hz, 
2H), 5.61 (ddd, J = 6.7, 4.8, 4.6 Hz, 1H), 5.51 (qd, J = 6.6, 4.8 Hz, 1H), 4.35 (dd, J = 
12.0, 4.6 Hz, 1H), 4.32 (dd, J = 12.0, 6.7 Hz, 1H), 2.37 (m, 2H), 2.12 (m, 2H), 1.63–1.52 
(multiple peaks, 6H), 1.44 (d, J = 6.6 Hz, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 
165.8, 165.7, 161.4, 132.98. 132.95, 130.1 130.0, 129.7, 129.6, 128.31, 128.30, 73.9, 
71.5, 69.7, 32.0, 26.8, 25.7, 25.5, 25.3, 16.5. IR (thin film, neat, mixture of isomers): 
2936, 1716, 1451 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C24H28NO5, 
410.1962; found, 410.1949. 
 
Oxime Ether 21. The general procedure was followed using 
substrate 19 (83.6 mg, 0.50 mmol, 1 equiv), PdCl2(PhCN)2 
(9.6 mg, 0.025 mmol, 0.05 equiv), PhI(OBz)2 (446 mg, 1.00 
mmol, 2 equiv), and dry toluene (4.2 mL). Compound 21 was 
isolated in 65% yield as a colorless oil (Rf = 0.15 in 84% 
hexanes/15% Et2O/1% Et3N) with diastereomeric ratio 
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threo:erythro ~ 1 : 13 as measured by 13C NMR. Major (Erythro) Isomer: 1H NMR (700 
MHz, CDCl3): δ 8.06 (d, J = 7.9 Hz, 2H), 8.02 (d, J = 7.9 Hz, 2H), 7.56 (t, J = 7.8 Hz, 
1H), 7.55 (t, J = 7.8 Hz, 1H), 7.43 (dd, J = 7.9, 7.8 Hz, 2H), 7.42 (dd, J = 7.9, 7.8 Hz, 
2H), 5.64 (ddd, J = 7.0, 4.1, 4.1 Hz, 1H), 5.50 (qd, J = 6.6, 4.4 Hz, 1H), 4.42 (dd, J = 
11.9, 4.1 Hz, 1H), 4.37 (dd, J = 11.9, 7.0 Hz, 1H), 2.37 (m, 2H), 2.12 (m, 2H), 1.63–1.51 
(multiple peaks, 6H), 1.49 (d, J = 6.6 Hz, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 
165.62, 165.55, 163.4, 133.0, 132.9, 130.13, 130.11, 129.7, 129.6, 128.3, 73.8, 71.2, 70.0, 
32.0, 26.8, 25.7, 25.5, 25.3, 15.8. Two 13C resonances are coincidentally overlapping. IR 
(thin film, neat, mixture of isomers): 2937, 1716, 1450 cm-1. HRMS electrospray (m/z): 
[M+H]+ calcd for C24H28NO5, 410.1962; found, 410.1953. 
 
Oxime Ether 31. The general procedure was followed 
using substrate 24 (19.7 mg, 0.095 mmol, 1 equiv), 
PdCl2(PhCN)2 (1.8 mg, 0.0047 mmol, 0.05 equiv), 
PhI(OBz)2 (84.8 mg, 0.19 mmol, 2 equiv), and dry 
toluene (0.79 mL). Compound 31 was isolated in 63% 
yield as a colorless oil (Rf = 0.09 in 91% hexanes/8% 
Et2O/1% Et3N) with diastereomeric ratio 52:48 as 
measured by 1H NMR. Major Isomer: 1H NMR (700 MHz, C6D6): δ 8.16 (d, J = 7.9 Hz, 
2H), 8.10 (d, J = 7.9 Hz, 2H), 7.07 (t, J = 7.7 Hz, 1H), 7.05 (t, J = 7.7 Hz, 1H), 7.007 (dd, 
J = 7.9, 7.7 Hz, 2H), 6.97 (dd, J = 7.9, 7.7 Hz, 2H), 5.940 (m, 1H), 4.60 (dd, J = 12.0, 4.0 
Hz, 1H), 4.48 (dd, J = 11.8, 6.5 Hz, 1H), 4.35–4.32 (multiple peaks, 2H), 3.18 (q, J = 7.0 
Hz, 1H), 2.44 (dd, J = 16.6, 1.2 Hz, 1H), 2.23 (d, J = 16.6 Hz, 1H), 1.054 (d, J = 7.0 Hz, 
3H), 1.04 (m, 1H), 0.764 (d, J = 6.9 Hz, 3H), 0.754 (d, J = 6.9 Hz, 3H), 0.604 (m, 1H), 
0.27 (dd, J = 8.3, 4.3, 1.2 Hz, 1H), –0.02 (dd, J = 4.3, 4.3 Hz, 1H). 13C{1H} NMR (176 
MHz, C6D6): δ 167.7, 166.0, 165.81, 132.98, 132.95, 130.8, 130.5, 130.2, 130.0, 128.6, 
128.5, 72.12, 71.4, 63.8, 37.8, 32.37, 31.99, 30.43, 27.28, 19.81, 19.80, 17.5, 16.1. Minor 
Isomer (distinct resonances): 1H NMR (700 MHz, C6D6): δ 8.17 (d, J =7.9 Hz, 2H), 7.012 
(dd, J = 7.9, 7.7 Hz, 2H), 4.57 (dd, J = 12.0, 3.7 Hz, 1H), 4.47 (dd, J = 12.0, 6.4 Hz, 1H), 
3.15 (q, J = 7.0 Hz, 1H), 2.43 (dd, J = 16.6, 1.2 Hz, 1H), 2.29 (d, J = 16.6 Hz, 1H), 1.048 
(d, J = 7.0 Hz, 3H), 1.03 (m, 1H), 0.750 (d, J = 6.9 Hz, 3H), 0.732 (d, J = 6.9 Hz, 3H), 
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0.604 (m, 1H), 0.30 (ddd, J = 8.3, 4.3, 1.2 Hz, 1H), 0.15 (dd, J = 4.3, 4.3 Hz, 1H). 
13C{1H} NMR (176 MHz, C6D6): δ 167.8, 165.75, 72.11, 71.2, 37.7, 32.39, 32.01, 30.38, 
27.26, 20.1, 20.0, 17.6, 16.0. IR (thin film, neat, mixture of isomers): 2959, 1718, 1452 
cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C27H32NO5, 450.2275; found, 
450.2280. 
 
Oxime Ether 32. The general procedure was followed 
using substrate 25 (20.7 mg, 0.10 mmol, 1 equiv), 
PdCl2(PhCN)2 (1.9 mg, 0.0050 mmol, 0.05 equiv), 
PhI(OBz)2 (89.2 mg, 0.200 mmol, 2 equiv), and dry 
toluene (0.83 mL). Compound 32 was isolated in 64% 
yield as a colorless oil (Rf = 0.09 in 91% hexanes/8% 
Et2O/1% Et3N) with diastereomeric ratio 63:37 as 
measured by 13C NMR. Major Isomer: 1H NMR (700 MHz, CDCl3): δ 8.06 (d, J = 7.9 
Hz, 2H), 8.02 (d, J = 7.9 Hz, 2H), 7.56 (t, J = 7.2 Hz, 1H), 7.55 (t, J = 7.2 Hz, 1H), 7.43 
(dd, J = 7.9, 7.2 Hz, 2H), 7.42 (dd, J = 7.9, 7.2 Hz, 2H), 5.70 (m, 1H), 4.66 (m, 1H), 4.55 
(dd, J = 12.1, 6.1 Hz, 1H), 4.38–4.33 (multiple peaks, 2H), 2.63 (m, 1H), 2.54 (d, J = 
17.8 Hz, 1H), 2.30 (br d, J = 17.8 Hz, 1H), 1.30 (sept, J = 7.0 Hz, 1H), 1.11 (d, J = 7.2 
Hz, 3H), 0.926 (d, J = 7.0 Hz, 3H), 0.88 (m, 1H), 0.85 (d, J = 7.0 Hz, 3H), 0.50 (m, 1H), 
0.06 (app t, J = 4.6 Hz, 1H). 13C{1H} NMR (176 MHz, CDCl3): δ 169.5, 166.2, 165.7, 
133.09, 133.06, 129.94, 129.76, 129.71, 129.67, 128.4, 128.3, 71.7, 70.6, 63.5, 40.70, 
32.19, 31.3, 28.8, 26.6, 21.38, 19.9, 19.6, 16.6. Minor Isomer (distinct resonances): 1H 
NMR (700 MHz, CDCl3): δ 2.59 (d, J = 17.8 Hz, 1H), 2.32 (br d, J = 17.8 Hz, 1H), 1.14 
(d, J = 7.2 Hz, 3H), 0.931 (d, J = 7.0 Hz, 3H), 0.89 (d, J = 7.0 Hz, 3H), –0.04, (app t, J = 
4.6 Hz, 1H). 13C{1H} NMR (176 MHz, CDCl3): δ 169.3, 165.8, 133.08, 133.07, 129.93, 
129.77, 129.72, 71.6, 70.7, 40.73, 32.17, 31.4, 29.0, 26.8, 21.41, 20.0, 16.8. IR (thin film, 
neat, mixture of isomers): 2958, 1718, 1456 cm-1. HRMS electrospray (m/z): [M+H]+ 




Oxime Ether 33. The general procedure was followed 
using substrate 27 (96.6 mg, 0.50 mmol, 1 equiv), 
PdCl2(PhCN)2 (9.6 mg, 0.035 mmol, 0.05 equiv), 
PhI(OBz)2 (446 mg, 1.00 mmol, 2 equiv), and dry toluene 
(4.2 mL). Compound 33 was isolated in 68% yield as a 
colorless oil (Rf = 0.18 in 84% hexanes/15% Et2O/1% 
Et3N) with diastereomeric ratio 59:41 as measured by 13C NMR. Major Isomer: 1H NMR 
(700 MHz, CDCl3): δ 8.06 (d, J = 7.9 Hz, 2H), 8.02 (d, J = 7.9 Hz, 2H), 7.55 (t, J = 7.2 
Hz, 1H), 7.54 (t, J = 7.2 Hz, 1H), 7.43 (dd, J = 7.9, 7.2 Hz, 2H), 7.41 (dd, J = 7.9, 7.2 Hz, 
2H), 5.73 (m, 1H), 4.68 (m, 1H), 4.58 (m 1H), 4.38 (app d, J = 6.1 Hz, 2H), 2.70 (m, 1H), 
2.54 (m, 1H), 2.46–2.36 (multiple peaks, 2H), 2.04 (m, 1H), 1.88 (m, 1H), 1.83 (m, 1H), 
1.29 (d, J = 10.5 Hz, 1H), 1.253 (s, 3H), 0.78 (s, 3H). 13C{1H} NMR (176 MHz, CDCl3): 
δ 166.2, 165.77, 165.75, 133.1, 133.01, 130.0, 129.74, 129.716, 129.66, 128.34, 128.29, 
71.5, 70.7, 63.6, 47.9, 40.5, 40.40, 27.09, 25.52, 22.06, 21.99, 18.51. Minor Isomer 
(distinct resonances): 1H NMR (700 MHz, CDCl3): δ 1.35 (d, J = 10.5 Hz, 1H), 1.248 (s, 
3H), 0.76 (s, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 165.74, 133.03, 129.75, 129.722, 
128.30, 71.4, 70.8, 63.5, 40.37, 27.14, 25.49, 22.05, 22.01, 18.53. IR (thin film, neat, 
mixture of isomers): 2948, 1718, 1452 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for 
C26H30NO5, 436.2118; found, 436.2126. 
 
Oxime ether 34. The general procedure was followed 
using substrate 27 (104 mg, 0.50 mmol, 1 equiv), 
PdCl2(PhCN)2 (9.6 mg, 0.025 mmol, 0.05 equiv), 
PhI(OBz)2 (446 mg, 1.00 mmol, 2 equiv), and dry 
toluene (4.2 mL). Compound 34 was isolated in 25% 
yield as a colorless oil (Rf = 0.12 in 84% hexanes/15% 
Et2O/1% Et3N) with diastereomeric ratio 75:25 as measured by 13C NMR. Major Isomer: 
1H NMR (700 MHz, CDCl3): δ 8.07 (d, J = 7.8 Hz, 2H), 8.03 (d, J = 7.8 Hz, 2H), 7.55 (t, 
J = 7.8 Hz, 1H), 7.54 (t, J = 7.8 Hz, 1H), 7.43 (t, J = 7.8 Hz, 2H), 7.42 (t, J = 7.8 Hz, 2H), 
5.73 (m, 1H), 4.66 (dd, J = 12.0, 3.5 Hz, 1H), 4.57 (dd, J = 12.0, 6.3 Hz, 1H), 4.42–4.36 
(multiple peaks, 2H), 2.45 (m, 1H), 1.92 (d, J = 18.0 Hz, 1H), 1.83 (m, 1H), 1.79 (m, 
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1H), 1.67 (m, 1H), 1.45 (m, 1H), 1.17 (m, 1H), 0.95 (s, 3H), 0.88 (s, 3H), 0.74 (s, 3H). 
13C{1H} NMR (176 MHz, CDCl3): δ  170.5, 166.2, 165.7, 133.05, 133.02, 130.01, 
129.76, 129.75, 129.66, 128.35, 128.30, 71.3, 70.90, 63.59, 51.83, 48.15, 43.6, 33.75, 
32.72, 27.2, 19.38, 18.4, 11.0. Minor Isomer (distinct resonances): 1H NMR (700 MHz, 
CDCl3): δ 2.43 (m, 1H), 1.96 (d, J = 18.0 Hz, 1H), 1.38 (m, 1H), 0.76 (s, 3H). 13C{1H} 
NMR (176 MHz, CDCl3): δ 170.4, 165.8, 133.01, 130.02, 129.77, 128.29, 71.4, 70.92, 
63.61, 51.81, 48.11, 33.70, 32.69, 19.35, 18.5. IR (thin film, neat, mixture of isomers): 
2956, 1718, 1452 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C27H32NO5, 
450.2275; found, 450.2281. 
 
Oxime Ether 35. The general procedure was followed 
using substrate 28 (104 mg, 0.50 mmol, 1 equiv), 
PdCl2(PhCN)2 (9.6 mg, 0.025 mmol, 0.05 equiv), 
PhI(OBz)2 (446 mg, 1.00 mmol, 2 equiv), and dry toluene 
(4.2 mL). Compound 35 was isolated in 68% yield as a 
colorless oil (Rf = 0.24 in 84% hexanes/15% Et2O/1% Et3N) with diastereomeric ratio 
66:34 as measured by 13C NMR. Major Isomer: 1H NMR (700 MHz, CDCl3): δ 8.06 (d, J 
= 8.1 Hz, 2H), 8.02 (d, J = 8.1 Hz, 2H), 7.55 (t, J = 8.1 Hz, 1H), 7.54 (t, J = 8.1 Hz, 1H), 
7.43 (t, J = 8.1 Hz, 2H), 7.41 (t, J = 8.1 Hz, 2H), 5.72 (m, 1H), 4.67 (dd, J = 12.3, 3.9 Hz, 
1H), 4.58 (dd, J = 12.3, 6.4 Hz, 1H), 4.32–4.30 (multiple peaks, 2H), 2.45 (m, 1H), 1.85 
(d, J = 16.3 Hz, 1H), 1.81–1.78 (multiple peaks, 2H), 1.61–1.54 (multiple peaks, 2H), 
1.24 (s, 3H), 1.20 (m, 1H), 0.86 (s, 3H), 0.80 (s, 3H). 13C{1H} NMR (176 MHz, CDCl3): 
δ 166.8, 166.1, 165.7, 133.04, 133.00, 130.0, 129.8, 129.73, 129.66, 128.34, 128.29, 71.8, 
70.7, 63.6, 55.16, 48.8, 43.8, 36.5, 32.7, 27.3, 20.2, 18.2, 14.0. Minor Isomer (distinct 
resonances): 1H NMR (700 MHz, CDCl3): δ 1.86 (d, J = 16.3 Hz, 1H), 1.26 (s, 3H), 0.85 
(s, 3H), 0.81 (s, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 165.8, 70.8, 55.18, 43.9, 32.6, 
14.1. IR (thin film, neat, mixture of isomers): 2956, 1718, 1452 cm-1. HRMS electrospray 
(m/z): [M+H]+ calcd for C27H32NO5, 450.2275; found, 450.2287. 
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Oxime Ether 37. The general procedure was followed 
using substrate 30 (104.7 mg, 0.50 mmol, 1 equiv), 
PdCl2(PhCN)2 (9.6 mg, 0.025 mmol, 0.05 equiv), 
PhI(OBz)2 (446 mg, 1.00 mmol, 2 equiv), and dry 
toluene (4.2 mL). Compound 37 was isolated in 75% 
yield as a colorless oil (Rf = 0.18 in 91% hexanes/8% 
Et2O/1% Et3N) with diastereomeric ratio 74:26 as measured by 13C NMR. Major Isomer: 
1H NMR (700 MHz, CDCl3): δ 8.06 (d, J = 7.8 Hz, 2H), 8.03 (d, J = 7.8 Hz, 2H), 7.56–
7.53 (multiple peaks, 2H), 7.44–7.40 (multiple peaks, 4H), 5.72 (m, 1H), 4.69 (dd, J = 
11.9, 3.7 Hz, 1H) 4.59 (dd, J = 11.9, 6.2 Hz, 1H), 4.40 (app d, J = 5.9 Hz, 2H), 2.83 (dd, 
J = 12.8, 3.5 Hz, 1H), 2.09 (m, 1H), 1.85–1.82 (multiple peaks, 2H), 1.78 (m, 1H), 1.74–
1.67 (multiple peaks, 2H), 1.36 (m, 1H), 1.11 (m, 1H), 0.91 (d, J = 6.3 Hz, 3H), 0.89 (d, J 
= 7.0 Hz, 6H). 13C{1H} NMR (176 MHz, CDCl3): δ 166.2, 165.78, 162.1, 133.02, 
132.99, 130.1, 129.8, 129.74, 129.66, 128.34, 128.28, 71.2, 71.0, 63.6, 48.59, 32.30, 
32.20, 32.18, 26.7, 26.37, 21.5, 21.1, 19.3. Minor Isomer (distinct resonances): 13C{1H} 
NMR (176 MHz, CDCl3): δ 165.76, 161.2, 71.3, 70.9, 48.61, 32.34, 32.24, 32.16, 26.35, 
19.2. IR (thin film, neat, mixture of isomers): 2956, 1718, 1452 cm-1. HRMS electrospray 
(m/z): [M+H]+ calcd for C27H34NO5, 452.2431; found, 452.2434. 
  
Oxime Ether 43. The general procedure was followed 
using substrate 38 (50 mg, 0.0112 mmol, 1 equiv), 
PdCl2(PhCN)2 (4.3 mg, 0.0112 mmol, 0.05 equiv), 
PhI(OBz)2 (300 mg, 0.672 mmol, 3 equiv), and dry 
toluene (1.9 mL). Compound 43 was isolated in 69% 
yield as a colorless oil (Rf = 0.22 in 91% hexanes/8% 
Et2O/1% Et3N) with diastereomeric ratio 86:14 as measured by 13C NMR.  Major Isomer: 
1H NMR (700 MHz, CDCl3): δ 8.06 (dd, J = 8.4, 1.3 Hz, 2H), 8.03 (dd, J = 8.4, 1.3 Hz, 
2H), 7.56–7.53 (multiple peaks, 2H), 7.44–7.41 (multiple peaks, 4H), 5.72 (m, 1H), 4.68 
(dd, J = 12.0, 3.6 Hz, 1H), 4.58 (dd, J = 12.0, 6.1 Hz, 1H), 4.42–4.37 (multiple peaks, 
2H), 3.10 (ddd, J = 12.8, 4.5 1.8 Hz, 1H), 1.98 (m, 1H), 1.84 (dd, J = 11.5, 4.2 Hz, 1H), 
1.78 (m, 1H), 1.61 (m, 1H), 1.38 (dd, J = 12.9, 11.3 Hz, 1H), 1.34 (m, 1H), 1.06 (m, 1H), 
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1.026 (s, 9H), 0.91 (d, J = 6.5 Hz, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 166.2, 
165.75, 162.1, 133.02, 132.99, 130.0, 129.8, 129.74, 129.65, 128.33, 128.27, 71.27, 
70.96, 63.6, 53.3, 34.56, 34.38, 33.6, 32.7, 28.5, 28.3, 22.11. Minor Isomer (distinct 
resonances): 1H NMR (700 MHz, CDCl3): δ 1.031 (s, 3H), 0.87 (d, J = 6.6 Hz, 3H).  
13C{1H} NMR (176 MHz, CDCl3): δ 165.74, 129.73, 71.23, 70.86, 53.4, 34.58, 34.36, 
33.5, 22.06. IR (thin film, CH2Cl2, mixture of isomers): 2951, 1719, 1452 cm-1. HRMS 
electrospray (m/z): [M+H]+ calcd for C28H36NO5, 466.2588; found, 466.2591. 
 
Oxime Ether 44. The general procedure was followed 
using substrate 39 (50 mg, 0.211 mmol, 1 equiv), 
PdCl2(PhCN)2 (4.0 mg, 0.0105 mmol, 0.05 equiv), 
PhI(OBz)2 (282 mg, 0.633 mmol, 3 equiv), and dry 
toluene (1.8 mL). Compound 44 was isolated in 70% 
yield as a colorless oil (Rf = 0.23 in 91% hexanes/8% 
Et2O/1% Et3N) with diastereomeric ratio 86:14 as measured by 13C NMR.  Major Isomer: 
1H NMR (700 MHz, C6D6): δ 8.16 (d, J =  7.8 Hz, 2H), 8.11 (d, J =  7.8 Hz, 2H), 7.06 (t, 
J = 7.6 Hz, 1H), 7.04 (t, J = 7.6 Hz, 1H), 6.99 (dd, J = 7.8, 7.6 Hz, 2H), 6.96 (dd, J = 7.8, 
7.6 Hz, 2H), 5.94 (m, 1H), 4.61(dd, J = 12.0, 3.8 Hz, 1H), 4.51 (dd, J = 12.0, 6.5 Hz, 
1H), 4.35 (multiple peaks, 2H), 3.31 (ddd, J = 12.7, 4.2, 1.9 Hz, 1H), 1.87–1.80 (multiple 
peaks, 2H), 1.72 (m, 1H), 1.53–1.49 (multiple peaks, 2H), 1.40 (m, 1H), 1.23 (m, 1H), 
1.19 (s, 3H), 1.18 (m, 1H), 1.04 (s, 3H), 0.86 (t, J = 7.8 Hz, 3H), 0.80–0.73 (multiple 
peaks, 4H). 13C{1H} NMR (176 MHz, CDCl3): δ 166.1, 165.7, 162.1, 133.00, 132.98, 
129.98, 129.8, 129.7, 129.6, 128.31, 128.25, 71.23, 70.93, 63.59, 50.48, 35.06, 34.66, 
34.44, 33.7, 33.1, 28.09, 25.32, 24.5, 22.2, 8.1. Minor Isomer (distinct resonances): 
13C{1H} NMR (176 MHz, CDCl3): δ 71.15, 70.85, 63.56, 50.55, 35.05, 34.69, 34.42, 
33.6, 28.11, 25.35, 22.1. IR (thin film, neat, mixture of isomers): 2956, 2872, 1722, 1452 





Oxime Ether 45. The general procedure was followed 
using substrate 40 (50 mg, 0.188 mmol, 1 equiv), 
PdCl2(PhCN)2 (3.6 mg, 0.0094 mmol, 0.05 equiv), 
PhI(OBz)2 (252 mg, 0.564 mmol, 3 equiv), and dry 
toluene (1.6 mL). Compound 45 was isolated in 54% 
yield as a colorless oil (Rf = 0.24 in 91% hexanes/8% 
Et2O/1% Et3N) with diastereomeric ratio 86:14 as measured by 13C NMR.  Major Isomer: 
1H NMR (700 MHz, C6D6): δ 8.15 (d, J = 7.9 Hz, 2H), 8.11 (d, J = 7.9 Hz, 2H), 7.07 (t, J 
= 7.4 Hz, 1H), 7.05 (t, J = 7.4 Hz, 1H), 7.00 (dd, J = 7.9, 7.4 Hz, 2H), 6.97 (dd, J = 7.9, 
7.4 Hz, 2H), 5.95 (m, 1H), 4.63 (dd, J = 12.0, 3.7 Hz, 1H), 4.52 (dd, J = 12.0, 6.4 Hz, 
1H), 4.39–4.34 (multiple peaks, 2H), 3.33 (ddd, J = 12.6, 4.1, 1.9 Hz, 1H), 1.84 (dd, J = 
12.1, 4.1 Hz, 1H), 1.79–1.73 (multiple peaks, 2H), 1.68 (app sept, J = 6.3 Hz, 1H), 1.54–
1.52 (multiple peaks, 2H), 1.34 (dd, J = 14.4, 5.4 Hz, 1H), 1.24 (m, 1H), 1.21 (s, 3H), 
1.16 (dd, J = 13.1, 11.8 Hz, 1H), 1.10 (s, 3H), 1.02 (d, J = 6.6 Hz, 3H), 1.00 (d, J = 6.6 
Hz, 3H), 0.80 (m, 1H), 0.77 (d, J = 6.4 Hz, 3H). 13C{1H} NMR (176 MHz, C6D6): δ 
166.0, 165.74, 162.13, 133.0, 132.9, 130.8, 130.5, 130.1, 130.0, 128.6, 128.5, 71.9, 71.5, 
63.83, 52.4, 49.6, 36.1, 35.06, 35.01, 34.14, 28.9, 26.8, 26.0, 25.9, 25.8, 24.4, 22.33.  
Minor Isomer (distinct resonances): 1H NMR (700 MHz, C6D6): δ 1.23 (s, 3H), 0.74 (d, J 
= 6.4 Hz, 3H). 13C{1H} NMR (176 MHz, C6D6): δ 165.71, 162.11, 71.7, 71.3, 63.79, 
49.7, 35.10, 34.97, 34.05, 26.9, 22.29. IR (thin film, neat, mixture of isomers): 2952, 
1723, 1452 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C31H42NO5, 508.3057; 
found, 508.3064. 
 
Oxime Ether 46. The general procedure was 
followed using substrate 41 (143 mg, 0.50 mmol, 1 
equiv), PdCl2(PhCN)2 (9.6 mg, 0.025 mmol, 0.05 
equiv), PhI(OBz)2 (446 mg, 1.00 mmol, 2 equiv), 
and dry toluene (4.2 mL).  Compound 46 was 
isolated in 44% yield as a colorless oil (Rf = 0.16 in 
91% hexanes/8% Et2O/1% Et3N)  with diastereomeric ratio 85:15 as measured by 13C 
NMR.  Major Isomer: 1H NMR (700 MHz, CDCl3): δ 8.06 (d, J = 7.5 Hz, 2H), 8.04 (d, J 
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= 7.5 Hz, 2H), 7.558 (t, J = 7.5 Hz, 1H), 7.556 (t, J = 7.5 Hz, 1H), 7.44 (app t, J = 7.5 Hz, 
4H), 7.36 (d, J = 8.0 Hz, 2H), 7.27 (t, J = 8.0 Hz, 2H), 7.13 (t, J = 8.0 Hz, 1H), 5.49 
(dddd, J = 6.2, 6.0, 5.2, 3.4 Hz, 1H), 4.59 (dd, J = 12.0, 3.4 Hz, 1H), 4.49 (d, J = 12.0, 6.2 
Hz, 1H), 4.29 (dd, J = 12.0, 6.0 Hz, 1H), 4.25 (J = 12.0, 5.2 Hz, 1H), 3.05 (dd, J = 13.4, 
4.5 Hz, 1H), 2.48 (dd, J = 11.8, 3.7 Hz, 1H), 1.76–1.69 (multiple peaks, 2H),  1.55 (m, 
1H), 1.51 (s, 3H), 1.41 (s, 3H), 1.38–1.33 (multiple peaks, 2H), 1.00 (m, 1H), 0.89 (d, J = 
6.5 Hz, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 166.2, 165.7, 161.2, 150.5, 133.1, 
133.00, 130.0, 129.8, 129.72, 129.65, 128.4, 128.3, 127.70, 125.8, 125.2, 71.4, 70.83, 
63.6, 52.9, 39.9, 34.6, 34.27, 33.39, 28.67, 26.0, 25.9, 22.1  Minor Isomer (distinct 
resonances): 1H NMR (700 MHz, CDCl3): δ 5.57 (m, 1H), 4.40 (dd, J = 12.0, 6.2 Hz, 
1H), 1.53 (s, 3H), 1.40 (s, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 161.0, 150.6, 
133.03, 127.74, 125.7, 125.1, 70.79, 70.7, 63.4, 53.1, 39.8, 34.7, 34.30, 33.44, 28.75, 
26.6, 25.6.  IR (thin film, CH2Cl2, mixture of isomers): 3062, 2953, 2927, 1718, 1452 cm-
1. HRMS electrospray (m/z): [M+H]+ calcd for C33H38NO5, 528.2744; found, 528.2745. 
 
Oxime Ether 47. The general procedure was 
followed using substrate 42 (50 mg, 0.199 mmol, 1 
equiv), PdCl2(PhCN)2 (3.8 mg, 0.01 mmol, 0.05 
equiv), PhI(OBz)2 (266 mg, 0.597 mmol, 3 equiv), 
and dry toluene (1.6 mL). Compound 47 was isolated 
in 37% yield as a colorless oil (Rf = 0.24 in 91% 
hexanes/8% Et2O/1% Et3N) with diastereomeric ratio 90:10 as measured by 13C NMR.  
Major Isomer: 1H NMR (700 MHz, C6D6): δ 8.15 (dd, J = 8.1, 1.3 Hz, 2H), 8.10 (dd, J = 
8.1, 1.3 Hz, 2H), 7.07 (tt, J = 7.5, 1.3 Hz, 1H), 7.04 (tt, J = 7.5, 1.3 Hz, 1H), 7.00 (dd, J = 
8.1, 7.5 Hz, 2H), 6.97 (dd, J = 8.1, 7.5 Hz, 2H), 5.92 (dddd, J = 6.5, 5.6, 5.6, 3.8 Hz, 1H), 
4.61 (dd, J = 11.8, 3.8 Hz, 1H), 4.50 (dd, J = 11.8, 6.5 Hz, 1H), 4.35 (app d, J = 5.6 Hz, 
2H), 3.32 (ddd, J = 12.6, 4.4, 2.0 Hz, 1H), 2.44 (app sept, J = 7.0 Hz, 1H), 1.96 (dd, J = 
11.9, 3.9 Hz, 1H), 1.75 (app dq, J = 13.1, 4.0 Hz, 1H), 1.58–1.52 (multiple peaks, 2H), 
1.25 (app qd, J = 13.0, 3.6 Hz, 1H), 1.19 (s, 3H), 1.18 (dd, J = 12.3, 11.6 Hz, 1H), 0.89 
(d, J = 7.0 Hz, 3H), 0.85 (s, 3H), 0.84 (d, J = 7.0 Hz, 3H), 0.78 (m, 1H), 0.77 (d, J = 6.4 
Hz, 3H). 13C{1H} NMR (C6D6): δ 166.0, 165.7, 162.4, 133.0, 132.9, 130.8, 130.5, 130.1, 
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130.0, 128.6, 128.5, 71.80, 71.44, 63.84, 50.7, 37.8, 35.17, 35.08, 34.4, 32.9, 29.1, 22.35, 
20.8, 20.7, 17.7, 17.61. Minor Isomer (distinct resonances): 1H NMR (700 MHz, C6D6): δ 
1.21 (s, 3H). 13C{1H} NMR (C6D6): δ 162.3, 71.76, 71.36, 63.82, 50.8, 35.20, 35.03, 
34.3, 22.31, 17.58. IR (thin film, neat, mixture of isomers): 2962, 1722, 1452 cm-1. 
HRMS electrospray (m/z): [M+H]+ calcd for C30H40NO5, 494.2901; found, 494.2903. 
 
Oxime Ether 61. The general procedure was followed 
using substrate 60 (83.6 mg, 0.50 mmol, 1 equiv), 
PdCl2(PhCN)2 (9.6 mg, 0.025 mmol, 0.05 equiv), 
PhI(OBz)2 (446 mg, 1.00 mmol, 2 equiv), and dry toluene 
(4.2 mL). Compound 61 was isolated in 53% yield as a 
colorless oil (Rf = 0.10 in 91% hexanes/8% Et2O/1% Et3N) 
with diastereomeric ratio 55:45 as measured by 13C NMR.  
Major Isomer: 1H NMR (700 MHz, CDCl3): δ 8.06 (d, J = 7.8 Hz, 2H), 8.03 (d, J = 7.8 
Hz, 2H), 7.56–7.54 (multiple peaks, 2H), 7.44–7.41 (multiple peaks, 4H), 5.72 (m, 1H), 
4.71–4.64 (multiple peaks, 3H), 4.59 (dd, J = 11.9, 6.2 Hz, 2H), 3.31 (m, 1H), 2.15, (m 
1H), 2.00 (m, 1H), 1.92 (m, 1H), 1.81 (m, 1H), 1.69 (s, 3H), 1.54 (m, 1H), 1.39 (m, 1H), 
1.18 (m, 1H), 1.05 (d, J = 6.5 Hz, 3H).  13C{1H} NMR (176 MHz, CDCl3): δ 166.18, 
165.8, 162.98, 148.5, 133.1, 130.0, 129.78, 129.76, 129.74, 129.66, 128.4, 128.3, 109.2, 
71.33, 71.0, 63.68, 44.9, 37.3, 35.39, 30.81, 30.13, 20.7, 16.17. Minor Isomer (distinct 
resonances): 1H NMR (700 MHz, CDCl3): δ 5.72 (m, 1H), 4.58 (dd, J = 11.9, 6.2 Hz, 
1H), 1.65 (s, 3H), 1.24 (m, 1H), 1.06 (d, J = 6.5 Hz, 3H). 13C{1H} NMR (176 MHz, 
CDCl3): δ 166.19, 165.7, 163.01, 133.0, 109.1, 71.28, 70.7, 63.67, 44.8, 37.4, 35.42, 
30.83, 30.10, 20.6, 16.18. IR (thin film, neat, mixture of isomers): 2965, 2929, 1721, 
1451 cm-1. [M+H]+ calcd for C27H31NO5, 450.2275; found, 450.2265. 
 
Details for Control Reactions in Table 4.2 and Scheme 4.14, and Additional Studies with 
Added Acid 
Table 4.2, Entry 2. Substrate 16 (7.7 mg, 0.05 mmol, 1 equiv) and PhI(OBz)2 (44.6 mg, 
0.10 mmol, 2 equiv) were combined in toluene-d8 (0.42 mL) in a 4 mL scintillation vial 
and sealed with a Teflon-lined cap. Reaction was stirred at 50 ºC for 8 h, then the reaction 
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mixture was transferred into an NMR tube along with 1,3-dinitrobenzene as an internal 
standard (8.4 mg, 0.05 mmol, 1 equiv). No characteristic peaks corresponding to 
dioxygenated products were observed by 1H NMR, and 99% starting material remained. 
 
Table 4.2, Entries 3 and 4. Substrate 16 (7.7 mg, 0.05 mmol, 1 equiv), PhI(OBz)2 (44.6 
mg, 0.10 mmol, 2 equiv), and 0.42 mL of a 0.00595 M or 0.131 M stock solution of 
TfOH in toluene (0.0025 or 0.055 mmol, 0.05  or 1.10 equiv) were combined in a 4 mL 
scintillation vial and sealed with a Teflon-lined cap. Reactions were stirred at 50 ºC for 8 
h, then 1,3-dinitrobenzene was added as an internal standard (8.4 mg, 0.05 mmol, 1 
equiv). A 0.1 mL aliquot was transferred to an NMR tube and diluted with CDCl3. No 
characteristic peaks corresponding to dibenzoylated products were observed by 1H NMR 
in either case, and 83% and 89% starting material remained in entries 3 and 4, 
respectively.  
 
Scheme 4.14. Allyl propyl ether (5.0 mg, 0.05 mmol, 1 equiv), PdCl2(PhCN)2 (1.0 mg, 
0.0025 mmol, 0.05 equiv), and PhI(OBz)2 (44.6 mg, 0.10 mmol, 2 equiv) were combined 
in toluene-d8 (0.42 mL) in a 4 mL scintillation vial and sealed with a Teflon-lined cap. 
Reaction was stirred at 50 ºC for 8 h, then the reaction mixture was transferred into an 
NMR tube along with 1,3-dinitrobenzene as an internal standard (8.4 mg, 0.05 mmol, 1 
equiv). No characteristic peaks corresponding to dioxygenated products were observed 
by 1H NMR, and 71% starting material remained. 
 
Additional Experiment: Superstoichiometric Acid. We hypothesized that an acid-
catalyzed reaction pathway was not feasible using substoichiometric quantitities of acid 
because of the presence of a basic nitrogen in the oxime ether substrate. Thus, we were 
interested in the outcome of using superstoichiometric acid (> 1 equiv). Entries 3 and 4 in 
Table 4.2 were repeated using 110 or 120 mol% of TfOH or BF3•OEt2, respectively. With 
superstoichiometric TfOH, 20% of the starting material remained at the end of the 
reaction, and numerous small peaks in the 4.5–6.5 ppm region of the 1H NMR spectrum 
(not corresponding to dibenzoylated products) were observed. No products were 
observable by gas chromatographic analysis, and we believe that substantial degradation 
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of the oxime ether substrate (including auxiliary cleavage) occurs under these relatively 
harsh conditions. Similarly, with superstoichiometric BF3•OEt2, only a small amount of 
starting material remained by 1H NMR (20%), although no other peaks were observed in 
the 4.5–6.5 ppm region of the 1H NMR spectrum. 
 
Additional Experiment: Duplicating Published Reaction Conditions. The 
dibenzoylation experiments involving TfOH or BF3•OEt2 in Table 4.2 were designed to 
imitate published reaction conditions for TfOH-20 or BF3•OEt221-catalyzed alkene 
diacetoxylation, but using our solvent (toluene) and our dioxygenating reagent 
[PhI(OBz)2]. However, we also duplicated the published acid-catalyzed reaction 
conditions more exactly (using PhI(OAc)2 and the alternative solvent systems), and 
achieved results very similar to those described in Table 4.2. Reactions were analyzed by 
gas chromatography, and the amounts of remaining starting material given below in 
Table 4.7 are GC calibrated yield based on a hexadecane standard. 
 











Synthesis and Characterization of Authentic Diol 23 (Scheme 4.19) and Comparison to 
23 Derived from 21 (Scheme 4.18) 
Authentic Diol 23. Substrate 19 (46 mg, 0.30 mmol, 1 equiv), AD-
mix-α (420 mg), and CH3SO2NH2 (28.5 mg, 0.300 mmol, 1 equiv) 
were combined in tBuOH (1.5 mL) and H2O (1.5 mL) and stirred at 0 
ºC for 6 h, then at room temperature for 1 h. To the mixture was 
added Na2SO3 (460 mg) and KOH (168 mg), and stirring was continued at room 
temperature for 1 h. Reaction mixture was diluted with EtOAc, washed with brine, dried 
over MgSO4, filtered, concentrated, and purified by column chromatography to afford 23 
in 82% yield as a colorless oil (Rf = 0.19 in 50% hexanes/50% EtOAc). 1H NMR (700 
MHz, CDCl3): δ 4.13–4.12 (multiple peaks, 2H), 3.83 (m, 1H), 3.75 (m, 1H), 2.90 (br s, 
2H), 2.44 (m, 2H), 2.17 (m, 2H), 1.66 (m, 2H), 1.61–1.57 (multiple peaks, 4H), 1.22 (d, J 
= 6.7 Hz, 3H). 13C{1H} NMR (176 MHz, CDCl3): δ 161.6, 75.3, 73.1, 68.4, 32.2, 26.9, 
25.64, 25.62, 25.2, 18.3. IR (thin film, neat): 3378 (br), 2929, 2857, 1449 cm-1. [M+H]+ 
calcd for C10H20NO3, 202.1438; found, 202.1438. 
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Stereoselectivity for Dibenzoylation of 30 with Different Pd Catalysts 
A number of different PdII salts were screened for the dibenzoylation reaction of chiral 
substrate 30. Table 4.8 summarizes the results. Although some catalysts [Pd(OTf)2 and 
Pd(TFA)2] provided better stereoselectivity than PdCl2(PhCN)2, the yield of the reaction 
was substantially better with PdCl2(PhCN)2. 
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A Transformable Directing Group for Pd-Catalyzed C–H 
Oxygenation 
 
5.1  Background and Significance 
The use of a directing group for palladium-catalyzed C–H functionalization is an 
effective strategy for achieving rate acceleration and control over site-selectivity (Chapter 
1).1 However, limitations of this strategy are apparent in situations when a directing 
group moiety is undesired in the final target molecule. In such cases, this substrate-
control strategy for selective C–H functionalization is only advantageous if the directing 
group can be temporarily installed and subsequently removed or transformed. The 
majority of directing groups for Pd-catalyzed C–H functionalization, however, are 
nitrogen-containing heterocycles or other functional groups that are not easily 
manipulated following the C–H functionalization event (e.g., Figure 5.1).1c 
 
 
Figure 5.1. Examples of Substrates With Nitrogen-Containing Directing Groups for Pd-






























An ideal directing ligand would be sufficiently robust to tolerate C–H 
activation/functionalization conditions, but could subsequently be converted into diverse 
functional groups. Instances of such directing groups in Pd-catalyzed reactions are still 
relatively rare, and at the time the work in this chapter was published2 only a few 
examples were known (Schemes 5.1–5.5). Indirect C–H alkylation of substituted toluenes 
has been shown via a sequence involving (1) N,N-dimethylbenzylamine-directed C–H 
olefination and (2) reduction of both the dimethylbenzylamine and the installed olefin 
(Scheme 5.1).3 Benzyl amines protected by trifluoromethylsulfonyl groups have been 
used to direct C–H fluorination, followed by nucleophilic displacement of the amine 
directing group (Scheme 5.2).4  
 





Scheme 5.2. Triflamide-Directed C–H Fluorination Followed by Nucleophilic 
Displacement of Directing Group4 
 
 
Oxazolines have been utilized for Pd-catalyzed C–H iodination reactions followed 
by H2SO4-catalyzed hydrolysis to afford carboxylic acids (Scheme 5.3).5 Carboxylic 
acids have also been employed to direct Pd-catalyzed C–H arylations, and have then been 
removed by decarboxylation (Scheme 5.4).6 Amides have proven effective for directing 

































transformed into nitriles (Scheme 5.5)7a, fluorenones7a, or carboxylic acids7b,c (Scheme 
5.6). In addition to these examples, a number of other transformable directing groups 
have been disclosed since the publication of the work described in this chapter. These 
reports are reviewed in sections 5.7 and 5.8 below. 
 










































H 5 mol % Pd(OAc)2
1.3 equiv AgOAc
3.5 equiv AcOH















1. 5 mol % Pd(OAc)2
1.2 equiv AgOAc
TFA, 120 ºC, 1 h
Cl
3 equiv
2.  2 equiv CF3CO2CCF3











Ketones would be particularly attractive directing groups because they are 
versatile and widely-used synthetic intermediates.8 However, they are poor ligands for 
PdII, and thus are usually ineffective directing groups for Pd-catalyzed C–H 
functionalization. Ketone-directed C–H arylation reactions catalyzed by Ru have been 
shown, but metals such as these are typically ineffective for converting C–H into C–
heteroatom bonds.9 Two examples of ketone-directed C–H arylation have been 
demonstrated under basic10a or strongly acidic conditions.10b Recently, a ketone-directed 
C–H amidation was reported using an electron-deficient Pd complex in conjunction with 
K2S2O8 or [F+] oxidants (Scheme 5.7).10c This transformation is limited to the 
functionalization of sp2 C–H bonds.  
 




Ortho-C–H arylation of benzaldehydes has been shown in the presence of an N-
heterocyclic carbene ligand (Scheme 5.8),11 but ketone- or aldehyde-directed 








10 mol % Pd(OAc)2




















10 mol % Pd(OTf)2
2 equiv [F+]
DCE










ketone-directed C–H activation/C–heteroatom bond forming reaction would enable 
access to compounds with valuable substitution patterns; for example, C–H oxygenation 
directed by a ketone or ketone surrogate could serve as a route to (a) β-hydroxy ketones, 
(b) homoallyl alcohols, (c) 1,3-diols, (d) 1,3-aminoalcohols, (e) 3-oxoaldehydes, (f) β-
amino aldehydes, (g) isoxazolines, and (h) benzisoxazoles (Scheme 5.9). 
 




Scheme 5.9. Ketones as Synthons for Diverse β-Oxygenated Motifs 
 
 
In contrast to ketones, nitrogen-containing groups have proven to be effective 
directing ligands for Pd-catalyzed C–H functionalization reactions (see Figure 5.1). As 
such, we sought to temporarily mask ketones as more coordinating imine or oxime 




1 mol % Pd(OAc)2








































(Scheme 5.10). This strategy would enable the formal β or ortho-C–H functionalization 
of ketones. 
 




5.2  Directing Group Optimization 
Two key challenges exist in the design of a ketone surrogate for Pd-catalyzed C–
H functionalization. First, the protecting group must be stable to the catalytic reaction 
conditions. Second, the group must be readily removed in high yield without affecting the 
newly installed functional group. Our prior studies have shown that oxime ethers such as 
1 are highly effective directing groups for Pd-catalyzed sp2- and sp3-C–H bond 
acetoxylation reactions with PhI(OAc)2 (Scheme 5.11).12,13 However, removal of the 
oxime ether protecting group from the β-functionalized products is problematic. As 
summarized in Scheme 5.12 for substrate 2, acid-catalyzed hydrolysis14 is sluggish and 
produces significant quantities of elimination products 3 and 4. Alternatively, conversion 
of oxime ethers to ketones has been reported using Amberlyst 15 at temperatures ranging 
from 25 to 110 °C.15 In our hands, however, 2 and derivatives were unreactive under 
these conditions at room temperature, and at elevated temperatures (80 °C), 2 reacted to 
form a complex mixture of products that did not include the expected β-acetoxy or"β-
hydroxy ketone. The use of superstoichiometric TiCl3 is effective in some cases,16 but 



























Imines would be a versatile alternative to oxime ethers, as they are readily 
hydrolyzed under mild conditions. Pd-catalyzed imine-directed acetoxylation of an sp2 
C–H bond has been reported;13a however, in our hands imines have proven too labile for 
analogous sp3 C–H functionalizations. For example, the reaction of 5 under standard 
acetoxylation conditions affords the hydrolyzed ketone 6 as the major identifiable 
product (39% yield, Scheme 5.13). 
 
Scheme 5.13. Lability of Alkyl Imines Under C–H Acetoxylation Conditions 
 
 
Simple hydroxyl (OH) oximes are another attractive ketone surrogate. These 
readily available, stable, often crystalline starting materials are known to direct 
stoichiometric cyclopalladation at both sp2- and sp3- C–H sites17 and are much more 
readily cleaved than their oxime ether counterparts.18  In addition, they can be prepared 






5 mol % Pd(OAc)2
2 equiv PhI(OAc)2
AcOH/Ac2O (1:1)




















O5 mol % Pd(OAc)22 equiv PhI(OAc)2
AcOH/Ac2O (1:1)





these advantages, oximes are known to undergo rapid oxidative cleavage in the presence 
of oxidants like PhI(OAc)2 (Scheme 5.14).20  
 
Scheme 5.14. Oxidative Cleavage of Hydroxyl Oximes by PhI(OAc)220 
 
 
For example, combining oxime 7 with Pd(OAc)2 and PhI(OAc)2 in AcOH results 
in a nearly instantaneous color change from colorless to blue-green, concomitant with 
regeneration of the parent ketone 6 (Scheme 5.15). This color change is consistent with 
prior observations by Moriarty and coworkers20 and can be attributed to rapid formation 
of a nitroso species 8 which decomposes to produce the corresponding ketone (Scheme 
5.16). Importantly, the mechanism of this oxidative cleavage involves an O–H 
deprotonation step and therefore is expected to be specific to hydroxyl oximes. 
 





Scheme 5.16. Mechanism of Oxidative Cleavage of Hydroxyl Oximes by PhI(OAc)220 
 
 
Encouragingly, a similar color change is not observed when the reaction solvent is 







































6 (4% by GC) are formed; instead the major product (68% by GC) is the O-acetylated/C–
H acetoxylated compound 10 (Scheme 5.17). This initial result suggested that the in situ 
reaction of 7 with Ac2O affords a stable O-acetyl oxime (9) capable of directing C–H 
acetoxylation. 
 
Scheme 5.17. O-Acetylation and C–H Acetoxylation of Hydroxyl Oximes in the 
Presence of Ac2O 
 
 
Further study led to the development of the following protocol that is general for a 
range of hydroxyl oxime substrates: (1) stirring the oxime starting material in 
AcOH/Ac2O for 2 h at 25 ºC to effect quantitative in situ O-acetylation, (2) addition of Pd 
catalyst and oxidant, and (3) heating the reaction mixture at 80 ºC (sp2-C–H 
acetoxylation) or 100 ºC (sp3-C–H acetoxylation) for 4–24 h. This protocol affords 10 in 
70% GC yield from 7 (Scheme 5.18). 
 




5.3  Scope of O-Acetyl Oxime-Directed Acetoxylation 
As summarized in Table 5.1, a number of dialkyl oximes underwent in situ 
acetylation/β-acetoxylation in modest to good yields using the optimized reaction 
conditions. The observed trends in reactivity and selectivity were similar to those in sp3-
C–H functionalization reactions of related oxime ethers.12a For example, oxidation 
(4%)GC Yield:
AcOH/Ac2O (1:1)
100 ºC, 1.5 h
Ph
NHO




















   rt, 2 h
2. 5 mol % Pd(OAc)2
    2 equiv PhI(OAc)2





occurred selectively at 1º β-sp3 C–H bonds over the analogous 2º sites (entries 1–4). 
Acetoxylation of a 2º C–H group could be achieved in modest yield in the rigid trans-
decalone system (entry 6). The reaction conditions were compatible with a number of 
functional groups including alkyl chlorides (entry 4) and protected amines (entry 3); 
furthermore, remote benzylic C–H bonds were well tolerated under the oxidizing reaction 
conditions (entry 1). The acetoxylated products were typically isolated as mixtures of E/Z 
oxime stereoisomers, which rapidly interconvert under the catalytic reaction conditions. 
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   rt, 2 h
2. cat. Pd(OAc)2
   PhI(OAc)2
100 ºC
aGeneral conditions: substrate (1 equiv), AcOH/Ac2O (1:1, 0.12 M in substrate), 2 h, rt; then Pd(OAc)2 (0.05 
equiv),  PhI(OAc)2 (1.5–3 equiv), 100 ºC, 12 h. bThe remaining mass balance (as determined by GC of the 
crude reaction mixtures) was generally unreacted O-acetyloxime (analogous to 9 in Scheme 17). cStarting 
material and product consisted of a mixture of oxime E/Z stereoisomers. dGC yield.
OAc
169 
O-Acetyl ketoximes are also effective directing groups for Pd-catalyzed 
acetoxylation at sp2-C–H sites (Table 5.2). Both electron poor and electron rich aryl rings 
underwent mono-ortho-oxygenation in high yields (entries 1 and 4). Further, aryl 
bromides (entry 2) and silyl-protected phenols (entry 5) were compatible with the 
reaction conditions.  
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NHO 1. AcOH/Ac2O (1:1)   rt, 2 h
2. 5 mol % Pd(OAc)2






aGeneral conditions: substrate (1 equiv), AcOH/Ac 2O (1:1, 0.12 M in substrate), 2 h, rt; then Pd(OAc) 2 (0.05 
equiv),  PhI(OAc)2 (1–2 equiv), 80 ºC, 4–24 h. bThe remaining mass balance (as determined by GC of the crude 
reaction mixtures) was generally unreacted O-acetyloxime (analogous to 9 in Scheme 17). cProduct consisted of 
a mixture of oxime E/Z stereoisomers.
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One notable limitation of this method is that O-acetyl aldoximes such as 35 were 
susceptible to rapid elimination of AcOH to generate nitriles (36, Scheme 5.19). Similar 
reactivity of O-acetyl aldoximes has been previously reported (Scheme 5.20).21 
 









5.4  Deprotection to β- and ortho-Hydroxyketones 
The C–H acetoxylation products in Tables 5.1 and 5.2 were obtained in yields 
comparable to those previously reported with oxime ethers as directing groups.12a,c 
Importantly, however, the O-acetyl oxime directing group is significantly more readily 
deprotected. For example, β-hydroxy ketones can be accessed in high yield via an 
operationally simple two-step procedure involving initial methanolysis of both acetate 
groups (to afford β-hydroxy oximes) followed by removal of the oxime functionality. 
The first step can be accomplished via treatment of starting materials like 10 with K2CO3 









   rt, 2 h
2. 5 mol % Pd(OAc)2
  1.1 equiv PhI(OAc)2
80 ºC, 4 h












Scheme 5.21. Methanolysis of Acetate Groups in 10 
 
 
While numerous methods exist for the second step (conversion of an oxime to a 
ketone), many of our substrates are susceptible to competing formation of side products 
(e.g., via alcohol oxidation, isoxazoline formation, or elimination). After extensive 
experimentation, we identified the use of NaHSO3 in EtOH/H2O22 as the most general 
and high yielding method to transform our oximes into β-hydroxy ketones, while 
circumventing undesired side reactions and persistent byproducts. Under these 
conditions, substrate 37 could be converted cleanly to 38 in 80% yield (Scheme 5.22). 
Compound 38 was obtained in pure form after a simple extraction, obviating the need for 
chromatography. 
 
Scheme 5.22. Cleavage of Oxime 37 by NaHSO3 to Afford β-Hydroxy Ketone 38 
 
 
The two deprotection steps could also be combined to provide an operationally 
simple, high yielding, one-pot route from O-acetyl oxime C–H oxidation products to β-
hydroxy ketones. For example, treatment of 10 with K2CO3 in MeOH, followed by 
addition of NaHSO3 and H2O provided 38 in 80% yield after a simple extractive work-up 
(Scheme 5.23). As shown in Table 5.3, this one-pot deprotection could also be achieved 
with other substrates. Under these conditions, elimination products were not observed, 
and isoxazoline formation was limited to ≤5% (for characterization of the isoxazoline 










































































aConditions in entries 1–3 (one pot): K2CO3 (3 x 0.15 equiv/2.5 h), MeOH, 25 ºC, then 3.5 equiv of NaHSO3, 
H2O, 80 ºC, 3 h. Conditions in entry 4 (two steps): (i) 0.15 equiv of K2CO3, MeOH, 25 ºC, 1 h, then (ii) 3.5 equiv 
of NaHSO3, H2O, EtOH, 90 ºC, 12 h.
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5.5  Diverse Transformations of the O-Acetyl Oxime Directing Group 
An important characteristic of the O-acetyl oxime directing group is that it 
enables access to diverse motifs from a single synthetic intermediate. As exemplified 
with 32 in Scheme 5.24, K2CO3-catalyzed methanolysis of the acetyl groups provided 
oxime 43 in quantitative yield. Product 43 could then be converted to the corresponding 
acetophenone 44, to benzoxazole 45 (via Beckmann rearrangement followed by 
intramolecular condensation), to amino phenol 46 (via reduction), and to diol 47 (via 
oxime hydrolysis followed by reduction). 
 




5.6  Other C–H Functionalizations of O-Acetyl Oximes 


































groups for other Pd-catalyzed C–H functionalization reactions. For example, as shown in 
Schemes 5.25 and 5.26, the Pd-catalyzed iodination of 48 and chlorination of 50 proceed 
to form aryl halides 49 and 51 in modest to good yields.23 Interestingly, under standard 
Pd-catalyzed C–H arylation conditions with PhI and AgOAc in trifluoroacetic acid 
(TFA),24 50 underwent an in situ Beckmann rearrangement/C–H phenylation to afford 
acetamide 52 (Scheme 5.27). 
 


















5 mol % Pd(OAc)2
2 equiv NIS
AcOH/Ac2O (2.8:1)









5 mol % Pd(OAc)2
2 equiv NCS
AcOH/Ac2O (2.7:1)























5.7  Subsequent Examples of Transformable Directing Groups 
Since the publication of the work described in this chapter,2 a number of other 
transformable directing groups for Pd-catalyzed C–H functionalization have been 
disclosed25, including two examples of transformable aldoxime ethers.26,27 Methyl 
aldoxime ether-directed ortho bromination with subsequent deprotection using 
superstoichiometric TsOH under microwave conditions affords ortho-brominated 
benzaldehydes (Scheme 5.28).26 Acetoxylation of sp3 C–H bonds at the exo position of 
aldoxime ethers has also been shown, and subsequent deprotection of products like 53 
with Zn/AcOH affords 1,2-diols (54, Scheme 5.29).27  
 




Scheme 5.29. Exo-Aldoxime Ether-Directed C–H Acetoxylation Followed by 
Conversion to a Diol27 
 
 
Several other types of transformable directing groups feature a coordinating 
pyridine moiety tethered to a substrate by a cleavable silyl,28 sulfone,29 aminal,30a 
amide,30b or sulfoximine31 linkage. For example, Gevorgyan has demonstrated ortho 
acyloxylation of arenes using the pyridyldiisopropylsilyl (PyDipSi) directing group (55, 
Scheme 5.30).28a This group can act as a ‘traceless’ ligand that can be completely 
















100 ºC, µwave, 15 min
(86%)
10 mol % Pd(OAc)2
2 equiv NBS
10 mol % AgOCOCF3
DCE
120 ºC, 24 h
(37%)
10 mol % Pd(OAc)2
1.3 equiv PhI(OAc)2
AcOH/Ac2O (50:1)

















C–H functionalization product like 56 into an aryl iodide, aryl boronate, catechol, and a 
biaryl has also been demonstrated. Arene acyloxylation with the PyDipSi directing group 
is highly mono-selective; however, double-fold acyloxylation can be achieved with the 
related pyrimidinyldiisopropylsilyl (PyrDipSi) moiety (Scheme 5.31).28b 
 





Scheme 5.31. Pyrimidinyldiisopropylsilyl as a Traceless Directing Group for Double-
Fold C–H Acyloxylation28b 
 
 
 The lability of silyl linkages has also been exploited for C–H olefination32a,b and 
oxygenation32c of aryl substrates that employ silanol as a transformable directing ligand 
(e.g., 58, Scheme 5.32). When tethered by an oxygen atom, removal of the silanol 
directing group from 59 reveals phenol 60 (Scheme 5.32).32a,c Alternatively, silanols 
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Scheme 5.32. Silanol-Directed ortho C–H Olefination of Arenes with Subsequent 
Deprotection to a Phenol32a 
 
 
Finally, a number of other recent examples of transformable directing groups for 
acetoxylation33, arylation34, and olefination35 rely on amide-type linkages that can be 
hydrolyzed to carboxylic acids or amines.  
 
5.8  Conclusions and Outlook  
This chapter describes the use of in situ generated O-acetyl oximes as effective 
directing groups in Pd-catalyzed C–H functionalization reactions. These directing groups 
are stable under the catalytic reaction conditions but can then be readily manipulated to 
afford ketones, alcohols, amines, and heterocycles. At present, this work represents the 
only instance of a ketone-derived transformable directing group for Pd-catalyzed C–H 
functionalization. Over the past 5 years, the search for effective, convenient, and versatile 
transformable directing groups has gained momentum. Nevertheless, numerous 
challenges remain to be addressed. 
Table 5.4 summarizes the current state-of-the-art for transformable directing 
groups for Pd-catalyzed C–H functionalization. Clearly, a broad range of substrate 
classes can serve as synthons for C–H functionalized products. These synthons include 
phenols (entry 1), thiophenols (entry 2), aryl halides (entries 3 and 4), anilines (entry 5), 







      imidazole
       THF, rt
2.  DCM, NBS
3.    NaOH
    DMF, H2O
        (86%)
10 mol % Pd(OAc)2





























benzylamines (entries 13 and 14),  benzyl chlorides (entry 15), 3-aryl carboxylic acids 
(entry 16), aliphatic alcohols (entry 17), aliphatic amines (entry 18), alkyl ketones (entry 
19), and alkyl carboxylic acids (entries 20–22). Although much progress has been made 
over the past few years, most of the groups represented in Table 5.4 have limited 
generality, and have only been developed for a single type of C–H functionalization 
reaction. Furthermore, deprotection usually requires relatively high temperatures and/or 
the use of strong acids or bases. Silyl-tethered directing groups (entries 1 and 14) can be 
removed under relatively mild conditions (room temperature with a fluoride source, 


























































































































































































Moreover, a major drawback to the directing group strategy is the requirement for 
stoichiometric quantities of a directing ligand. Instead, the ability to use a directing ligand 
catalytically would be more atom economical and would eliminate the need for separate 
deprotection steps. Examples of catalytic directing groups exist for transformations 
mediated by other metals. For instance, rhodium-catalyzed ortho arylation of phenols can 
be achieved using only 15 mol % of an arylphosphinite ligand, which binds to the 
substrate (and to Rh) reversibly in situ (Scheme 5.33).36 
 




It is expected that maturation of the field of ligand-directed Pd-catalyzed C–H 
functionalization will result in the development of directing groups that are general for 
diverse transformations and can be used catalytically.  
 
5.9  Experimental Procedures and Characterization Data 
General Procedures 
NMR spectra were obtained on a Varian Inova 500 (499.90 MHz for 1H; 125.70 MHz for 
13C), a Varian Inova 400 (399.96 MHz for 1H; 100.57 MHz for 13C), or a Varian MR400 
(399.54 or 400.52 MHz for 1H; 100.71 MHz for 13C; 376.88 MHz for 19F) spectrometer.  
1H and 13C NMR chemical shifts are reported in parts per million (ppm) relative to TMS, 
with the residual solvent peak used as an internal reference.  Multiplicities are reported as 
follows: singlet (s), doublet (d), doublet of doublets (dd), doublet of doublets of doublets 
OH
5 mol % [RhCl(PPh3)3]























(ddd), doublet of doublets of doublets of doublets (dddd), triplet (t), quartet (q), quintet 
(quin), sextet (sext), doublet of triplets (dt), triplet of doublets (td), quartet of triplets (qt), 
multiplet (m), and broad resonance (br). IR spectra were obtained on a Perkin-Elmer 
Spectrum BX FT-IR spectrometer. Melting points were determined with a Mel-Temp 3.0, 
a Laboratory Devices Inc, USA instrument, and are uncorrected. HRMS data were 
obtained on a Micromass AutoSpec Ultima Magnetic Sector mass spectrometer. Gas 
chromatography was carried out on a Shimadzu 17A using a Restek Rtx®-5 (Crossbond 
5% diphenyl – 95% dimethyl polysiloxane; 15 m, 0.25 mm ID, 0.25 µm df) column. 
 
Materials and Methods. All commercial reagents and solvents were used as received 
without further purification. Pd(OAc)2 and PhI(OAc)2 were obtained from Pressure 
Chemical and TCI America, respectively.  Ac2O was obtained from EMD Chemicals, and 
all other solvents were obtained from Fisher Chemical. Flash chromatography was 
performed on EM Science silica gel 60 (0.040-0.063 mm particle size, 230-400 mesh) 
and thin layer chromatography was performed on Merck TLC plates pre-coated with 
silica gel 60 F254. Ketone 6 and the ketone used to prepare oxime substrate 15 were 
prepared by the sequential oxidation of a commercial alcohol to an aldehyde, treatment 
with sec-butyl Grignard, and oxidation of the resulting alcohol to the ketone (below). The 
parent ketone of oxime 13 was prepared by further treatment of the alkyl chloride parent 
ketone of 15 with potassium phthalimide. 
 










R =  –C3H6Ph
   or –C7H14Cl
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 Synthesis and Characterization of Compounds in Schemes 5.11–5.13 
Oxime Ether 1.  Ketone 6 (500 mg, 2.45 mmol, 1 equiv) was 
combined with NH2OMe•HCl (256 mg, 2.94 mmol, 1.2 equiv) 
in pyridine (1.06 mL) in a 20 mL scintillation vial. The vial was 
sealed with a Teflon-lined cap and heated to 80 °C for 15 min. 
The reaction mixture was then diluted with EtOAc (5 mL) and washed with 20% aqueous 
AcOH (5 x 5 mL) to remove pyridine. The organic layer was then neutralized with 
aqueous NaHCO3, washed with brine, dried over MgSO4, and concentrated to yield 
methyl oxime 1 as a colorless oil consisting of ~1.6:1 ratio of major and minor E/Z 
isomers (556 mg, 97% yield). Major Isomer: 1H NMR (400 MHz, CDCl3): δ 7.29 (m, 
2H), 7.21–7.19 (multiple peaks, 3H), 3.813 (s, 3H), 2.66 (m, 2H), 2.30–2.14 (multiple 
peaks, 3H), 1.92–1.79 (multiple peaks, 2H), 1.50 (m, 1H), 1.36 (m, 1H), 1.05 (d, J = 6.8 
Hz, 3H), 0.872 (t, J = 7.2 Hz, 3H). 13C{1H} NMR (CDCl3): δ 164.13, 141.94, 128.35, 
128.27, 125.80, 61.01, 40.71, 36.37, 27.92, 27.06, 26.43, 17.88, 11.92. Minor Isomer 
(distinct resonances): 1H NMR (400 MHz, CDCl3): δ 3.809 (s, 3H), 3.08 (m, 1H), 1.02 
(d, J = 7.2 Hz, 3H), 0.867 (t, J = 7.2 Hz, 3H). 13C{1H} NMR (CDCl3): δ 163.63, 142.22, 
128.43, 125.72, 61.03, 35.77, 34.17, 29.97, 28.53, 26.54, 16.74, 12.15. IR (thin film, 
mixture of E/Z isomers): 2962, 2935, 1454 cm-1. HRMS electrospray (m/z): [M+H]+ 
calcd for C15H24NO (mixed isomers),  234.1858; found, 234.1866. 
 
β-Acetoxy Oxime Ether 2. Methyl oxime 1 (14.6 mg, 
0.050 mmol, 1 equiv) was combined with Pd(OAc)2 (0.6 
mg, 0.0025 mmol, 0.05 equiv) and PhI(OAc)2 (32.2 mg, 
0.100 mmol, 2 equiv) in AcOH/Ac2O (1:1, 416 µL) in a 4 
mL scintillation vial. The vial was sealed with a Teflon-lined cap and heated to 100 °C 
for 12 h to afford 2 as a pale yellow oil (64% calibrated GC yield). 1H NMR (400 MHz, 
CDCl3): δ 7.28 (m, 2H), 7.21–7.17 (multiple peaks, 3H), 4.11 (m, 2H), 3.81 (s, 3H), 2.64 
(t, J = 7.6 Hz, 2H), 2.48 (quin, J = 7.2 Hz, 1H), 2.31–2.15 (multiple peaks, 2H), 2.02 (s, 
3H), 1.81 (m, 2H), 1.52 (m, 2H), 0.89 (t, J = 7.6 Hz, 3H). 13C{1H} NMR (CDCl3): δ 





22.34, 20.90, 11.31. IR (thin film): 2963, 2936, 1740 cm-1. HRMS electrospray (m/z): 
[M+Na]+ calcd for NaC17H25NO3, 314.1732; found, 314.1731. 
 
Elimination Products 3 and 4. β-Acetoxylated oxime ether 2 
(12.7 mg, 0.0436 mmol, 1 equiv) was dissolved in 0.5 M 
HCl/CH2Cl2 (436 µL) in a 4 mL scintillation vial. The vial was 
sealed with a Teflon-lined cap and heated to 70 °C for 3 h. 
Reaction solvent was removed by rotary evaporator and crude residue was analyzed by 
1H NMR.  Elimination was identifed by the presence of two sets of olefin peaks (see 
NMR spectrum in Supporting Information of reference 2). Integration of these peaks 
relative to an internal standard (PhNO2) indicates a total of 41% yield of elimination 
products . 
 
Butyl Imine 5.  Ketone 6 (250 mg, 1.22 mmol, 1 equiv) was 
combined with n-butylamine (2.42 mL, 24.48 mmol, 20 equiv), 
p-TsOH monohydrate (4.6 mg, 0.0244 mmol, 0.02 equiv), and 4 
Å molecular sieves (2 g) in toluene (1.9 mL) in a 20 mL 
scintillation vial. The vial was sealed with a Teflon-lined cap and heated to 110 °C for 16 
h.  Solid NaHCO3 was added (30 mg); reaction was then diluted with hexanes, filtered 
through celite, and concentrated to afford imine 5 as a yellow oil consisting of ~3:1 ratio 
of major to minor E/Z isomers (300 mg, 95% yield). Major Isomer: 1H NMR (400 MHz, 
CDCl3): δ 7.31–7.17 (multiple peaks, 5H), 3.25 (t, J = 7.2 Hz, 2H), 2.64 (t, J = 7.6 Hz, 
2H), 2.26–2.15 (multiple peaks, 3H), 1.75 (m, 2H), 1.60–1.55 (multiple peaks, 2H), 1.44–
1.24 (multiple peaks, 4H), 1.02 (d, J = 6.8 Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H), 0.84 (t, J = 
7.4 Hz, 3H). 13C{1H} NMR (CDCl3): δ 175.71, 141.55, 128.37, 128.34, 125.98, 50.44, 
45.56, 36.29, 33.33, 29.45, 28.41, 27.48, 20.66, 18.22, 14.02, 12.08. Minor Isomer 
(distinct resonances): 1H NMR (400 MHz, CDCl3): δ 3.34 (t, J = 7.2 Hz, 2H), 2.79 (m, 
1H), 1.89 (m, 2H), 0.98 (d, J = 7.0 Hz, 3H), 0.93 (t, J = 7.4 Hz, 3H). 13C{1H} NMR 
(CDCl3): δ 175.29, 142.64, 128.46, 128.18, 125.57, 49.65, 36.44, 35.95, 33.48, 33.04, 
29.03, 27.09, 20.70, 17.43, 12.27. IR (thin film, mixture of E/Z isomers): 2959, 2930, 
Ph
X




2872, 1711, 1657 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C18H30N (mixture of 
E/Z isomers), 260.2378; found, 260.2380. 
 
Ketone 6. Ketone 6 was synthesized as described in the 
Materials and Methods section. Additionally, 6 was formed as 
the major product from the reaction depicted in Scheme 5.13. 
From reaction of imine 5: Imine 5 (10 mg, 0.0385 mmol, 1 
equiv) was combined with Pd(OAc)2 (0.4 mg, 0.0019 mmol, 0.05 equiv) and PhI(OAc)2 
(24.8 mg, 0.077 mmol, 2 equiv) in AcOH/Ac2O (1:1, 320 µL) in a 4 mL scintillation vial. 
The vial was sealed with a Teflon-lined cap and heated to 100 °C for 1 h to afford ketone 
6 as the major product observable by GC (39% calibrated GC yield). 1H NMR (400 MHz, 
CDCl3): δ 7.28 (m, 2H), 7.21–7.17 (multiple peaks, 3H), 2.62 (t, J = 7.4 Hz, 2H), 2.46–
2.38 (multiple peaks, 3H), 1.91 (quin, J = 7.4 Hz, 2H), 1.66 (sept, J = 7.4 Hz, 1H), 1.36 
(sept, J = 7.4 Hz, 1H), 1.04 (d, J = 7.0 Hz, 3H), 0.86 (t, J = 7.4 Hz, 3H). 13C{1H} NMR 
(CDCl3): δ 214.59, 141.72, 128.43, 128.33, 125.87, 47.85, 40.31, 35.14, 25.90, 25.08, 
15.90, 11.69. IR (thin film, mixture of E/Z isomers): 2964, 2933, 2876, 1707 cm-1. 
HRMS electrospray (m/z): [M+Na]+ calcd for C14H20O (mixture of E/Z isomers), 
227.1412; found, 227.1411. 
O
186 
Synthesis and Characterization of Oxime Substrates 
General Procedure: Ketone (1 equiv) and NH2OH•HCl (1.35 equiv) were combined in 
pyridine (0.385 mL/mmol ketone) in a scintillation vial. The vial was sealed with a 
Teflon-lined cap, and the mixture was heated to 80 °C for 15 min or until the starting 
material had disappeared (as determined by TLC) after which time an aqueous layer was 
observable in the reaction mixture. The reaction mixture was diluted by 5-fold with 
EtOAc or Et2O and washed with 20% aqueous AcOH (5 x equal volume to the organic 
layer) to remove pyridine. The organic layer was then neutralized with aqueous NaHCO3, 
washed with brine, dried over MgSO4, and concentrated to yield the oxime. Where noted, 
the oximes were obtained as mixtures of E and Z stereoisomers. In these cases, the ratio is 
reported based on 1H NMR integration. In all cases, complete 1H and 13C NMR data are 
reported for the major isomer. In addition, all of the distinct resonances associated with 
the minor isomer are reported for both the 1H and 13C NMR spectra (many of the peaks 
for the minor isomer are coincidentally overlapping with those of the major isomer). 
 
Oxime 7. The general procedure was followed utilizing 
ketone 6 (4.68 g, 22.9 mmol). The product was obtained as a 
pale yellow oil consisting of a ~3.3:1 mixture of major and 
minor oxime stereoisomers (4.99 g, 99% yield). Major 
Isomer: 1H NMR (400 MHz, CDCl3): δ 8.05 (br s, 1H), 7.28 (m, 2H), 7.21–7.18 (multiple 
peaks, 3H), 2.68 (t, J = 7.6 Hz, 2H), 2.37–2.21 (multiple peaks, 3H), 1.88 (m, 2H), 1.52 
(m, 1H), 1.37 (m, 1H), 1.06 (d, J = 7.2 Hz, 3H), 0.87 (t, J = 7.6 Hz, 3H).  13C{1H} NMR 
(CDCl3): δ 164.43, 141.90, 128.35, 128.26, 125.78, 40.55, 36.33, 27.51, 26.96, 26.46, 
17.61, 11.81. Minor Isomer (distinct resonances): 1H NMR (400 MHz, CDCl3): δ 3.21 
(sextet, J = 7.2 Hz, 1H), 2.18 (m, 2H), 1.04 (d, J = 7.2 Hz, 3H), 0.88 (t, J = 7.2 Hz, 3H). 
13C{1H} NMR (CDCl3): δ 163.95, 141.91, 128.41, 125.74, 35.55, 33.36, 29.67, 27.56, 
26.40, 16.51, 12.13. IR (thin film, mixture of E/Z isomers): 3251, 2962, 2931, 2874, 1453 
cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C14H22NO (mixture of E/Z isomers), 




Oxime 11. The general procedure was followed utilizing 3-methyl-2-
pentanone (2.00 g, 20.0 mmol). The product was obtained as a colorless 
oil consisting of an ~8:1 mixture of major and minor oxime stereoisomers 
(1.90 g, 83% yield). Major Isomer: 1H NMR (400 MHz, CDCl3): δ 8.20 
(br s, 1H), 2.28 (sext, J = 7.2 Hz, 1H), 1.81 (s, 3H), 1.52 (m, 1H), 1.40 (m, 1H), 1.07 (d, J 
= 7.2 Hz, 3H), 0.86 (t, J = 7.6 Hz, 3H).  13C{1H} NMR (CDCl3): δ 161.97, 41.20, 26.80, 
17.49, 11.76, 10.36. Minor Isomer (distinct resonances): 1H NMR (400 MHz, CDCl3): δ 
3.30 (m, 1H), 1.78 (s, 3H), 1.03 (d, J = 6.8 Hz, 3H), 0.89 (t, J = 7.4 Hz, 3H). 13C{1H} 
NMR (CDCl3): δ 32.53, 26.46, 16.60, 15.32, 11.93. IR (thin film, mixture of E/Z 
isomers): 3230, 2963, 2932, 2876, 1460 cm-1. HRMS electron impact (m/z): [M]+ calcd 
for C6H13NO (mixture of E/Z isomers), 115.0997; found, 115.1001. 
 
Oxime 13. The general procedure was followed 
utilizing 2-(9-methyl-8-oxoundecyl)isoindoline-1,3-
dione (4.00 g, 12.1 mmol). The product was 
obtained as a pale yellow solid consisting of a ~3.4:1 
mixture of major and minor oxime stereoisomers (3.68 g, 88% yield, mp = 39–43 °C).  
Major Isomer: 1H NMR (400 MHz, CDCl3): δ 8.90 (br s, 1H), 7.76 (dd, J = 5.6, 3.2 Hz, 
2H), 7.68 (dd, J = 5.6, 3.2 Hz, 2H), 3.65 (t, J = 7.6 Hz, 2H), 2.28–2.18 (multiple peaks, 
3H), 1.65 (m, 2H), 1.57–1.45 (multiple peaks, 3H), 1.33 (br s, 7H), 1.04 (d, J = 7.2 Hz, 
3H), 0.85 (t, J = 7.2 Hz, 3H). 13C{1H} NMR (CDCl3): δ 168.41, 164.76, 133.77, 132.10, 
123.09, 40.48, 37.96, 29.98, 28.80, 28.48, 26.98, 26.68, 26.59, 25.82, 17.60, 11.77. Minor 
Isomer (distinct resonances): 1H NMR (400 MHz, CDCl3): δ 3.18 (sext, J = 7.2 Hz, 1H), 
2.09 (m, 2H), 1.02 (d, J = 7.2, 3H), 0.86 (t, J = 7.2 Hz, 3H). 13C{1H} NMR (CDCl3): δ 
164.19, 33.27, 29.30, 28.85, 28.45, 26.59, 26.40, 26.02, 16.53, 12.10. IR (KBr, mixture of 
E/Z isomers): 3252, 2931, 2858, 1768, 1716, 1394 cm-1. HRMS electrospray (m/z): 












Oxime 15. The general procedure was followed utilizing 
11-chloro-3-methylundecan-4-one (2.11 g, 9.64 mmol). 
The product was obtained as a colorless oil consisting of a 
~6:1 mixture of major and minor oxime stereoisomers 
(612 mg, 27% yield). Major Isomer: 1H NMR (400 MHz, CDCl3): δ 3.53 (t, J = 6.8 Hz, 
2H), 2.29–2.22 (multiple peaks, 3H), 1.77 (quin, J = 6.8 Hz, 2H), 1.62–1.50 (multiple 
peaks, 3H), 1.48–1.31 (multiple peaks, 7H), 1.07 (d, J = 6.8 Hz, 3H), 0.88 (J = 7.6 Hz, 
3H). Exchangeable proton (OH) was not observed. 13C{1H} NMR (CDCl3): δ 165.12, 
45.10, 40.55, 32.57, 29.99, 28.54, 27.03, 26.74, 26.57, 25.86, 17.67, 11.83. Minor Isomer 
(distinct resonances): 1H NMR (400 MHz, CDCl3): δ 3.21 (sext, J = 7.2 Hz, 1H), 2.13 
(m, 2H), 1.05 (d, J = 7.2 Hz, 3H), 0.89 (t, J = 7.6 Hz, 3H). 13C{1H} NMR (CDCl3): δ 
33.36, 30.05, 29.35, 28.65, 26.77, 26.47, 26.12, 12.15.  IR (thin film, mixture of E/Z 
isomers): 3250, 2961, 2931, 2858, 1457 cm-1. HRMS electrospray (m/z): [M+H]+ calcd 
for C12H25ClNO (mixture of E/Z isomers), 234.1625; found, 234.1624.  
 
Oxime 17. The general procedure was followed utilizing 2-
methylcyclohexanone (1.35 g, 12.0 mmol). The product was obtained as 
a pale yellow oil consisting of a ~5:1 mixture of major and minor oxime 
stereoisomers (1.37 g, 90% yield).  Major Isomer: 1H NMR (500 MHz, 
CDCl3): δ 8.82 (br s, 1H), 3.09 (m, 1H), 2.31 (m, 1H), 1.94–1.84 (multiple peaks, 2H), 
1.78 (m, 2H), 1.48 (m, 2H), 1.31 (m, 1H), 1.12 (d, J = 7.0 Hz, 3H). 13C{1H} NMR 
(CDCl3): δ 163.49, 37.16, 35.57, 26.02, 24.67, 23.82, 16.82. Minor Isomer (distinct 
resonances): 1H NMR (500 MHz, CDCl3): δ 9.12 (br s, 1H), 3.58 (m, 1H), 2.22 (m, 2H). 
13C{1H} NMR (CDCl3): δ 31.57, 28.27, 26.63, 20.33, 16.21. IR (thin film, mixture of E/Z 
isomers): 3270, 2963, 2927, 2856, 1444 cm-1. HRMS electron impact (m/z): [M]+ calcd 
for C7H13NO (mixture of E/Z isomers), 127.0997; found, 127.1001. 
 
Oxime 19. The general procedure was followed utilizing trans-1-
decalone (4.58 g, 30.1 mmol). The product was obtained as a white 








= 157–158 °C). 1H NMR (500 MHz, CDCl3): δ 3.42 (dddd, J = 13.8, 4.4, 2.7, 2.0 Hz, 
1H), 1.94 (m, 1H), 1.88 (m, 1H), 1.82–1.74 (multiple peaks, 2H), 1.72–1.67 (multiple 
peaks, 3H), 1.61 (td, J = 13.8, 5.0 Hz, 1H), 1.43 (qt, J = 13.0, 4.0 Hz, 1H), 1.35–1.16 
(multiple peaks, 5H), 1.08 (m, 1H). Exchangeable proton (OH) was not observed. 
13C{1H} NMR (CDCl3): δ 162.22, 47.63, 44.20, 34.26, 33.59, 26.63, 25.95, 25.90, 25.33, 
24.77. IR (KBr): 3226, 2161, 2923, 2847, 1439 cm-1. HRMS electrospray (m/z): [M]+ 
calcd for C10H17NO, 167.1310; found, 167.1310. 
 
Oxime 21. The general procedure was followed utilizing 3'-
(trifluoromethyl)acetophenone (759 mg, 4.03 mmol). The product 
was obtained as a white solid consisting of a single oxime isomer 
(789 mg, 96% yield, mp = 58–60 °C). 1H NMR (500 MHz, CDCl3): 
δ 9.41 (s, 1H), 7.89 (s, 1H), 7.82 (d, J = 8.0 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.51 (t, J = 
8.0 Hz, 1H), 2.33 (s, 3H).  13C{1H} NMR (CDCl3): δ 155.09, 137.27, 130.99 (q, J = 32.7 
Hz), 129.24 (q, J = 1.1 Hz), 129.02, 125.83 (q, J = 3.8 Hz), 123.94 (q, J = 272.5 Hz), 
122.95 (q, J = 3.8 Hz), 12.22. 19F NMR (CDCl3): δ –62.8. IR (KBr): 3256, 3086, 2924, 
1465 cm-1.  HRMS electrospray (m/z): [M+H]+ calcd for C9H8F3NO, 204.0636; found, 
204.0636. 
 
Oxime 23.  The general procedure was followed utilizing 3'-
bromoacetophenone (2.99 g, 15.0 mmol). The product was obtained 
as a white solid consisting of a single oxime isomer (3.17 g, 99% 
yield, mp = 92–93 °C). 1H NMR (500 MHz, CDCl3): δ 8.69 (s, 1H), 
7.77 (t, J = 1.7 Hz, 1H), 7.56 (m, 1H), 7.51 (ddd, J = 7.8, 1.7, 1.0 Hz, 1H), 7.257 (t, J = 
7.8 Hz, 1H), 2.28 (s, 3H). 13C{1H} NMR (CDCl3): δ 154.98, 138.42, 132.19, 130.00, 
129.16, 124.61, 122.68, 12.27. IR (KBr): 3239, 2912, 1418 cm-1.  HRMS electron impact 
(m/z): [M]+ calcd for C8H8BrNO 212.9789; found, 212.9790. 
 
Oxime 25. The general procedure was followed utilizing 3'-








as a white solid consisting of a single oxime isomer (1.71 g, 76% yield, mp = 51–52 °C). 
1H NMR (500 MHz, CDCl3): δ 8.09 (s, 1H), 7.45 (br s, 1H), 7.42 (br d, J = 8 Hz, 1H), 
7.27 (t, J =8 Hz, 1H), 7.19 (br d, J = 8 Hz, 1H), 2.38 (s, 3H), 2.28 (s, 3H). 13C{1H} NMR 
(CDCl3): δ 156.15, 138.12, 136.44, 130.00, 128.39, 126.70, 123.21, 21.44, 12.44. IR 
(KBr): 3215, 2041, 2920, 1490, 1456 cm-1. HRMS electron impact (m/z): [M]+ calcd for 
C9H11NO, 149.0841; found, 149.0837. 
 
Oxime 27. The general procedure was followed utilizing 3'-
methoxyacetophenone (2.25 g, 15.0 mmol). The product was 
obtained as a colorless oil consisting of a single oxime isomer 
(2.26 g, 91% yield). 1H NMR (500 MHz, DMSO): δ 11.21 (s, 1H), 
7.30 (t, J = 8.1 Hz, 1H), 7.21 (m, 1H), 7.18 (m, 1H), 6.94 (ddd, J = 8.1, 2.4, 1.0 Hz, 1H), 
3.77 (s, 3H), 2.14 (s, 3H). 13C{1H} NMR (CDCl3): δ 159.62, 156.02, 137.90, 129.48, 
118.61, 115.09, 111.31, 55.29, 12.26. IR (thin film): 3228, 2938, 2836, 1578, 1427 cm-1. 
HRMS electron impact (m/z): [M]+ calcd for C9H11NO2, 165.0790; found, 165.0790. 
 
Oxime 29. The general procedure was followed utilizing 
TBDPS-protected 3'-hydroxyacetophenone (4.39 g, 11.7 mmol). 
The product was obtained as a white solid consisting of a single 
oxime isomer (4.30 g, 94% yield, mp = 89–93 °C). 1H NMR 
(400 MHz, CDCl3): δ 8.55 (br s, 1H), 7.75–7.72 (multiple peaks, 4H), 7.46–7.36 
(multiple peaks, 6H), 7.16 (dt, J = 8.0, 1.2 Hz, 1H), 7.08–7.04 (multiple peaks, 2H), 6.72 
(ddd, J = 8.0, 2.4, 1.2 Hz, 1H), 2.09 (s, 3H), 1.13 (s, 9H). 13C{1H} NMR (CDCl3): δ 
155.77, 155.65, 137.70, 135.51, 132.76, 129.94, 129.18, 127.80, 120.44, 118.69, 117.68, 
26.53, 19.47, 12.02. IR (KBr): 3214, 3070, 2934, 2859, 1580, 1427 cm-1. HRMS 
electrospray (m/z): [M+Na]+ calcd for C24H27NO2Si,  412.1709; found, 412.1699. 
 
Oxime 31. The general procedure was followed utilizing 4'-tert-
butylacetophenone (3.00 g, 17.0 mmol). The product was 
obtained as a white solid consisting of a single oxime isomer 








(d, J = 6.8 Hz, 2H), 7.40 (d, J = 6.8 Hz, 2H), 2.28 (s, 3H), 1.33 (s, 9H). 13C{1H} NMR 
(CDCl3): δ 155.83, 152.43, 133.66, 125.75, 125.44, 34.67, 31.20, 12.18. IR (KBr): 3243, 
2965, 1457 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C12H18NO, 192.1388; 
found, 192.1381. 
 
Oxime 33. The general procedure was followed utilizing α-tetralone 
(2.00 g, 13.7 mmol). The product was obtained as a red-brown solid 
consisting of a single oxime isomer (1.99 g, 90% yield, mp = 95–96 
°C). 1H NMR (400 MHz, CDCl3): δ 8.06 (br s, 1H), 7.89 (dd, J = 7.4, 
1.2 Hz, 1H), 7.27 (ddd, J = 7.4, 7.4, 1.2 Hz, 1H), 7.23–7.14 (multiple peaks, 2H), 2.82 (t, 
J = 6.7 Hz, 2H), 2.77 (t, J =5.3 Hz, 2H), 1.88 (m, 2H). 13C{1H} NMR (CDCl3): δ 155.38, 
139.81, 130.40, 129.21, 128.66, 126.47, 124.02, 29.78, 23.84, 21.27. IR (KBr): 3194, 
3063, 2935, 1486, 1450 cm-1. HRMS electron impact (m/z): [M]+ calcd for C10H11NO, 
161.0841; found, 161.0835. 
 
Oxime 35. The general procedure was followed utilizing m-
tolualdehyde (1.80 g, 15.0 mmol). The product was obtained as a 
pale yellow solid consisting of a single oxime isomer (1.88 g, 93% 
yield, mp = 51–53 °C). 1H NMR (500 MHz, CDCl3): δ 8.13 (s, 
1H), 8.08 (s, 1H), 7.41 (br s, 1H), 7.38 (br d, J = 7.6 Hz, 1H), 7.28 (t, J = 7.6 Hz, 1H), 
7.21 (br d, J = 7.6 Hz, 1H), 2.38 (s, 3H). 13C{1H} NMR (CDCl3): δ 150.47, 138.49, 
131.76, 130.90, 128.66, 127.53, 124.30, 21.28. IR (KBr): 3167, 3087, 2986, 2872, 2777, 






Synthesis and Characterization of Acetoxylated Products 
General Procedure: The oxime substrate was dissolved in 1:1 AcOH/Ac2O in a loosely 
capped 20 mL scintillation vial or a larger pressure vessel. This solution was stirred at 
room temperature for 2 h. Pd(OAc)2 and PhI(OAc)2 were added, and the reaction vessel 
was sealed with a Teflon-lined cap or a Teflon bushing. The reaction was then heated at 
80 or 100 °C for 12 h (unless otherwise noted). The resulting mixture was filtered 
through glass wool, diluted with EtOAc (2 x volume of reaction solvent), and washed 
several times with equal volumes of saturated NaHCO3 until the aqueous solution was no 
longer acidic. The organic layer was then washed with brine, dried over MgSO4, and 
concentrated to give the crude product, which was purified by chromatography on silica 
gel. Where noted, the oximes were obtained as mixtures of E and Z stereoisomers. In 
these cases, the ratio is reported based on 1H NMR integration. In all cases, complete 1H 
and 13C NMR data are reported for the major isomer. In addition, all of the distinct 
resonances associated with the minor isomer are shown for both the 1H and 13C NMR 
spectra (many of the peaks for the minor isomer are coincident with those of the major 
isomer). All other characterization (HRMS, IR, melting point) was carried out on a 
mixture of the oxime E/Z isomers.  
 
Acetoxylated Product 10.  The general procedure was 
followed utilizing substrate 7 (2.00 g, 9.12 mmol, 1 
equiv), Pd(OAc)2 (102 mg, 0.456 mmol, 0.05 equiv), 
PhI(OAc)2 (6.06 g, 18.2 mmol, 2 equiv), AcOH (38 mL), 
and Ac2O (38 mL), with heating at 100 °C. Product 10 was obtained as a pale yellow oil 
consisting of a ~3:1 mixture of major and minor oxime stereoisomers (1.44 g, 49% yield, 
Rf = 0.20  in 80% hexanes/20% EtOAc).  Major Isomer: 1H NMR (500 MHz, CDCl3): δ 
7.30 (m, 2H), 7.22–7.17 (multiple peaks, 3H), 4.21 (dd, J = 11.2, 5.6 Hz, 1H), 4.12 (dd, J 
= 11.2, 8.3 Hz, 1H), 2.70–2.66 (multiple peaks, 3H), 2.32 (t, J = 8.3 Hz, 2H), 2.09 (s, 
3H), 2.01 (s, 3H), 1.88–1.82 (multiple peaks, 2H), 1.62–1.53 (multiple peaks, 2H), 0.92 
(t, J = 7.3 Hz, 3H). 13C{1H} NMR (CDCl3): δ 170.70, 168.88, 168.64, 140.94, 128.40, 
128.30, 126.09, 64.39, 45.51, 35.85, 27.84, 27.43, 22.15, 20.77, 19.60, 11.39. Minor 




1.99 (s, 3H). 13C{1H} NMR (CDCl3): δ 128.36, 125.88, 64.04, 41.43, 35.40, 31.25, 
27.58, 21.77, 19.68, 11.89. IR (thin film, mixture of E/Z isomers): 2966, 1740 cm-1. 
HRMS electrospray (m/z): [M+Na]+ calcd for NaC18H25NO4 (mixture of E/Z isomers), 
342.1681; found, 342.1674. 
 
Acetoxylated Product 12. The general procedure was followed 
utilizing substrate 11 (1.90 g, 16.5 mmol, 1 equiv), Pd(OAc)2 (185 
mg, 0.825 mmol, 0.05 equiv), PhI(OAc)2 (7.97 g, 24.75 mmol, 1.5 
equiv), AcOH (60 mL), and Ac2O (60 mL), with heating at 100 °C. 
Product 12 was obtained as a pale yellow oil consisting of an ~11:1 mixture of major and 
minor oxime stereoisomers (2.17 g, 61% yield, Rf = 0.28 in 70% hexanes/30% EtOAc).  
Major Isomer: 1H NMR (500 MHz, CDCl3): δ 4.22–4.06 (multiple peaks, 2H), 2.76 
(dddd, J = 7.9, 7.9, 6.2, 6.2 Hz, 1H), 2.17 (s, 3H), 2.03 (s, 3H), 1.92 (s, 3H), 1.64–1.47 
(multiple peaks, 2H), 0.92 (t, J = 7.6 Hz, 3H). 13C{1H} NMR (CDCl3): δ 170.79, 168.68, 
166.00, 64.14, 45.97, 21.73, 20.80, 19.68, 12.39, 11.33. Minor Isomer (distinct 
resonances): 1H NMR (500 MHz, CDCl3): δ 3.54 (m, 1H), 2.15 (s, 3H), 2.03 (s, 3H), 1.98 
(s, 3H). 13C{1H} NMR (CDCl3): δ 63.94, 40.17, 21.51, 19.57, 16.31, 11.58. IR (thin film, 
mixture of E/Z isomers): 2967, 2938, 2880, 1739, 1366 cm-1. HRMS electrospray (m/z): 
[M+Na]+ calcd for NaC10H17NO4 (mixture of E/Z isomers), 238.1055; found, 238.1059.  
 
Acetoxylated Product 14. The general 
procedure was followed utilizing substrate 13 
(325 mg, 0.944 mmol, 1 equiv), Pd(OAc)2 (10.6 
mg, 0.047 mmol, 0.05 equiv), PhI(OAc)2 (608 
mg, 1.89 mmol, 2 equiv), AcOH (3.9 mL), and Ac2O (3.9 mL), with heating at 100 °C. 
Product 14 was obtained as an orange oil consisting of a ~3.6:1 mixture of major and 
minor oxime stereoisomers (272 mg, 65% yield, Rf = 0.29 in 65% hexanes/35% EtOAc). 
Major Isomer: 1H NMR (400 MHz, CDCl3): δ 7.79 (dd, J = 5.6, 3.2 Hz, 2H), 7.67 (dd, J 
= 5.6, 3.2 Hz, 2H), 4.17 (dd, J = 11.2, 6.0 Hz, 1H), 4.17 (dd, J = 11.2, 8.0 Hz, 1H), 3.63 
(t, J = 7.2 Hz, 2H), 2.64 (dddd, J = 7.6, 7.6, 6.4, 6.4 Hz, 1H), 2.31–2.18 (multiple peaks, 











J = 7.6 Hz, 3H). 13C{1H} NMR (CDCl3): δ 170.62, 168.98, 168.70, 168.27, 133.77, 
131.97, 123.00, 64.38, 45.39, 37.73, 29.62, 28.53, 28.41, 28.34, 26.47, 25.78, 22.16, 
20.71, 19.66, 11.32. Minor Isomer (distinct resonances): 1H NMR (400 MHz, CDCl3): δ 
3.31 (dddd, J = 8.8, 8.8, 6.2, 6.2 Hz, 1H), 2.15 (s, 3H), 2.04 (s, 3H). 13C{1H} NMR 
(CDCl3): δ 170.56, 168.48, 168.32, 133.72, 64.02, 41.42, 37.78, 31.84, 29.22, 28.73, 
26.57, 25.88, 21.75, 20.69, 19.62. IR (thin film, mixture of E/Z isomers): 2934, 2860, 
1766, 1742, 1708 cm-1. HRMS electrospray (m/z): [M+Na]+ calcd for NaC24H32N2O6 
(mixture of E/Z isomers), 467.2158; found, 467.2163. 
 
Acetoxylated Product 16.  The general procedure was 
followed utilizing substrate 15 (500 mg, 1.80 mmol, 1 
equiv), Pd(OAc)2 (20.2 mg, 0.090 mmol, 0.05 equiv), 
PhI(OAc)2 (1.16 g, 3.60 mmol, 2 equiv), AcOH (7.5 
mL), and Ac2O (7.5 mL), with heating at 100 °C. Product 16 was obtained as a pale 
yellow oil consisting of a ~3:1 mixture of major and minor oxime stereoisomers (330 mg, 
48% yield, Rf = 0.27  in 77% hexanes/23% EtOAc). Major Isomer: 1H NMR (500 MHz, 
CDCl3): δ 4.22 (dd, J = 11.2, 5.9 Hz, 1H), 4.17 (dd, J = 11.2, 8.1 Hz, 1H), 3.53 (t, J = 6.8 
Hz, 2H), 2.69 (m, 1H), 2.35–2.26 (multiple peaks, 2H), 2.18 (s, 3H), 2.03 (s, 3H), 1.80–
1.73 (multiple peaks, 2H), 1.65–1.57 (multiple peaks, 2H), 1.55–1.48 (multiple peaks, 
2H), 1.47–1.40 (multiple peaks, 2H), 1.40–1.32 (multiple peaks, 4H), 0.94 (t, J = 7.3 Hz, 
3H). 13C{1H} NMR (CDCl3): δ 170.78, 168.98, 168.93, 64.53, 45.55, 45.00, 32.46, 
29.75, 28.57, 28.41, 26.64, 25.88, 22.34, 20.86, 19.81, 11.45. Minor Isomer (distinct 
resonances): 1H NMR (500 MHz, CDCl3): δ 3.32 (dddd, J = 8.8, 6.1 Hz, 1H), 2.16 (s, 
3H), 2.03 (s, 3H). 13C{1H} NMR (CDCl3): δ 64.17, 49.98, 45.06, 41.56, 31.93, 29.31, 
26.71, 25.98, 21.91, 20.83, 19.74, 11.98. IR (thin film, mixture of E/Z isomers): 2934, 
2859, 1741 cm-1. HRMS electrospray (m/z): [M+Na]+ calcd for NaC16H28ClNO4 (mixture 
of E/Z isomers), 356.1605; found, 356.1610. 
 
Acetoxylated Product 18. The general procedure was followed 








mg, 0.059 mmol, 0.05 equiv), PhI(OAc)2 (570 mg, 1.77 mmol, 1.5 equiv), AcOH (4.9 
mL), and Ac2O (4.9 mL), with heating at 100 °C. Product 18 was obtained as a pale 
orange oil consisting of a ~4:1 mixture of major and minor oxime stereoisomers (177 mg, 
66% yield, Rf = 0.21 (major) and 0.29 (minor) in 72% hexanes/28% EtOAc). Major 
Isomer: 1H NMR (500 MHz, CDCl3): δ 4.49 (dd, J = 11.0, 6.6 Hz, 1H), 4.13 (dd, J = 
11.0, 7.3 Hz, 1H), 2.79–2.72 (multiple peaks, 2H), 2.34 (ddd, J = 13.9, 9.0, 4.6 Hz, 1H), 
2.16 (s, 3H), 2.05 (s, 3H), 1.98 (m, 1H), 1.74–1.53 (multiple peaks, 5H). 13C{1H} NMR 
(CDCl3): δ 170.93, 169.27, 167.57, 63.92, 41.40, 29.89, 25.92, 25.63, 23.19, 20.87, 
19.77. Minor Isomer (distinct resonances): 1H NMR (500 MHz, CDCl3): δ 4.26–4.18 
(multiple peaks, 2H), 3.76 (br m, 1H), 2.59 (br d, J = 15.0 Hz, 1H), 2.14 (s, 3H). 13C{1H} 
NMR (CDCl3): δ 170.72, 168.61, 167.83, 63.05, 34.25, 27.05, 26.34, 20.79, 20.69, 19.56. 
IR (thin film, mixture of E/Z isomers): 2939, 2863, 1762, 1736 cm-1. HRMS electrospray 
(m/z): [M+Na]+ calcd for NaC11H17NO4 (mixture of E/Z isomers), 250.1055; found, 
250.1044. 
 
Acetoxylated Product 20. The general procedure was followed 
utilizing substrate 19 (1.32 g, 7.87 mmol, 1 equiv), Pd(OAc)2 (88.3 
mg, 0.394 mmol, 0.05 equiv), PhI(OAc)2 (7.60 g, 23.6 mmol, 3 equiv), 
AcOH (33 mL), and Ac2O (33 mL), with heating at 100 °C. Product 
20 was obtained as a pale orange waxy solid consisting of a single oxime isomer (922 
mg, 44% yield, Rf = 0.25 in 77% hexanes/23% EtOAc, mp = 69–74 °C).  1H NMR (400 
MHz, CDCl3): δ 5.14 (ddd, J = 10.9, 10.9, 4.7 Hz, 1H), 3.32 (br d, J = 13.1 Hz, 1H), 2.14 
(s, 3H), 2.02 (s, 3H), 1.96–1.65 (multiple peaks, 6H), 1.52–1.22 (multiple peaks, 6H), 
1.10 (m, 1H). 13C{1H} NMR (CDCl3): δ 170.45, 166.25, 69.92, 52.20, 43.66, 33.08, 
33.00, 31.53, 27.41, 25.87, 23.02, 21.20, 19.98. Two 13C resonances are coincidentally 
overlapping. IR (KBr): 2939, 2863, 1760, 1742, 1637, 1448 cm-1. HRMS electrospray 







Acetoxylated Product 22. The general procedure was followed 
utilizing substrate 21 (250 mg, 1.23 mmol, 1 equiv), Pd(OAc)2 
(27.6 mg, 0.123 mmol, 0.10 equiv), PhI(OAc)2 (792 mg, 2.46 
mmol, 2 equiv), AcOH (5.1 mL), and Ac2O (5.1 mL), with 
heating at 80 °C for 24 h. Product 22 was obtained as a pale yellow oil consisting of a 
~16:1 mixture of major and minor oxime stereoisomers (227 mg, 61% yield, Rf = 0.21 in 
80% hexanes/20% EtOAc). The minor isomer was assigned as a stereoisomer (not a 
regioisomer) by analogy to compounds 26 and 28 as well as based on the previously 
reported analogous reactions of oxime ether12b and 2-phenylpyridine-based substrates13b. 
Major Isomer: 1H NMR (400 MHz, CDCl3): δ 7.73 (d, J = 2.0 Hz, 1H), 7.69 (dd, J = 8.4, 
2.0 Hz, 1H), 7.30 (d, J = 8.4 Hz, 1H), 2.34 (s, 3H), 2.33 (s, 3H), 2.24 (s, 3H). 13C{1H} 
NMR (CDCl3): δ 168.72, 168.02, 160.63, 150.63 (q, J = 1.1 Hz), 129.45, 128.45 (q, J = 
33.4 Hz), 127.81 (q, J = 3.5 Hz), 126.95 (q, J = 3.5 Hz), 124.05, 123.39 (q, J = 272.4 
Hz), 21.01, 19.57, 16.57. 19F NMR (CDCl3): δ –62.41. Minor Isomer (distinct 
resonances): 1H NMR (400 MHz, CDCl3): δ 2.39 (s, 3H), 2.04 (s, 3H). 13C{1H} NMR 
(CDCl3): δ 128.62, 126.36, 21.85, 19.36. IR (thin film, mixture of E/Z isomers): 3075, 
2940, 1766 cm-1. HRMS electrospray (m/z): [M+Na]+ calcd for NaC13H12F3NO4 (mixture 
of E/Z isomers), 326.0616; found, 326.0614.  
 
Acetoxylated Product 24. The general procedure was followed 
utilizing substrate 23 (1.50 g, 7.01 mmol, 1 equiv), Pd(OAc)2 (78.7 
mg, 0.351 mmol, 0.05 equiv), PhI(OAc)2 (2.48 g, 7.71 mmol, 1.1 
equiv), AcOH (29 mL), and Ac2O (29 mL), with heating at 80 °C. 
Product 24 was obtained as a pale yellow oil consisting of a ~12:1 mixture of major and 
minor oxime stereoisomers (1.89 g, 86% yield, Rf = 0.29 in 77% hexanes/23% EtOAc). 
The minor isomer was assigned as a stereoisomer (not a regioisomer) by analogy to 
compounds 26 and 28 (in the current paper) as well as based on the previously reported 
analogous reactions of oxime ether12b and 2-phenylpyridine-based substrates13b. Major 
Isomer: 1H NMR (400 MHz, CDCl3): δ 7.61 (d, J = 2.8 Hz, 1H), 7.54 (dd, J = 8.6, 2.8 
Hz, 1H), 7.04 (d, J = 8.6 Hz, 1H), 2.30 (app. s, 6H), 2.24 (s, 3H). 13C{1H} NMR 








20.97, 19.57, 16.48. Minor Isomer (distinct resonances): 2.31 (s, 3H), 2.22 (s, 3H), 1.98 
(s, 3H). IR (thin film, mixture of E/Z isomers): 2932, 1762 cm-1. HRMS electrospray 
(m/z): [M+Na]+ calcd for NaC12H12BrNO4 (mixture of E/Z isomers), 335.9847; found, 
335.9847.  
 
Acetoxylated Product 26. The general procedure was followed 
utilizing substrate 25 (800 mg, 5.36 mmol, 1 equiv), Pd(OAc)2 
(60.2 mg, 0.268 mmol, 0.05 equiv), PhI(OAc)2 (1.90 g, 5.90 
mmol, 1.1 equiv), AcOH (22 mL), and Ac2O (22 mL), with 
heating at 80 °C.  Product 26 was obtained as a pale orange waxy solid consisting of an 
~8:1 mixture of major and minor oxime stereoisomers (962 mg, 72% yield, Rf = 0.24 in 
77% hexanes/23% EtOAc, mp = 57–65 °C). The minor isomer was assigned as a 
stereoisomer (not a regioisomer) on the basis of the fact that hydrolysis led to a single 
ketone product 42. Major Isomer: 1H NMR (500 MHz, CDCl3): δ 7.27 (s, 1H), 7.22 (d, J 
= 8.0 Hz, 1H), 7.02 (d, J = 8.0 Hz, 1H), 2.36 (s, 3H), 2.30 (s, 3H), 2.29 (s, 3H), 2.23 (s, 
3H). 13C{1H} NMR (CDCl3): δ 169.53, 168.45, 161.89, 145.88, 135.87, 131.48, 130.01, 
128.23, 122.96, 21.08, 20.79, 19.71, 16.67. Minor Isomer (distinct resonances): 2.38 (s, 
3H), 2.22 (s, 3H), 1.99 (s, 3H). IR (KBr, mixture of E/Z isomers): 2942 1758 cm-1. 
HRMS electrospray (m/z): [M+Na]+ calcd for NaC13H15NO4 (mixture of E/Z isomers), 
272.0899; found, 272.0892. 
  
Acetoxylated Product 28. The general procedure was followed 
utilizing substrate 27 (1.50 g, 9.08 mmol, 1 equiv), Pd(OAc)2 
(102 mg, 0.454 mmol, 0.05 equiv), PhI(OAc)2 (3.22 g, 9.99 
mmol, 1.1 equiv), AcOH (38 mL), and Ac2O (38 mL), with 
heating at 80 °C for 4 h. Product 28 was obtained as an orange oil consisting of a ~20:1 
mixture of major and minor oxime stereoisomers (1.78 g, 74% yield, Rf = 0.23 in 70% 
hexanes/30% EtOAc). The minor isomer was assigned as a stereoisomer (not a 
regioisomer) on the basis of the fact that hydrolysis led to a single ketone product. Major 
Isomer: 1H NMR (400 MHz, CDCl3): δ 7.04 (d, J = 8.8 Hz, 1H), 6.97–6.92 (multiple 








δ 169.70, 168.36, 161.58, 157.12, 141.50, 129.27, 124.07, 115.97, 114.59, 55.70, 20.98, 
19.66, 16.58. Minor Isomer (distinct resonances): 1H NMR (400 MHz, CDCl3): δ 3.83 (s, 
3H), 2.31 (s, 3H), 2.20 (s, 3H), 1.97 (s, 3 3H). IR (thin film, mixture of E/Z isomers): 
2938, 1760 cm-1. HRMS electrospray (m/z): [M+Na]+ calcd for NaC13H15NO5 (mixture of 
E/Z isomers), 288.0848; found, 288.0851.  
 
Acetoxylated Product 30.  The general procedure was 
followed utilizing substrate 29 (200 mg, 0.513 mmol, 1 equiv), 
Pd(OAc)2 (5.8 mg, 0.026 mmol, 0.05 equiv), PhI(OAc)2 (182 
mg, 0.564 mmol, 1.1 equiv), AcOH (2.1 mL), and Ac2O (2.1 
mL), with heating at 80 °C for 10 h. Product 30 was obtained as pale yellow viscous oil 
consisting of a ~19:1 mixture of major and minor oxime stereoisomers (198 mg, 79% 
yield, Rf = 0.25 in 80% hexanes/20% EtOAc). The minor isomer was assigned as a 
stereoisomer (not a regioisomer) by analogy to compounds 26 and 28 (in the current 
paper). Major Isomer: 1H NMR (400 MHz, CDCl3): δ 7.70–7.68 (multiple peaks, 4H), 
7.45–7.35 (multiple peaks, 6H), 6.82–6.80 (multiple peaks, 2H), 6.72 (dd, J = 8.8, 2.8 
Hz, 1H), 2.23 (s, 3H), 2.18 (s, 3H), 2.07 (s, 3H), 1.10 (s, 9H). 13C{1H} NMR (CDCl3): δ 
169.74, 168.40, 161.18, 153.15, 141.55, 135.46, 132.26, 130.09, 128,94, 127.90, 123.78, 
121.49, 120.21, 26.41, 21.00, 19.66, 19.39, 16.24. Minor Isomer (distinct resonances): 1H 
NMR (400 MHz, CDCl3): δ 2.15 (s, 3H), 2.04 (s, 3H), 1.92 (s, 3H), 1.11 (s, 9H). IR (thin 
film, mixture of E/Z isomers): 3074, 2933, 2859, 1765 cm-1. HRMS electrospray (m/z): 
[M+Na]+ calcd for NaC28H31NO5Si (mixture of E/Z isomers), 512.1869; found, 512.1865.  
 
Acetoxylated Product 32.  The general procedure was followed 
utilizing substrate 31 (1.91 g, 10.0 mmol, 1 equiv), Pd(OAc)2 
(112 mg, 0.500 mmol, 0.05 equiv), PhI(OAc)2 (3.22 g, 10.0 
mmol, 1 equiv), AcOH (42 mL), and Ac2O (42 mL), with heating at 80 °C.  Product 32 
was obtained as a pale orange solid consisting of an ~11:1 mixture of major and minor 
oxime stereoisomers (2.32 g, 80% yield, Rf = 0.29 in 77% hexanes/23% EtOAc, mp = 
43–51 °C).  Major Isomer: 1H NMR (500 MHz, CDCl3): δ 7.41 (d, J = 8.1 Hz, 1H), 7.29 








3H), 1.31 (s, 9H). 13C{1H} NMR (CDCl3): δ 169.56, 168.46, 161.50, 154.96, 147.87, 
129.12, 125.55, 123.14, 120.35, 34.84, 31.01, 21.14, 19.71, 16.37. Minor Isomer (distinct 
resonances): 1H NMR (500 MHz, CDCl3): δ 2.30 (s, 3H), 2.22 (s, 3H), 2.01 (s, 3H), 1.34 
(s, 9H).  IR (KBr, mixture of E/Z isomers): 2961, 1772 cm-1. HRMS electrospray (m/z): 
[M+Na]+ calcd for NaC16H21NO4 (mixture of E/Z isomers), 314.1368; found, 314.1362. 
 
Acetoxylated Product 34.  The general procedure was followed 
utilizing substrate 33 (1.5 g, 9.30 mmol, 1 equiv), Pd(OAc)2 (104 mg, 
0.465 mmol, 0.05 equiv), PhI(OAc)2 (3.30 g, 10.2 mmol, 1.1 equiv), 
AcOH (39 mL), and Ac2O (39 mL), with heating at 80 °C.  Product 
34 was obtained as a tan powder consisting of a single oxime isomer (1.34 g, 55% yield, 
Rf = 0.26 in 77% hexanes/23% EtOAc, mp = 127–128 °C). 1H NMR (400 MHz, CDCl3): 
δ 7.33 (t, J = 7.8 Hz, 1H), 7.10 (dd, J = 7.8, 1.2 Hz, 1H), 6.96 (dd, J = 8.2, 1.2 Hz, 1H), 
2.88 (t, J = 6.4 Hz, 2H), 2.78 (t, J = 6.4 Hz, 2H), 2.40 (s, 3H), 2.19 (s, 3H), 1.84 (m, 2H). 
13C{1H} NMR (CDCl3): δ 170.58, 167.58, 160.15, 148.92, 143.67, 130.84, 126.48, 
122.39, 122.15, 30.31, 26.15, 21.37, 20.78, 19.65. IR (KBr): 2942, 1764 cm-1. HRMS 
electrospray (m/z): [M+Na]+ calcd for NaC14H15NO4, 284.0899; found, 284.0898. 
 
Benzonitrile Product 36. The general procedure was followed 
utilizing substrate 35 (30 mg, 0.222 mmol, 1 equiv), Pd(OAc)2 (2.5 
mg, 0.011 mmol, 0.05 equiv), PhI(OAc)2 (78.7 mg 0.244 mmol, 1.1 
equiv), AcOH (920 µL), and Ac2O (920 µL), with heating at 80 °C for 4 h. The calibrated 






Synthesis and Characterization of β- and ortho-Hydroxy Ketones 
General Procedure For One Pot Deprotection: To a solution of the O-acetyl oxime in 
MeOH (0.46 mL/mmol oxime) in a loosely capped scintillation vial at room temperature 
was added finely ground K2CO3 (0.15 equiv every 2 h over the course of 6 h, 0.45 equiv 
total). NaHSO3 (3.5 equiv) and H2O (equal amount as MeOH) were then added, and the 
vial was sealed with a Teflon-lined cap and heated at 80 °C for 3 h.22 The reaction 
mixture was concentrated by rotary evaporation to remove methanol. The remaining 
primarily aqueous reaction mixture was diluted with CHCl3 (4 x volume of reaction 
solvent) and rinsed briefly with 1 M HCl (2 x volume of reaction solvent). The layers 
were separated, and the aqueous layer was extracted several times with CHCl3. The 
combined organic extracts were neutralized with aqueous NaHCO3, washed once with 
brine, dried over MgSO4, filtered through a plug of silica, and concentrated to afford the 
β-hydroxyketone.   
 
β-Hydroxy Oxime 37. To a solution of acetyl oxime 10 
(170 mg, 0.532 mmol, 1 equiv) in MeOH (1.16 mL) in a 
loosely capped scintillation vial at room temperature was 
added finely ground K2CO3 (11 mg, 0.0798 mmol, 0.15 
equiv). After stirring at room temperature for 12 h, the MeOH was removed by rotary 
evaporation, and the crude product was purified by column chromatography to yield the 
unprotected β-hydroxy oxime 37 as pale yellow solid consisting of a 4:1 mixture of major 
and minor oxime isomers (113.4 mg, 91% yield, Rf = 0.27 and 0.19 in 60% hexanes/40% 
EtOAc, mp = 68–74 °C). Major Isomer: 1H NMR (400 MHz, CDCl3): δ 7.95 (br s, 1H), 
7.28 (m, 2H), 7.20–7.17 (multiple peaks, 3H), 3.70 (m, 2H), 2.67 (t, J = 7.8 Hz, 2H), 2.48 
(m, 1H), 2.31–2.19 (multiple peaks, 2H), 1.87 (m, 2H), 1.53 (quint, J = 7.4 Hz, 2H), 0.91 
(t, J = 7.4 Hz, 3H). One exchangeable proton (OH) is not observed. 13C{1H} NMR 
(CDCl3): δ 163.56, 141.71, 128.36, 128.33, 125.89, 62.76, 47.74, 36.16, 27.30, 27.26, 
22.13, 11.77. Minor Isomer: 1H NMR (400 MHz, CDCl3): δ 7.28 (m, 2H), 7.20–7.16 
(multiple peaks, 3H), 3.74 (dd, J = 10.8, 5.6 Hz, 1H), 3.67 (dd, J = 10.8, 8.4 Hz, 1H), 




Hz, 2H), 1.90 (m, 2H), 1.52 (m, 2H), 0.92 (t, J = 7.4 Hz, 3H). Both exchangeable protons 
(OH) are not observed. 13C{1H} NMR (CDCl3): δ 161.82, 141.87, 128.42, 128.32, 
125.82, 63.72, 43.29, 35.47, 30.97, 27.54, 21.02, 12.22. IR (KBr, mixture of E/Z 
isomers): 3203, 2963, 2923, 1496, 1453 cm-1. HRMS electrospray (m/z): [M+Na]+ calcd 
for NaC14H21NO2 (mixture of E/Z isomers), 258.1470; found, 258.1471. 
 
β-Hydroxy Ketone 38.  From Hydroxyl Oxime: Oxime 
37 (150 mg, 0.637 mmol, 1 equiv) was combined with 
NaHSO3 (232.2 mg, 2.231 mmol, 3.5 equiv) in EtOH/H2O 
(1:1, 1.28 mL) in a scintillation vial.  The vial was sealed 
with a Teflon-lined cap and heated to 80 °C for 3 h. The resulting solution was 
concentrated by rotary evaporation to remove ethanol. The remaining primarily aqueous 
reaction mixture was diluted with CHCl3 (8 mL), and rinsed briefly with 1 M HCl (5 
mL). The layers were separated, and the aqueous layer was extracted several times with 
CHCl3. The combined organic extracts were neutralized with aqueous NaHCO3, washed 
once with brine, dried over MgSO4, filtered through Celite, and concentrated to afford 38 
as a colorless oil (113 mg, 80% yield). From acetyl oxime: The one pot deprotection 
procedure was followed utilizing 10 (50 mg, 0.156 mmol), to yield 38 as a colorless oil 
(28 mg, 80% yield) contaminated with ~3% of the corresponding isoxazoline. 1H NMR 
(400 MHz, CDCl3): δ 7.28 (m, 2H), 7.21–7.17 (multiple peaks, 3H), 3.78 (m, 1H), 3.69 
(m, 1H), 2.65–2.57 (multiple peaks, 3H), 2.51 (td, J = 7.0, 2.0, 2H), 2.03 (br t, J = 5.9 Hz, 
1H), 1.93 (quin, J = 7.4 Hz, 2H), 1.69–1.46 (multiple peaks, 2H), 0.91 (t, J = 7.4 Hz, 3H). 
13C{1H} NMR (CDCl3): δ 214.70, 141.55, 128.43, 128.37, 125.94, 62.44, 55.00, 41.98, 
35.03, 24.78, 21.28, 11.78. IR (thin film): 3423, 2926 cm-1. HRMS electrospray (m/z): 
[M+Na]+ calcd for NaC14H20O2, 243.1361; found, 243.1360. 
 
Isoxazoline 61. To confirm the identity of the contaminant in 
the one-pot deprotection of 10, isoxazoline 61 was isolated as 
a colorless oil (Rf = 0.47 in 80% hexanes/20% EtOAc) and 
characterized as follows: 1H NMR (400 MHz, CDCl3): δ 7.28 






8.0, 8.0 Hz, 1H), 3.10 (m, 1H), 2.74–2.63 (multiple peaks, 2H), 2.42 (m, 1H), 2.22 (ddd, 
J = 14.8, 8.8, 6.0 Hz, 1H), 2.00–1.88 (multiple peaks, 2H), 1.65 (m, 1H), 1.40 (m, 1H), 
0.91 (t, J = 8.0 Hz, 3H). 13C{1H} NMR (CDCl3): δ 161.21, 141.46, 128.45, 128.38, 
125.96, 72.70, 51.26, 35.32, 27.66, 25.56, 23.34, 11.43. IR (thin film): 2962, 2932, 2864 
cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C14H20NO, 218.1545; found, 
218.1546. 
 
β-Hydroxy Ketone 39. The one pot deprotection 
procedure was followed utilizing 14 (50 mg, 
0.112 mmol), to yield 39 as a colorless oil (31 
mg, 79% yield) contaminated with ~5% of the 
corresponding isoxazoline. 1H NMR (500 MHz, CDCl3): δ 7.82 (dd, J = 5.5, 3.0 Hz, 2H), 
7.69 (dd, J = 5.5, 3.0 Hz, 2H), 3.76 (br t, J = 7.5 Hz, 1H), 3.69–3.60 (multiple peaks, 3H), 
2.61 (m, 1H), 2.46 (t, J = 7.5 Hz, 2H), 2.16 (m, 1H), 1.66–1.46 (multiple peaks, 6H), 
1.32–1.23 (multiple peaks, 6H), 0.90 (t, J = 7.5 Hz, 3H). 13C{1H} NMR (CDCl3): δ 
215.06, 168.46, 133.84, 132.14, 123.14, 62.44, 54.93, 42.76, 37.92, 28.96, 28.85, 28.45, 
26.58, 23.21, 21.30, 11.81. IR (thin film): 3472, 2932, 2858, 1770, 1702 cm-1 HRMS 
electrospray (m/z): [M+Na]+ calcd for NaC20H27NO4, 368.1838; found, 368.1826. 
 
β-Hydroxy Ketone 40. The one pot deprotection 
procedure was followed utilizing 16 (50 mg, 0.159 
mmol), to yield 40 as a colorless oil (21 mg, 56% yield) 
contaminated with ~5% of the corresponding 
isoxazoline. 1H NMR (400 MHz, CDCl3): δ 3.80 (dd, J = 10.8, 7.6 Hz, 1H), 3.70 (dd, J = 
11.2, 4.0 Hz, 1H), 3.52 (t, J = 6.8 Hz, 2H), 2.63 (dddd, J = 7.2, 7.2, 7.2, 4.0 Hz, 1H), 2.49 
(td, J = 7.2, 1.2 Hz, 2H), 2.30–2.20 (br s, 1H), 1.76 (quin, J = 6.8 Hz, 2H), 1.69–1.49 
(multiple peaks, 4H), 1.42 (m, 2H), 1.36–1.26 (multiple peaks, 4H), 0.92 (t, J = 7.3 Hz, 
3H). 13C{1H} NMR (CDCl3): δ 215.05, 62.45, 54.94, 45.07, 42.78, 32.51, 29.00, 28.67, 
26.66, 23.21, 21.31, 11.82. IR (thin film): 3412, 2932, 2857, 1703 cm-1 HRMS 











β-Hydroxy Ketone 41. The one pot deprotection procedure was 
followed utilizing 20 (300 mg, 1.122 mmol), to yield 41 as a white solid 
(157 mg, 83% yield, mp = 43–44 °C). 1H NMR (400 MHz, CDCl3): δ 
3.81 (m, 1H), 3.61 (d, J = 2.0, 1H), 2.42–2.27 (multiple peaks, 2H), 2.06 
(m, 1H), 1.98 (m, 2H), 1.84–1.61 (multiple peaks, 4H), 1.46 (m, 2H), 1.29 (m, 2H), 1.18 
(m, 1H). 13C{1H} NMR (CDCl3): δ 214.82, 69.15, 61.79, 42.82, 41.90, 33.50, 32.68, 
32.04, 26.09, 23.35. IR (KBr): 3446, 2927, 2862, 1701 cm-1.  HRMS electrospray (m/z): 
[M+Na]+ calcd for NaC10H16O2 191.1048; found, 191.1045. 
 
ortho-Hydroxy Oxime 62. To a solution of acetyl oxime 26 (100 
mg, 0.402 mmol, 1 equiv) in MeOH (870 µL) in a loosely capped 
scintillation vial was added finely ground K2CO3 (8.3 mg, 0.060 
mmol, 0.15 equiv). After stirring at room temperature for 0.5 h, the 
MeOH was removed by rotary evaporation, and the crude reaction mixture was diluted 
with CH2Cl2 (4 mL) and neutralized with dilute aqueous AcOH. The organic layer was 
concentrated to afford 62 as a white solid (62 mg, 93% yield, mp = 136–138 °C). 1H 
NMR (400 MHz, CDCl3): δ 10.91 (s, 1H), 7.22 (s, 1H), 7.14 (br s, 1H), 7.07 (dd, J = 8.4, 
2.0 Hz, 1H), 6.87 (d, J = 8.4 Hz, 1H), 2.35 (s, 3H), 2.30 (s, 3H). 13C{1H} NMR (CDCl3): 
δ 159.68, 155.32, 131.53, 128.10, 127.86, 118.06, 117.05, 20.64, 10.78. IR (KBr): 3335, 
2918, 2861, 1636, 1504 cm-1. HRMS electrospray (m/z): [M]+ calcd for C9H11NO2 
165.0790; found, 165.0790. 
 
ortho-Hydroxy Ketone 42. Oxime 62 (50 mg, 0.303 mmol, 1 equiv) 
was combined with NaHSO3 (110.3 mg, 1.06 mmol, 3.5 equiv) in 
EtOH/H2O (1:1, 380 µL) in a scintillation vial. The vial was sealed 
with a Teflon-lined cap and heated to 90 °C for 12 h. The reaction 
mixture was concentrated by rotary evaporation to remove ethanol. The remaining 
primarily aqueous reaction mixture was diluted with CHCl3 (1.5 mL) and rinsed briefly 
with 1 M HCl (~1 mL).  The layers were separated and the aqueous layer was extracted 
several times with CHCl3.  The combined organic extracts were neutralized with aqueous 











white solid (42 mg, 91% yield). The spectroscopic data for 42 matched those reported in 
the literature.37 
 
ortho-Hydroxy Oxime 43. To a solution of acetyl oxime 32 
(400 mg, 1.373 mmol, 1 equiv) in MeOH (3 mL) in a loosely 
capped scintillation vial was added finely ground K2CO3 (29 mg, 
0.206 mmol, 0.15 equiv). After stirring at room temperature for 1 h, the MeOH was 
removed by rotary evaporation. The crude product was purified by column 
chromatography to afford 43 as a pale yellow solid (276 mg, 97% yield, Rf = 0.8 in 65% 
hexanes/35% EtOAc, mp = 82–92 °C). 1H NMR (500 MHz, CDCl3): δ 7.37 (d, J = 8.3 
Hz, 1H), 7.01 (d, J = 2.0 Hz, 1H), 6.94 (dd, J = 8.3, 2.0 Hz, 1H), 2.35 (s, 3H), 1.31 (s, 
9H). Extremely broad OH peaks were visible in the baseline. 13C{1H} NMR (CDCl3): δ 
159.43, 157.22, 154.80, 127.29, 116.51, 115.77, 114.31, 34.71, 31.03, 10.74. IR (KBr): 
3380, 2956, 2869, 1563 cm-1. HRMS electron impact (m/z): [M]+ calcd for C12H17NO2, 
207.1259; found, 207.1255.  
 
ortho-Hydroxy Ketone 14. Oxime 43 (50 mg, 0.241 mmol, 1 
equiv) was combined with NaHSO3 (87.8 mg, 0.844 mmol, 3.5 
equiv) in EtOH/H2O (1:1, 300 µL) in a scintillation vial. The vial 
was sealed with a Teflon-lined cap and heated to 90 °C for 13 h. The reaction mixture 
was concentrated by rotary evaporation to remove ethanol. The remaining primarily 
aqueous reaction mixture was diluted with Et2O (1.5 mL) and rinsed briefly with 1 M 
HCl (~1 mL).  The layers were separated and the aqueous layer was extracted several 
times with Et2O. The combined organic extracts were neutralized with aqueous NaHCO3, 
washed once with brine, dried over MgSO4, and filtered through a plug of silica to afford 
44 as a colorless oil (42 mg, 91% yield). 1H NMR (400 MHz, CDCl3): δ 12.25 (s, 1H), 
7.66 (d, J = 8.2 Hz, 1H), 6.99 (d, J = 2.0 Hz, 1H), 6.94 (dd, J = 8.2, 2.0, 1H), 2.60 (s, 
3H), 1.31 (s, 9H). 13C{1H} NMR (CDCl3): δ 203.79, 162.31, 161.05, 130.37, 117.40, 
116.62, 115.02, 35.31, 30.76, 26.46. IR (thin film): 3249, 2964, 1639 cm-1.  HRMS 








 Synthesis and Characterization of Remaining Compounds in Schemes 5.24–5.27 
Benzoxazole 45. Oxime 43 (41 mg, 0.198 mmol, 1 equiv), p-
TsOH monohydrate (3.8 mg, 0.0198 mmol, 0.1 equiv), and ZnCl2 
(31.1 mg, 0.228 mmol, 1.15 equiv) were dissolved in MeCN (1 
mL), and the resulting solution was heated to 90 °C for 5 h.38 The reaction mixture was 
concentrated by rotary evaporation, and the crude product was taken up in Et2O, washed 
with aqueous NaHCO3 and brine, dried over MgSO4, and concentrated to afford 45 as a 
colorless oil (23 mg, 56% yield, Rf = 0.38 in 80% hexanes/20% EtOAc). 1H NMR (400 
MHz, CDCl3): δ 7.55 (d, J = 8.4 Hz, 1H), 7.49 (d, J = 1.7 Hz, 1H), 7.35 (dd, J = 8.4, 1.7 
Hz, 1H), 2.61 (s, 3H), 1.37 (s, 9H). 13C{1H} NMR (CDCl3): δ 163.52, 151.20, 148.43, 
139.08, 121.63, 118.43, 106.90, 35.01, 31.68, 14.49. IR (thin film): 3224, 3062, 2959, 
1614 cm-1.  HRMS electrospray (m/z): [M+H]+ calcd for C12H15NO 190.1232; found, 
190.1226. 
 
Amine 46. Oxime 43 (60 mg, 0.289 mmol, 1 equiv) was combined 
with 2 drops of conc. HCl and 10 wt % Pd/C (31 mg, 0.0289 mmol 
Pd, 0.1 equiv) in MeOH (1.5 mL). A H2 balloon was attached to 
the reaction vessel, and the reaction was stirred at 25 °C for 12 h.39  Solid NaHCO3 (30 
mg, 0.360 mmol, 1.2 equiv) was added, and the reaction mixture was then filtered 
through glass wool and concentrated. The crude product was taken up in CH2Cl2, filtered 
through Celite, and concentrated to yield 46 as a tan crystalline solid (56 mg, 100% yield, 
mp = 123–128 °C). 1H NMR (500 MHz, CD3OD): δ 7.18 (d, J = 7.8 Hz, 1H), 6.95–6.93 
(multiple peaks, 2H), 4.56 (q, J = 7.0 Hz, 1H), 1.63 (d, J = 7.0 Hz, 3H), 1.29 (s, 9H). 
Exchangeable protons (OH and NH2) are not observed. 13C{1H} NMR (CD3OD): δ 
156.04, 155.06, 128.09, 122.22, 118.01, 113.80, 48.70, 35.44, 31.62, 18.92. IR (KBr): 
3229, 3034, 2964 cm-1. HRMS electrospray (m/z): [M+H]+ calcd for C12H20NO 
194.1545; found, 194.1544. 
 
Alcohol 47.  Ketone 44 (42.7 mg, 0.222 mmol, 1 equiv) and 










(340 µL) at 25 °C for 3.5 h.40  The reaction mixture was concentrated by rotary 
evaporation, and the crude residue was taken up in Et2O (2.5 mL) and washed with 2 M 
HCl (400 µL).  The aqueous layer was extracted with Et2O (5 x 500 µL). The combined 
organic layers were washed with water (2 x 500 µL), dried over MgSO4, and 
concentrated to afford 47 as a pale yellow wax (38.6 mg, 90% yield). 1H NMR (500 
MHz, CD3OD): δ 7.17 (d, J = 8.0 Hz, 1H), 6.85 (dd, J = 8.0, 2 Hz, 1H), 6.80 (d, J = 2 Hz, 
1H), 5.09 (q, J = 6.5 Hz, 1H), 1.42 (d, J = 6.5 Hz, 3H), 1.27 (s, 9H). Exchangeable 
protons (OH) are not observed. 13C{1H} NMR (CD3OD): δ 155.04, 152.35, 129.85, 
126.49, 117.43, 113.47, 67.03, 35.16, 31.78, 24.11. IR (KBr): 3417, 2965, 2904, 2868 
cm-1.  HRMS electron impact (m/z): [M]+ calcd for C12H18O2, 194.1307; found, 
194.1311. 
 
Acetyl Oxime 48. Oxime 25 (500 mg, 3.35 mmol) was stirred at 
room temperature in AcOH/Ac2O (1:1, 7.2 mL) for 3 h. The 
reaction mixture was diluted with EtOAc (50 mL) and quenched 
with aqueous NaHCO3. The organic layer was washed with brine 
(10 mL), dried over MgSO4, and concentrated to yield 48 as a white crystalline solid (635 
mg, 99% yield, mp 41–43 °C). 1H NMR (400 MHz, CDCl3): δ 7.58 (m, 1H), 7.51 (m, 
1H), 7.31–7.24 (multiple peaks, 2H), 2.38 (s, 3H), 2.37 (s, 3H), 2.27 (s, 3H). 13C{1H} 
NMR (CDCl3): δ 168.85, 162.57, 128.19, 134.69, 131.25, 128.34, 127.42, 124.08, 21.27, 
19.74, 14.38. HRMS electrospray (m/z): [M+Na]+ calcd for NaC11H13NO2 214.0844; 
found, 214.0844. 
 
Acetyl Oxime 50. Oxime 23 (1.00 g, 4.67 mmol) was stirred at 
room temperature in AcOH/Ac2O (1:1, 10 mL) for 3 h. The reaction 
mixture was diluted with EtOAc (65 mL) and quenched with 
aqueous NaHCO3. The organic layer was washed with brine (1 x 25 
mL), dried over MgSO4, and concentrated to yield 50 as a white crystalline solid (1.18 g, 
99% yield, mp 31–34 °C). 1H NMR (500 MHz, CDCl3): δ 7.89 (t, J = 2 Hz, 1H), 7.67 
(ddd, J = 7.8, 2, 1.0 Hz, 1H), 7.57 (ddd, J = 7.8, 2, 1.0 Hz, 1H), 7.28 (t, J = 7.8 Hz, 1H), 






130.03, 129.87, 125.54, 122.69, 19.72, 14.29. IR (KBr): 3068, 1769 cm-1. HRMS 
electrospray (m/z): [M+Na]+ calcd for NaC10H10BrNO2, 277.9793; found, 277.9784. 
 
Iodinated Product 49.  Acetyl oxime 48 (100 mg, 0.523 mmol, 1 
equiv), N-iodosuccinimide (235 mg, 1.046 mmol, 2 equiv), 
Pd(OAc)2 (5.9 mg, 0.0261 mmol, 5 mol %), AcOH (8 mL), and 
Ac2O (2.8 mL) were combined in a 20 mL scintillation vial, and the 
vial was sealed with a Teflon-lined cap. The reaction was heated to 110 °C for 12 h. The 
resulting mixture was filtered through glass wool and concentrated to give the crude 
product, which was purified by chromatography on silica gel to yield iodinated product 
49 as a pale yellow oil consisting of a single oxime isomer (77 mg, 46% yield, Rf = 0.19 
in 90% hexanes/10% EtOAc). 1H NMR (400 MHz, CDCl3): δ 7.71 (d, J = 8.0 Hz, 1H), 
7.10 (d, J = 1.8 Hz, 1H), 6.91 (m, 1H), 2.34 (s, 3H), 2.30 (s, 3H), 2.26 (s, 3H). 13C{1H} 
NMR (CDCl3): δ 168.70, 166.37, 140.87, 139.28, 138.40, 131.60, 130.42, 90.72, 20.78, 
19.79, 18.41. IR (thin film): 2923, 1762 cm-1.  HRMS electrospray (m/z): [M+Na]+ calcd 
for NaC11H12INO2, 339.9811; found, 339.9800. 
 
Chlorinated Product 51. Acetyl oxime 50 (105 mg, 0.410 mmol, 1 
equiv), N-chlorosuccinimide (104 mg, 0.820 mmol, 2 equiv), 
Pd(OAc)2 (4.6 mg, 0.0205 mmol, 5 mol %), AcOH (8.0 mL), and 
Ac2O (3.0 mL) were combined in a 20 mL scintillation vial, and the 
vial was sealed with a Teflon-lined cap. The reaction was heated to 100 °C for 22 h. The 
resulting mixture was filtered through glass wool, diluted with EtOAc (30 mL), and 
washed several times with saturated NaHCO3, until the aqueous solution was no longer 
acidic.  The organic layer was then washed with brine, dried over MgSO4, and 
concentrated to give the crude material, which was purified by chromatography on silica 
gel to yield chlorinated product 51 as a pale yellow solid consisting of an ~3:1 mixture of 
major:minor oxime E/Z isomers (85 mg, 71% yield, Rf = 0.36, 0.30 in 84% 
hexanes/16%EtOAc, mp of major isomer = 80–83 °C). The minor isomer was assigned as 
a stereoisomer (not a regioisomer) by analysis of the splitting pattern in the aromatic 








= 2.4 Hz, 1H), 7.47 (dd, J = 8.5, 2.4 Hz, 1H), 7.28 (d, J = 8.5 Hz, 1H), 2.36 (s, 3H), 2.26 
(s, 3H). 13C{1H} NMR (CDCl3): δ 168.24, 162.70, 136.80, 133.66, 133.04, 131.49, 
131.36, 120.59, 19.61, 17.65.  Minor Isomer: 1H NMR (500 MHz, CDCl3): δ 7.46 (dd, J 
= 8.6, 2.4 Hz, 1H), 7.31 (d, J = 8.6 Hz, 1H), 7.25 (d, J = 2.4 Hz, 1H), 2.33 (s, 3H), 2.00 
(s, 3H).  13C{1H} NMR (CDCl3): δ 168.05, 160.39, 136.00, 133.152, 131.12, 129.95, 
129.42, 120.44, 21.37, 19.36. IR (thin film, major isomer): 2936, 1783, 1768 cm-1.  
HRMS electrospray (m/z): [M+Na]+ calcd for NaC10H9ClNO2 (major isomer) 311.9403; 
found, 311.9397. 
 
Rearranged Acetanilide 55.  Acetyl oxime 50 (200 mg, 0.754 
mmol, 1 equiv), AgOAc (138 mg, 0.829 mmol, 1.1 equiv), 
Pd(OAc)2 (8.5 mg, 0.038 mmol, 0.05 equiv), iodobenzene (227 µL, 
2.037 mmol, 2.7 equiv), and trifluoroacetic acid (750 µL) were 
combined in a 4 mL scintillation vial, and the vial was sealed with a Teflon-lined cap.24  
The reaction was heated to 100 °C for 6 h, then concentrated. The resulting crude 
reaction mixture was purified by column chromatography to yield 55 as a pale yellow 
solid (111.7 mg, 51% yield, Rf = 0.29 in 70% hexanes/30% EtOAc, mp = 111–114 °C). 
Compound 55 was also prepared from N-(3-bromophenyl)acetamide using the same 
arylating conditions to confirm the identity of 55. 24 1H NMR (500 MHz, CDCl3): δ 8.55 
(br s, 1H), 7.50 (t, J = 7.5 Hz, 2H), 7.44 (m, 1H), 7.35–7.29 (multiple peaks, 3H), 7.10 
(m, 2H), 2.02 (s, 3H). 13C{1H} NMR (CDCl3): δ 168.10, 137.08, 135.86, 131.15, 130.58, 
129.29, 129.06, 128.36, 127.21, 124.00, 122.09, 24.62. IR (KBr): 3262, 3027, 2796, 1658 
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